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1 Abstract 
 
Mammalian skin is a highly-specialised organ, providing a robust barrier against 
environmental challenges. In order to maintain functional integrity and a healthy state, 
the skin’s constituent tissues undergo continuous renewal, controlled by finely-
controlled homeostatic mechanisms. Skin disease is incredibly common, ranging from 
debilitating (but not life threatening) disorders such as acne or eczema to increasingly 
aggressive, pernicious disorders like psoriasis, through to neoplasms such as carcinomas 
and melanoma.  Importantly, the skin may present manifestations of systemic disease 
such as in diabetes, obesity, cardiovascular diseases (CVD) and metabolic syndrome 
(Azfar and Gelfand, 2008, Van Hattem et al., 2008, Nawale et al., 2006). Such 
cutaneous alterations could be the first signs of the disease, and may precede diagnosis 
by many years.  
 
The integrity of the skin degrades with age, and numerous metabolic disorders lead to 
pathological conditions that exacerbate this process (Nikolakis et al., 2013). For 
example, the vast majority of individuals suffering from type 2 diabetes will experience 
skin complications during the natural history of their disease, especially with years of 
poorly- controlled plasma glucose (Romano et al., 1998, Levy and Zeichner, 2012). 
Problems range from the sub-clinical, such as neuropathy, chronic inflammation micro- 
and macrovascular damage and collagen disorganisation, which lead to potentially 
catastrophic events such as delayed wound healing, ulceration, infection and gangrene. 
Proactive control of the glycaemic state may prevent or delay many of these associated 
complications, but it may not reverse pathological changes once established. 
 
Obesity and related risk factors in humans are associated with increased fat deposition, 
with many studies documenting the abnormal structure and function of dermal adipose 
tissue. Impaired fibroblasts function may contribute to many dermatological changes, 
such as the loss of dermis or fibrosis, via mechanisms  related to insulin signalling 
(Rivera-Gonzalez et al., 2014). However, the dysfunction of dermal adipocyte which is 
characterised by adipocyte hyperplasia and hypertrophy, hypoxia, elevated 
inflammation, and adipokines signalling are now emerging as a potential mediator of 
insulin-resistance (Klöting and Blüher, 2014). Thus it is possible that the chronic 
exposure of fibroblasts to adipokines underlies their impaired function.  
vi 
 
Although many reports describe the use of mouse skin to reveal insights into aspects of 
human disease pathology and aetiology, it remains a challenge to find a standard 
protocol that can create optimal sections, retaining the intrinsic structure of mouse skin 
effectively, and researchers tend to use human skin histology protocols. This is not 
necessarily acceptable when one considers the anatomical differences between human 
and mice (Treuting and Dintzis, 2011). Mouse skin is thinner and more fragile than 
human skin, and so loss of architecture during processing has implications for 
downstream applications. Obtaining good histology from diabetic mouse skin, and 
maintaining subcutaneous adipocytes architecture and the discrimination of components 
such as fine elastic fibres, present a considerable challenge. Therefore, great care must 
be taken when selecting the conditions, particularly fixative type, to ensure that 
meaningful conclusions may be drawn (Al-Habian et al., 2014). The skin sections from 
mouse models used in chapter 3 were prepared using best practice at the time for a 
retrospective study, but I was able to better histology at the cost of time and materials in 
sectioning and staining by using tissue macroarrays techniques. Thus, for prospective 
analysis of mouse skin histology I revised some histology methods. By evaluating the 
processing protocol and then four commonly used fixatives I enhanced IHC, and 
histomorphological analysis of normal mouse skin. Moreover, these histopathology 
techniques are applicable to different mouse tissues, and I recommend using these 
findings as a guideline not only for diabetic mouse skin histology but for many tissues 
derived from a variety of species.  
 
The dermatologic sequelae of type 2 diabetes mellitus are manifold. Murine models of 
insulin resistance are useful in elucidating molecular mechanisms of impaired wound 
healing, but little is known of other pathophysiological changes in these models. A 
variety of histological and in vitro techniques were used in this thesis to study skin 
organisation in environmental (diet-induced obesity) and genetic (C57BL/6 
Lepob/Lepob and C57BLKS/J Leprdb/Leprdb) models of insulin resistance, type 2 
diabetes mellitus, and in chronological age. An expanded subcutis was accompanied by 
progressive dermal erosion in which the papillary dermis was spared at the expense of 
the deeper reticular layer as insulin resistance increased. Elastosis was also observed in 
our models, but damage was not accompanied by an increase in immune infiltration, nor 
an increase in advanced glycation end products. Altered epidermal differentiation was 
associated only with the most extreme obese phenotype. 
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 Moreover, compromised fibroblast function was maintained in vitro, with C57BL/6 
Lepob/Lepob cells displaying compromised growth and reduced collagen synthesis. 
While mouse skin does not necessarily model the range of cutaneous sequelae observed 
in human diabetic subjects, it is likely that underlying cellular mechanisms are shared. 
An improved understanding of the contribution of the layers of the skin, particularly the 
dermis during insulin resistance, and ageing and its pathological processes may provide 
new insights into the mitigation of damage. While impaired insulin signalling in skin is 
associated with disrupted skin homeostasis, and extra cellular matrix remodelling in 
ageing and type 2 diabetes mellitus (Nikolakis et al., 2013), a recent study has linked 
these changes to dermal fibroblast , and adipocyte dysfunction (Rivera-Gonzalez et al., 
2014). Interestingly, our observation showed that both aged and Lepob/Lepob murine 
fibroblasts show lowered insulin receptor expression suggesting that this will be a 
fruitful area for future investigation for improving insulin sensitivity and glucose 
utilisation in the dermal layers could have important consequences for cutaneous health.  
 
 This thesis reports a specific pattern of cutaneous damage that is initiated before the 
onset of frank diabetes and is exacerbated with increasing insulin resistance. This work 
provides a new insight into the consequences of metabolic disease on skin structure. 
Finally, further insights into how dermal damage in genetically modified and 
environmentally adapted diabetic mouse models and vice versa are likely to subserve in 
detecting early signs of cutaneous insulin resistance and may likely offer better 
approaches to prevent or at least cure the dermatological sequelae of type 2 diabetes 
mellitus. 
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2 Abbreviations 
 
α-ASMA α-Smooth Muscle antibody 
1ºAb First antibodies  
2ºAb  Secondary antibodies  
ACM Adipose conditioned medium  
AF Alcoholic formalin  
AR Antigen retrieval  
AT Adipose tissue 
CD31 Cluster of differentiation 31  
CD68 Cluster of differentiation 68 
DEJ Dermal-Epidermal Junction 
DIO Diet induced obesity   
ECM Extra cellular matrix 
EGF Epidermal growth factor  
EtOH Ethanol  
FITC Fluorescein isothiocyanate  
G & O Giemsa and orcein 
GMCSF Granulocyte macrophage colony-stimulatory factor 
H&E Haematoxylin and eosin 
HIF1-α Hypoxia-inducible factor 1-alpha 
IFN Interferon 
IHC  ImmunoHistoChemistry  
IL Interleukins 
K14 Keratin 14 
MCP1 Macrophage chemo-attractant protein 
MKC Mouse keratinocyte-derived cytokine  
MT Masson Trichrome 
NBF Neutral buffered formalin 
PAS Periodic acid Schiff 
PBS-T Phosphate buffered saline with tween 
PCNA Anti-proliferating Cell Nuclear Antigen 
PDGF Platelet derived growth factor  
 PS Picrosirius red 
RAGE Receptor for advanced glycation end products 
 RANTEs 
Regulated on activation, normal T cell expressed and secreted). 
ROS  Reactive oxygen species 
 RT Room temperature  
SAT Subcutaneous adipose tissue- 
SC Sub Cutaneous or subcutis  
TGF Transforming growth factor (TGF) 
TIMP-1  Tissue inhibitors of metalloproteinases -1 
TMA Tissue macro arrays 
TNF- Tumour necrosis factor - α 
TRITC Tetramethylrhodamine isothiocyanate 
VEGF Vascular endothelial growth factor 
WAT White adipose tissue 
Wt Wild-type  
ZnF zinc formalin  
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1 Chapter 1: Introduction 
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1.1 The skin in health and disease 
Mammalian skin is comprised of three main layers; the outer epidermis, the dermis, and 
the deeper hypodermis, (Figure 1.1 and 1.2A). The skin contains a number of epithelial-
derived structures, including sweat and sebaceous glands, and hair follicles, and is 
highly innervated and vascularised (Kanitakis, 2002). Moreover, the skin forms the 
integumentary system comprised of diverse tissue types. It is the largest mammalian 
organ, with many physiological, immunological and mechanical functions including, 
synthesis of vitamin D3, prevention of water loss, protection against the harmful effects 
of UV radiation, sensation, temperature control and immunological surveillance It also 
makes a significant contribution to whole-body homeostasis (Machens et al., 2013), as 
well as having an important psychological and social role (Taylor et al., 1997). 
Therefore, an understanding of the sophisticated interplay of factors that maintain and 
repair the skin’s integrity and function is essential if one is to gain meaningful insights 
into cutaneous physiology in health and disease.  
 
Recent technological advances have revolutionised skin research, for example 
immunohistochemistry (IHC), confocal and electron microscopy, as well as molecular 
biology have yielded insights of both clinical and cosmetic relevance (Varghese et al., 
2013). Not only has this led to a deeper understanding of cutaneous structure and 
function, but has also facilitated a more profound understanding of pathogenic 
mechanisms, with implications for the diagnosis and future treatment of dermatological 
diseases. It is useful to consider the individual structures of the layers of the skin, and 
these are described in the following sections. 
 
1.2 The epidermis 
The epidermis plays a vital role as it forms an external barrier with the environment, 
coordinating the inward\outward passage of water and electrolytes, controlling the loss 
of essential body fluids, limiting the penetration of toxic substances and preventing 
harmful effects of the sun and radiation (Cork et al., 2009). Microscopically, the 
epidermis consists of four distinct layers: the basal, spinous, granular and horny or 
cornified layers (as seen in Figure 1.2 B). It is separated from the underlying papillary 
dermis by a basement membrane (Ghadially, 2012). 
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The epidermis is comprised primarily of keratinocytes, and is in a constant state of self-
renewal. Transit-amplifying cells progress from the basal epidermal layer to the surface, 
accompanied by a highly-regulated process of differentiation to create a new outer 
cornified layer every 28 to 30 days (Archer, 2004). This is associated with the 
production and assembly of a range intermediate filaments to produce a resilient barrier 
(Simon and Green, 1984). The epidermis is also populated by various migratory cell 
types that include pigmented melanocytes, dendritic Langerhans cells and sensory 
Merkel cells (described below). It remains, to an extent, enigmatic precisely how these 
cells proliferate, stratify and differentiate into such an organised tissue, but a complex 
network of cytokines are central to this process. Cytokines are also involved in 
mediating the inflammatory and immune responses in the skin (Ansel et al., 1990). 
 
Figure 1-1 Overview of skin organisation. 
 Adapted from (Wang and Sanders, 2005). 
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Whist a number of cell types in the epidermis are capable of secreting cytokines 
including Langerhans cells, melanocytes and Merkel cells (Wilhelm et al., 2010), 
keratinocytes are the major source of cytokines in the epidermis. These include 
interleukins (IL) -1, 6, 8, tumour necrosis factor (TNF)-α, transforming growth factor 
(TGF) -α and -β, fibroblast growth factor (FGF), epidermal growth factor (EGF), 
platelet derived growth factor (PDGF), interferon (IFN) -α and -γ, and granulocyte 
macrophage colony- stimulatory factor (GM-CSF) (Shiraki et al., 2006). The individual 
layers are described below. 
  
 
 
Figure 1-2 Haematoxylin and Eosin stained sections of human skin. 
Images are shown at 20x original magnification (A), and at 50x original magnification (B) to highlight the 
epidermal layers.  
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1.2.1 The basal layer (or stratum basale) 
This is the deepest layer of the epidermis, and forms a single layer of cells in normal 
mammalian skin, although this may increase in hyper-proliferative conditions (Lippens 
et al., 2000). Cells comprising this layer are relatively small, with a dense cytoplasm 
and nuclei (as seen in Figure 1.3). Compartmental integrity and cell-cell communication 
in the stratum basale are provided by desmosomes, while the basal cells are attached to 
the basement membrane and dermal extracellular matrix (ECM) via hemi-desmosomes 
(McMillan and Shimizu, 2001). 
 
 
 
Figure 1-3 The layers of the epidermis.  
Adapted from the University of New South Wales Embryology Web (embryology.med.unsw.edu.au). 
 
The basal layer also harbours a population of stem cells that divide to form transit-
amplifying cells with a limited proliferative capacity (Balaji et al., 2010). The 
maintenance of balance between proliferation and differentiation is critical to a 
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functional epidermal barrier, along with the maintenance of effective cell-cell contacts. 
For example, disorders such as epidermolysis bullosa sequela, degradation of collagen 
type VII, result in a failure to attach to the basement membrane causing severe 
blistering (Chen et al., 1997). The cytoskeleton of basal cells is characterised by the 
presence of keratins 5 and 14 (Haake et al., 2001). 
1.2.2 The spinous layer (the stratum spinosum) 
Above the basal layer is the spinous layer, which is generally 5-10 cell layers deep, with 
cells attached by desmosomes, as a consequence of the spiny extensions that appear to 
connect these cells in histological sections, it is called also called the ‘prickle-layer’. 
The profile of intermediate filament expression is distinct with a progressive decrease in 
keratins K5 and K14, and an increase in keratins such as K1 and K10 (Wikramanayake 
et al., 2014). 
1.2.3 The granular layer 
The granular layer is 3-5 cells thick deep, and keratinocytes of this layer are 
characterised by intracellular granules of keratohyalin (irregular, amorphous granules 
filled with profilaggrin critical to the keratinization process in its cleaved form). 
Expression of proteins such as involucrin and loricrin, which are components of 
cornified envelopes are detectable in this layer. These cells are progressively 
characterized by a flattened shape and begin to lose their nuclei as they transit upwards. 
In addition to profilaggrin, the granules in this layer contain many compounds such as 
carbohydrates, various proteins, free sterols, lipids and hydrolytic enzymes. Basal 
phospholipids are gradually replaced by ceramides, which are the most abundant lipids 
in the outer layers, and play a crucial role in epidermal barrier function (Das et al., 
2009). Pathological processes that disrupt to this layer can result from viral infection or 
chemical irritation (Baden et al., 1974) (Fernandez-Flores, 2009). 
1.2.4 The clear layer (stratum lucidum) 
This layer is most apparent in thick skin and is named after its translucent appearance, 
presenting a thin layer of flattened, non-nucleated eosinophilic cells containing densely 
packed cytoplasmic keratin filaments (Walli, 2009). 
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1.2.5 The horny layer (stratum corneum) 
The stratum corneum is the outmost layer of the epidermis and is composed of 15-20 
cell layers of corneocytes, which are terminally-differentiated keratinocytes. The upper 
layers are comprised of completely anucleate, keratinized cells, creating what is often 
referred to as the horny layer, the outer cells of which are eventually shed by the 
desquamation process. Under the electronic microscope, dead keratinocytes in the 
cornified layer appear to be filled with keratin filaments that are lined with a marginal 
band (the cornified cell envelope) (Burns et al., 2010). The main compounds of the 
cornified envelope are the proteins involucrin and loricrin, which are cross-linked by 
transglutaminase enzymes and filaggrin that promotes the condensation of  intermediate 
filaments (Jain, 2012). The cornified cell envelope serves as a peripheral, resilient 
barrier against physicochemical factors and water loss from the body (Ghadially et al., 
1995a). 
1.3 Other cells of the epidermis 
While 95% of the cells of the epidermis are keratinocytes, they also interact with 
migratory cells such as melanocytes, Langerhans cells and Merkel cells. These cells all 
play a fundamental role in orchestrating skin physiology as described below. 
1.3.1 Melanocytes 
Melanocytes originate from the neural crest (ectoderm)-derived dendritic cells, and are 
found randomly dispersed in the basal layer. Melanocytes produce the pigment melanin 
(Sturm et al., 1998). Under light microscopy with routine H&E staining (Figure 1.4.A 
arrow), melanocytes have small, dark nuclei and clear cytoplasm (Droste, 2007). 
Depending on the location of the melanocytes (for example interfollicular epidermis, 
hair or iris), pigmentation may vary from black to brown to yellow (Burns et al., 2010). 
Melanin is delivered to the growing hair shaft, and to adjacent interfollicular 
keratinocytes by mature melanosomes, and this aggregates to form an umbrella-like 
shape conferring protection from UV rays by the absorption and scattering of incident 
light, as well as by scavenging reactive oxygen species (Solano, 2014). Recently, 
melanocytes have emerging as active players, like keratinocytes, in cutaneous immune 
responses, due to their synthesis and sensitivity to a variety of cytokines (Plonka et al., 
2009).  
1.3.2 Merkel cells 
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Merkel cells are located in the basal layer, hair follicles and sweat ducts, with greater 
numbers in the fingers and oral mucosa (Burns et al., 2013). They are rarely visible 
under light microscopy, rather identification requires electron microscopy and 
immunostaining. Their full functions have not yet been elucidated in human skin, but 
there is growing evidence that they act as touch receptors, providing tactile information 
to the sensory nerves via neurotransmitter secretion after physical stimulation 
(Maksimovic et al., 2014).  
1.3.3 Langerhans cells 
Langerhans cells (LCs) are dendritic cells derived from bone marrow precursors that 
serve as antigen presenting cells (APCs). LCs are integral to immune surveillance in the 
skin due to their ability to initiate an immune response through antigen uptake, 
processing, migration and presentation to T cells (Bodey et al., 2004). Functionally, LCs 
are primarily responsible for capturing pathogenic factors that the skin encounters, and 
so provide a primary defence against infection. Ultra-structurally, LCs are migratory 
dendritic cells without tonofilaments, and cell attachment structures such as 
desmosomes, and are characterised by antigen containing tennis racquet shaped Birbeck 
granules (Shimizu, 2007). 
1.3.4 The basement membrane or dermal-epidermal junction  
The boundary between the epidermis and the dermis consists of a special aggregation of 
attachment molecules collectively known as dermal-epidermal junction (DEJ) or BM 
(basement membrane) zone (Rook et al., 1986). It serves as an important physical 
interface between the epidermis and the dermis, enhanced by a partial penetration of the 
BM into the papillary dermis via irregular finger-like projections known as the rete-
ridges (Terstappen, 2008). These cone-shaped structures help in increasing the surface 
area of the epidermis, vasculature and lymphatics of the upper part of the dermis, and 
play a crucial role in controlling the exchange rate of nutrients and cell migration 
(Terstappen, 2008). 
 
Interestingly, as a person ages, the convoluted rete-ridges of the DEJ flatten out, 
resulting in reduced contact with the dermal vasculature network, and a reduction in 
exchange of material. However, these changes not only take place in age but also in 
diseases such as diabetes where rete-ridges compromised, either by flattening or by 
extension deeper into the dermis. Other disorders, such as lentigo,  impact the integrity 
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of the DEJ (Farage et al., 2009). DEJ cannot be observed using routine H&E staining 
(Figure 1.4.A) but rather with special staining protocols such as periodic acid Schiff 
(PAS) staining which interacts with glyco- proteins and mucopolysaccharides to reveal 
the DEJ as a thin purple band (Figure.1.4.B). 
 
1.4  The dermis 
The dermis is, by mass, the largest component of the skin in lean individuals. It varies in 
thickness from 5mm on the back to 1mm on the eyelids in man (James et al., 2011). The 
dermis consists primarily of an extracellular matrix comprised of unbranched collagens 
arranged in a basket-weave conformation, elastic fibres and “ground substance” (mainly 
glycosaminoglycans such as hyaluronan. The ECM is populated by dermal fibroblasts, 
and  highly vascularised but, unlike the epidermis, this tissue is innervated and host to 
migratory cells of the immune system, notably mast cells, dendritic cells, macrophages, 
lymphocytes, eosinophils and plasma cells (Burns et al., 2010). It also is likely to host a 
variety of stem cells (McGrath et al., 2010). The mammalian dermis is organized into a 
thinner upper papillary layer comprised of fine fibres (Figure 1.5A), and a thicker lower 
reticular layer comprised of coarser fibres (Figure1.5 B). The superficial papillary 
dermis forms an uneven junction with the epidermis, and is mainly composed of fine 
 
Figure 1-4 Comparison between human skin sections stained with PAS and H&E to identify 
the DEJ. 
With H&E staining, the DEJ cannot be discerned (A). The arrow identifies the DEJ in part as shown 
in B.  Both images were captured at 20x original magnification.  
 
10 
 
type III collagen and elastic fibres, with abundant capillaries to nourish not only the 
dermis, but also the epidermis. Type III fibres also characterise adnexal dermis (Rook et 
al., 1986). The deeper reticular dermis is comprised of thicker, predominantly type I 
collagen fibres and contains larger blood vessels (Ghosh et al., 1997). 
 
Figure 1-5 Human dermis stained with H&E.  
Dermal layers; arrow A shows the papillary layer (with thin collagen fibres) and arrow B the 
reticular layer (with thicker collagen fibre). Original image captured at 40x magnification. 
 
 This compartment is in contact with the subcutaneous fat layer (the hypodermis), with 
slightly lower cellularity than the papillary layer. The dermis has many functions 
including: 1) interaction with epidermal cells to promote the development and 
maintenance of the epidermis and its appendages (which are supported within the 
dermis); 2) protection of internal organs from mechanical injury; 3) thermoregulation 
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and regulation of water retention (Reddi et al., 2012); and 4) supporting dermal 
fibroblasts and facilitating tissue repair and renewal (2007, Burns et al., 2010). The key 
dermal components are discussed in more depth below. 
1.4.1 Dermal fibroblasts  
Dermal fibroblasts produce the collagens that provide tensile strength (and constitute 
the majority of the dermis), elastins that provide elasticity and proteoglycan molecules 
that provide viscosity and retain water (Orgel et al., 2011). Dermal fibroblasts are 
involved in a variety of physiological processes including cytokine secretion and 
responses (including pro-inflammatory mediators), and the turn-over of structural 
components of the ECM (Sherwood and Toliver-Kinsky, 2004) (Clark et al., 2007). 
These functions vary according to location, for example, isolated papillary fibroblasts 
have a higher capacity to produce collagen type III and fibronectin than reticular dermal 
fibroblasts, and are smaller and proliferate at a higher rate (Sorrell and Caplan, 2004a) 
(Wang et al., 2008).  
 
In healthy skin, fibroblasts appear as thin spindle shaped cells arranged along collagen 
fibres, as observed with H&E staining (Figure.1.5.A arrow). With advanced maturation, 
mature fibroblasts nuclei shrink and have reduced endoplasmic reticulum.  
 
Fibroblasts have the capacity to differentiate into myofibroblasts, smooth muscle cells, 
chondrocytes, and osteoclasts, as demonstrated in developing or regenerating tissues 
(Lei et al., 2014). For example, under in certain chronic stimuli or disorders associated 
with hypertrophic scaring (resulting in the creation of fibrotic plaques), myofibroblasts 
are characterized by expression of α-SMA (alpha smooth muscle actin) (Wang et al., 
2008). Figure1.6.A shows the immunodetection of α-SMA actin in a fibrotic plaque 
from a sample of irradiated human breast skin. Microscopically, with picrosirius 
staining, a fibrotic plaque can be observed under bright field microscopy (Figure.1.6.B). 
In contrast, under crossed-polar microscopy the plaque lacks the birefringement 
property of healthy collagen due to the loss of regular structure, and appears as a dark 
area (Nong et al., 2011) (Figure.1.6.C).  
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Figure 1-6 Fibrotic plaque 
Immunofluorescent detection of SMA expression (A); picrosirius staining viewed under bright-field 
(B); and (C) picrosirius staining viewed under crossed-polar microscopy. Images were captured at 20x 
original magnification. 
1.4.2 Collagen 
Collagen is the major component of the integument, accounting for 75% of the dry 
weight of the skin (Hookerman, 2014). It provides strength and support, with tensile 
strength being a function of collagen type and density. There are many types of collagen 
in the skin, and approximately 80-90% is type I (most commonly in reticular dermis), 8-
10% type III (most common in the papillary dermis) and around 5% is type V (Shimizu, 
2007). Skin collagen can be subdivided into fibrillar collagens (type I, II, III, V, and 
XI), non-fibrillar collagens (type IX, XI, XIV, and IV) and basement membrane 
collagen (type IV, VII, XVII). Procollagens are secreted by fibroblasts, which are 
processed and self-assembled into a triple helical structure, which results in three 
individual C-terminal peptides (Shimizu, 2007). This is followed by the intracellular 
ordering of helical binding between the C to the N termini of the three α chains via the 
modification of prolines within procollagen into hydroxyl-proline (which serves as 
stabilizing factor for the triple helix) (Boudko et al., 2002). In the extracellular space, 
the triple helices self-aggregate into irregular overlapping staggered fibres as seen in 
(Figure 1.7).  
 
Two kinds of helices exist. The first contains a triple–helical collagenous domain, 
consisting of uninterrupted GLY-X-Y repeated sequences, forming fibrillar collagens. 
The second type of helical chains are found in FACIT collagens (fibril-associated-
collagens with interrupted triple helices), which are non-fibrillar (Shimizu, 2007). 
 
Images viewed under light microscopy with Picrosirius staining (PS) do not reveal 
obvious collagen organization (Figure 1.6. A), while the birefringent properties of 
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highly regular collagen are revealed under polarized light, which readily allows 
assessment of collagen organisation (Figure.1.6. B) (Jones et al., 2002). A loss of  
organisation, particularly the basket-weave, is associated with many skin conditions and 
diseases such ageing, scarring, and type 2 diabetes (Osman et al., 2013a). Many 
histological stains are available to identify collagen organisation including Masson’s 
trichrome (Figure 1.8.B) and Herovici’s stain (Figure.1.8.A), the latter distinguishes 
young, newly formed collagen fibres which appear blue; from the mature, dense 
collagen fibres, which appear red, making this stain a very useful tool in the 
investigation of collagen synthesis and organisation (Collins et al., 2011b, Al-Habian et 
al., 2014). 
 
 
 
 
Figure 1-7 Schematic diagram of collagen synthesis. 
Synthesis begins with the translation of collagen pro-chains in the rough endoplasmic reticulum. After 
these chains form a triple helix, the molecule is secreted from the cell, where it undergoes further 
processing and aggregation into fibrils and fibres adapted from (McKleroy et al., 2013).
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 Figure 1-8 Human skin sections stained for connective tissues. 
Herovici’s stain (A) distinguishes young (blue) collagen fibres in the papillary dermis from mature (red) 
thick collagen fibres in the reticular dermis. Masson’s trichrome (B) shows the differential staining of thin 
collagen fibres (light blue) in comparison to thick collagen (dark blue). Images captured at 20x original 
magnification. 
1.4.3 Elastic fibres 
Elastin is a connective tissue protein with extremely good elastic properties, but it is not 
as strong as collagen. Elastin is the predominant protein in the walls of blood vessels, 
lymph vessels, lungs and the skin as well as the other extensible tissues such as tendons. 
The extraordinary elasticity is attributed to the “rubbery” and amorphous structure of 
elastin, allowing the elastin molecules to stretch and recoil when any deforming force is 
withdrawn (Mithieux and Weiss, 2005). The precursors of elastic fibres (like collagen 
fibres) are synthesized and secreted by dermal fibroblasts in the skin, chondroblasts in 
the elastic cartilage and smooth muscle cells in the vascular walls. After secretion, 
elastin molecules are assembled extracellularly to form fibrils and fibres (Burns et al., 
2010).  
 
Histological examination of mammalian skin sections does not reveal the presence of 
elastic fibres when stained with  H&E (Figure1.5). Elastin fibres can be observed after 
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staining with special stains such van Gieson (Lu et al., 2009) (Figure1.9.A) or with 
Giemsa and Orcein (Burns et al., 2010) (Figure1.9.B), where they appear as brownish 
black bundles (see Figure1.10 arrow), extending from the DEJ to the connective tissue 
of the subcutaneous fat layer (Kempf et al., 2008). 
 
 
Figure 1-9 Elastic fibre organization of human skin. 
Human skin section stained with van Gieson (A), and with Giemsa and Orcein (B). Elastic fibres appear 
as brownish black bundles scattered in the papillary (thin), and the reticular dermis (thicker) with both 
stains. Images captured at 20X original magnification. 
 
Elastic fibres distributed between collagen fibres have a convoluted appearance. In the 
normal dermis, the closer the elastic fibres are to the papillary layer the thinner they 
appear, orientated in a perpendicular plane relative to the skin surface (Figure1.10). 
Ultra-structural analysis reveals that fibrillar components may exist as isolated filaments 
(oxytalan) or randomly integrated with variable amounts of elastin (elunin). In the 
papillary dermis, oxytalan fibres are found in large numbers in the primitive stage and 
extend vertically from the lamina densa of the DEJ to the junction between the papillary 
and reticular dermis. Oxytalan fibres are also connected to the lamina densa of glands, 
sweat ducts, smooth muscles, nerves and blood vessels (Burns et al., 2010). At the 
papillary-reticular junction, oxytalan fibres merge horizontally to form more mature 
fibres called elunin fibres, which form the major components of elastic fibres in the 
reticular dermis and are less flexible than the fibres of the papillary (Robinson et al., 
2006). 
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Figure 1-10 Elastic fibre organisation of human skin stained with Giemsa and Orcein. 
Orcein stained elastic fibres appear as brownish black bundles (arrow), collagen as rose pink and nuclei as 
dark blue. Images were captured at 40x original magnification. 
 
1.4.4 Other cells in the dermis  
Beside the fibroblasts, the dermis also contains smooth muscle cells, axons and 
specialised nerve endings, pericytes, glomus cells, and mesenchymal stem cells. 
Furthermore, the dermis hosts various other cells including, mast cells, endothelial cells 
and variety of other hematopoietic cells such as macrophages, monocytes, lymphocytes, 
eosinophils, neutrophils and plasma cells (Rocken et al., 2012). Some of these cells are 
described  briefly below. 
 
1.4.4.1 Mast cells 
Mast cells are derived from bone marrow CD34+ stem cells, which under the influence 
of the ECM and other cellular factors, undergo a multistage differentiation process to 
become active mast cells in the connective tissues of the body at the interface of an 
organ and the environment (Chantrain et al., 2008). In the skin, mast cells are found 
mostly in papillary dermis near the DEJ and in the sheaths of epidermal appendages. 
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They are also harboured around the blood vessels and nerves in the sub-papillary 
plexus, and in subcutaneous tissues.   
 
Mast cells possess intra-cytoplasmic basophilic metachromatic granules containing 
mediators such as histamine, heparin, tryptase, chymase, carboxy-peptidase, and 
neutrophilic and eosinophilic cationic factors (Heib et al., 2008, Chugunova, 2004). 
They are identified under light microscope as spindle shaped cells with a round or oval 
nucleus and abundant cytoplasmic granules that do not stain with routine H&E stain. 
The cytoplasmic granules can be observed with colloidal iron, toluidine blue, methylene 
blue, and Giemsa and Orcein stains (Sams and Smith, 1961, Constantine, 1969). The 
mast cells population is elevated in many inflammatory dermatoses and they play a 
substantial role in the early phase of wound healing (Aroni et al., 2008). 
 
1.4.4.2 Dermal mesenchymal cells 
Dermal mesenchymal stem cells are anchored in the perifolicular connective tissue 
sheath and the papilla (Mercati et al., 2009). These cells have the capacity to 
differentiate into adipocytes, smooth muscle cells, osteocytes, chondrocytes, neurons, 
glia, hematopoietic cells of myeloid and erythroid lineages, and they are thought to be 
activated early in response to cutaneous injury (Brohem et al., 2013). 
 
1.4.4.3 Dermal dendrocytes, macrophages, lymphocytes and plasma cells  
Dermal dendrocytes, macrophages, lymphocytes and plasma cells exist only in small 
numbers in healthy skin, and most notably in the perivascular region. An increase in 
these cells characterises some pathogenic conditions (Bonamigo et al., 2011). 
1.5 The hypodermis   
The third layer of the skin is the hypodermis, also known as the subcutis (SC). The 
subcutaneous fat layer is found just beneath the dermis and is distinct from visceral fat, 
which is found within the peritoneal cavity. This layer is well vascularised and is 
primarily composed of adipocytes supported by a network of reticular fibres and 
connective tissues (Bennett, 2009). 
 
Excess energy in the body is stored in the form of triglyceride in the SC layer, which 
also serves as an insulating pad and a cushion resisting mechanical forces. In addition, 
SC adipocytes have a vital endocrine function as they secrete a variety of cytokines 
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(adipokines) such as leptin, which provides a feedback signal for the regulation of fat 
mass and appetite through signalling to the hypothalamus (Kelesidis et al., 2010, Baskin 
et al., 1999).  
 
The thickness of the SC layer varies considerably over the surface of the body, and also 
varies with age, sex, race, and endocrine and nutritional status (Bischof et al., 2013). 
The thickness of  the SC has been widely linked to glucose metabolism, energy 
homeostasis, insulin resistance, hypertension, atherosclerosis and cancer (Karastergiou 
and Mohamed-Ali, 2010). In addition to changes in physiological function of the fat 
layer, there are structural changes that occur under these conditions, for example, 
collagen type VI plays a crucial role in metabolic disorders and is associated with 
metabolic disease via ECM remodelling and inhibiting adipocyte hypertrophy (Divoux 
and Clement, 2011, Khan et al., 2009). 
1.6 Skin appendages 
The skin has several appendages and accessory structures that lie in the dermis and 
project onto the surface through the epidermis. These include hair, nails (the cornified 
appendages) and sebaceous and sweat glands (the glandular appendages). 
1.6.1 The hair 
The hair is an important appendage of the skin. It grows from a sac-like extension of the 
epidermis called a hair follicle. It may be divided longitudinally into the infundibulum 
(neck), the shaft (containing a bulge region) and the hair bulb (Figure 1.11). Horizontal 
sections reveal the outer cuticle, the cortex, and the medulla. Hair grows all over the 
body with the exception of the glabrous skin of the palms and the soles (Oshima et al., 
2001). More specifically, the hair follicle consists of many concentric cylinders of cell 
types, including the outer root sheath (ORS), the inner root sheath (IRS, compromised 
of Henley, Huxley and cuticle layers, and the innermost hair shaft (HS). The arrector 
pilus is a small smooth muscle containing numerous sensory fibres that enables the hair 
to stand erect in response to stimuli such as cold or emotions (Poblet et al., 2004). 
Pilosebaceous units include the sebaceous gland (described below). 
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Figure 1-11  Organization of the hair follicle. 
 A) H&E staining of a hair follicle in late catagen/telogen phase from mouse back skin. B) Schematic 
representation of the hair follicle and location of the stem cell compartments in the epidermis. AP, 
arrector pili; CCL, companion cell layer; DP, dermal papilla; HF, hair follicle; HS,hair shaft; IFE, 
interfollicular epidermis; Inf, infundibulum; IRS, inner root sheath; Ist, Isthmus; ORS, outer root sheath, 
SC,stem cells; SG, sebaceous gland; TACs, transit-amplifying cells. Modified from (Margadant et al., 
2010). 
1.6.2  Sweat glands 
Sweat glands are simple, highly coiled tubular glands located within the dermis over the 
majority of the body, and are divided into a coiled secretory region (located in the 
dermis), and an excretory duct that extends to the epidermis. Eccrine glands form a key 
part of the body’s thermoregulatory system and are innervated by sympathetic 
(cholinergic) nerve fibres (with an estimated population of 250,000 glands per human 
foot) found over the palms, soles, axillae and the forehead (Wood and Kelly, 2010). 
Apocrine glands are fewer in number and have relatively bigger ducts, which deposit 
their contents into the upper part of the hair follicle (the infundibulum).  
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1.6.3  Sebaceous glands 
Sebaceous glands are the third type of gland found in the dermis. They are derived from 
epidermal cells and have a close association with hair follicles, particularly those of the 
scalp, face, chest and back (Smith and Thiboutot, 2008). They produce an oily 
moisturizing sebum that contains various lipids, cholesterol esters, wax esters and 
triglycerides. Sebum, transits via the follicular canal to the skin surface and actively 
helps in maintaining epidermal barrier permeability, as well as having an acidic 
bactericidal function (with a pH of 4-6). Sebum may also offer protection from UV 
radiation and aid in the wound healing process (Makrantonaki et al., 2011). Peroxisome 
proliferator-activated receptors (PPARs) are well recognized as major players in lipid 
metabolism and adipogenesis. Furthermore, the agonists of PPARs (α, γ ,δ, and pan-
agonist) are potential drugs in dermatology via their effects on PPARs which are 
expressed in many cutaneous cellular elements (including keratinocytes (Mao-Qiang et 
al., 2004a), and fibroblasts (Ghosh et al., 2004b), and are much involved in many 
functions including epidermal growth and sebum production (Smith and Thiboutot, 
2008).  
1.6.4 Cutaneous vasculature 
The skin has an extensive blood supply comprising of a vascular network of distributing 
and collecting channels and horizontal plexi. These form a connected microcirculatory 
meshwork composed of arterioles, venules, and capillaries. Most of the microvascular 
structure is localised in the papillary dermis, while the arterioles and the venules form 
two plexi in the dermis (Braverman, 2000). Both networks are physiologically 
important as they are involved in thermoregulation by controlling the blood flow in 
capillaries of the upper dermis via dilation or constriction of their capillary loops. 
Another important contributor to thermoregulation are the arteriovenous anastomoses 
(AVA), which are found most abundantly in the dermis, close to the level of the sweat 
glands. These assist in regulating blood perfusion by shunting blood directly from the 
arterial to the venous system, bypassing the capillary network (Burns et al., 2010). 
 
Paralleling the blood supply of the skin is a lymphatic system that regulates interstitial 
fluids, as well as clearing the tissue of discarded proteins, lipids, microorganisms, cells 
and degraded materials from the extra-vascular components of the dermis. Lymphatic 
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vessels have a larger lumen and an more irregular shape in comparison to blood vessels, 
with a thinner endothelial vessel wall (Requena and Sangueza, 1997). The vasculature 
of the skin (the blood and lymphatic system) are implicated in many local and systemic 
disease such as atopic dermatitis, obesity, insulin resistance, and metabolic syndrome 
(Muris et al., 2013, Zgraggen et al., 2013). 
1.6.5 Innervation  
Many sensory nerves transmit tactile, pressure, pain and temperature sensations via free 
nerve endings, Merkel cells and structures such as Meissner corpuscles (located in the 
papillary dermis), and pacinian corpuscles (located in deep dermal and SC layer) 
(Shimizu, 2007). 
 
The autonomic nervous system supplies motor innervation via adrenergic fibres 
(sympathetic autonomic fibres distributed with sensory nerves in the dermis) until they 
branch (at which point they change from myelinated to non-myelinated fibres) to 
innervate vascular smooth muscle, the arrector pili muscle of the hair follicles, and 
apocrine glands, while the cholinergic fibres innervate eccrine sweat glands. The 
endocrine system regulates the sebaceous glands, which are not innervated by 
autonomic fibres (Gauglitz and Schauber, 2013). 
1.7 Obesity 
Obesity is a heterogeneous clinical disorder. It can be developed as the chronic 
imbalance between energy intake and expenditure, and encompass both environmental 
and genetic factors and their interactions and many other factors (Nguyen and El-Serag, 
2010). These factors might facilitate an excessive accumulation of fat as well as 
abnormal fat distribution (Despres, 2012). Obesity is thus considered as a medical 
condition not only characterized by the accumulation of excess body fat, but also by 
adverse effects on health (via its co-morbidities), leading to reduced life expectancy and 
increased health problems (according the World Health Organisation [WHO] report 
(Organization, 2009).  
 
Approximately 65% of the world's population live in countries where overweight and 
obesity kill more people than malnourishment (Nigro et al., 2014). The prevalence of 
obesity is increasing at an alarming rate and it is recognized as one of the most serious 
public health issues of the 21st Century (Barness et al., 2007). Studies indicate that 10-
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27% of men and up to 38% in women are obese in Europe (Cases, 2006). In the United 
Kingdom almost 30% of adults are currently classified as obese, while around 3 in ten 
children aged 2-5 years are either overweight or obese (Weight, Dunton, 2011). The 
obesity rates in the US population are dramatically increasing across different age 
groups, including older adults, and is expected to rise from 40.2 million to 88.5 million 
by 2050 (Fakhouri and Statistics, 2012).  
 
According to the WHO, there has been a 3-fold increase in the number of obese people 
in the last two decades globally. By 2015, 2.3 billion people will be overweight, and 
700 million people will be obese. Moreover, chronic metabolic disorders affect more 
than 500 million adults and 43 million children under the age of five worldwide 
(Bumaschny et al., 2012).  
 
The cumulative burden of the health care costs associated with the increasing 
prevalence of obesity is of particular concern (Lehnert et al., 2013). In the US it has 
been estimated that over 9.0% of annual medical expenditure relate to obesity, and in 
addition to the direct costs of treating obesity, the  related disorders such as type 2 
diabetes, hypertension, cardiovascular diseases and the other co-morbidities (listed in 
Table 1) account for 43% of the costs of health insurance (Kleinman et al., 2014). This 
is, therefore, an enormous problem of global reach. 
1.7.1 Health complications 
Table 1.1 summarises the most common diseases or disorders associated with obesity 
(adapted from (Cornier et al., 2011, Goran and Alderete, 2012a, Legro, 2012, Cameron 
et al., 2003, Boza et al., 2012). 
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                                          Disorders associated with obesity  
Insulin resistance Nutritional deficits 
Glucose intolerance and dyslipidaemia Cholecystitis 
Fatty liver disease Asthma & respiratory infections 
Hypertension Infertility 
Cardiovascular complications Increased risk of cancer 
Type 2 diabetes Depression and psychosocial problems 
Type 1 diabetes Early puberty 
Metabolic syndrome Orthopaedic alterations 
Eating disorders Lower pregnancy & live- birth rates 
Renal alterations & and hyperuricemia Obstructive sleep apnea (OSA) 
Dermatological complications Polycystic ovary syndrome 
Table 1-1 Obesity-associated disorders. 
Overweight and obese individuals are more prone to develop systemic inflammation, 
hypoxia, and hypo-perfusion, which may lead to multiple organ dysfunction syndrome. 
Many peripheral effects of systemic disease will necessarily be reflected in the skin, and 
obesity is known to exacerbate barrier damage, infection, (such as in intertrigo), 
pressure and diabetic ulcers, psoriasis, and delayed wound healing (Lowe, 2009).   
 
There are several parameters to measure overweight and obesity. The most common 
method is body mass index (BMI). The formula for BMI reflects a range of body weight 
indices and is derived by dividing an individual’s weight in kilograms by the square of 
their height in meters [weight (kg) / height (m
2
)] (Oka et al., 2013). Due to the broad 
range of body weights, the WHO classifies BMI into six categories as shown in Table 
1.2. 
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BMI Classification 
< 18.5 Underweight 
18.5–24.9 Normal weight 
25.0–29.9 Overweight 
30.0–34.9 Class I obesity 
35.0–39.9 Class II obesity 
≥ 40.0 Class III obesity 
 
Table 1-2 BMI classifications established by the WHO. 
 
There is, however, no strict cut-off from the physiological perspective and a sliding 
scale from a healthy BMI of 20, up to the morbidly obese >35 can be defined. This 
calculation for BMI is not accurate for children and adolescents if the impact of gender 
and physiological differences in body fat are not taken into account (Thompson et al., 
2012). BMI scales are remarkably dependant on age, gender and ethnic groups 
(Maxwell and Cole, 2012). Moreover, it is important to recognize that BMI alone is a 
rather crude indicator of overweight or obesity since it fails to measure the amount of 
body fat in certain groups of individuals. For example, athletes may have a BMI that 
identifies them as overweight even though they do not have excess body fat. However, 
in the majority of cases, an increased mass of adipose tissue combined with an increased 
body weight is observed in the obese state. For this reason, many studies have included 
one or more specific parameters of body composition such as: body fat percentage, lean 
tissue, bone and fluid mass, fat distribution (by measuring waist to hip ratio (WHR), 
visceral to subcutaneous fat tissue ratio (VSR) and waist circumference (WC) (Gorman, 
2011). Nevertheless, an assessment of adipose tissue only gives an approximate idea of 
general body fat distribution, and a more accurate measurement of these variables can 
be obtained by performing sophisticated analytical approaches such as bio-electrical 
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impedance, dual energy X-ray absorption (DEXA), computed tomography (CT), under 
water weighing and magnetic resonance imaging (MRI) (Bosello & Zamboni, 2000;Kuk 
et al., 2005; Gallagher et al., 2009, Bozzetto et al., 2010). 
1.7.2 Diabetes mellitus 
Diabetes mellitus DM is a serious endocrine disorder that is characterised by the 
disruption of intermediary metabolism when the pancreas does not produce enough 
insulin or when the body cannot effectively utilize the insulin produced, or both 
(Kolluru et al., 2012). Diabetes mellitus is commonly classified into types: type 1 
diabetes mellitus (Type 1 diabetes mellitus, or insulin-dependent diabetes mellitus, 
IDDM), and type 2 diabetes mellitus (Type 2 diabetes, or non- insulin dependent 
diabetes mellitus, NIDDM). Approximately 10% of diabetics have type 1 disease, and 
around 90%  have type 2 (Tuomilehto, 2013). Type 1 diabetes, was previously known 
as juvenile onset diabetes, as it predominantly occurs in children and adolescents. In this 
disorder, the pancreas does not produce sufficient insulin for blood glucose control due 
to an auto-immune destruction of pancreatic β-cells resulting in the inability to produce 
endogenous insulin. This type of diabetes can only be treated by life-long administration 
of regular insulin injections and careful monitoring of blood glucose concentration 
(Tchorsh-Yutsis et al., 2011). In contrast, type 2 diabetes is characterized by the 
inability of tissues to respond to normal levels of circulating insulin (Kolluru et al., 
2012). The successful treatment for type 2 diabetes can be achieved through various 
approaches, which range from consistent physical activity, diet control and taking 
insulin sensitising and/or  blood glucose suppressant medications  (Inzucchi et al., 
2012).  
 
 As the incidence of type 2 diabetes rises exponentially in the early part of the 21st 
Century, the global diabetes health care and financial burdens associated with this 
chronic disease was estimated to be $376 billion in 2010, and expected to rise to $490 
billion in 2030 (Zhang et al., 2010). Type 2 diabetes is a chronic disease that we can 
treat but not completely cure. According to current estimates, there are around 350 
million diabetics worldwide and the number is dramatically increasing (WHO, 2013 
factsheet) (Bernat-Karpinska and Piatkiewicz, 2014). In the United Kingdom, the 
estimated number of type 2 diabetics is in the order of 2.2 million, with a further 500 
thousand going undiagnosed (Information Centre Quality Outcomes Framework Data 
2005/06). This figure is expected to reach 5 million by 2025. In 2009, the prevalence of 
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diabetes was about 5.4% in the UK (Daultrey et al., 2011), and in the United States its 
prevalence was estimated at 7.8% in 2007 (according to The National Institute of 
Diabetes and Digestive and Kidney Diseases,) (Control et al., 2011). In Europe, 
according to the International Diabetes Federation (IDF) estimates, 55 million adults 
have diabetes mellitus((both type 1 and type. 2), predicted to rise to 66 million in 2030.  
1.7.3 Underlying mechanisms in type 2 diabetes mellitus 
Diabetes mellitus is a major contributor to morbidity and mortality in industrialized 
countries. Increasing urbanization, obesity, increased consumption of fructose corn 
syrup and other relatively cheap or junk foods, increasing economic impact on families, 
decreasing physical activity and genetic factors all contribute to the development of this 
disease (Hu, 2011). 
 
Insulin secretion in type 2 diabetes may ultimately be impaired as the pancreas becomes 
compromised following attempts to maintain glucose homeostasis by initially increasing 
insulin production, but at the outset impaired sensitivity to insulin-mediated glucose 
disposal (insulin resistance) is central to the disease process (Schwartz et al., 2013). 
While insulin has several metabolic and mitogenic functions (Rains and Jain, 2011), its 
key function is to stimulate glucose uptake in insulin-sensitive tissues, and so lower 
plasma glucose levels.  
 
An overview of the pathophysiology of the disease is shown (Figure 1.12). Due to 
reduced glucose uptake in muscle and adipose tissue (which leads to increased lipolysis 
and non-esterified fatty acid [NIFA] production), blood glucose concentrations remain 
high even in a fasting state (Richter and Hargreaves, 2013). At this stage, the liver 
might exacerbate this condition by increasing glucose production via gluconeogenesis. 
Elevated levels of glucagon from islet α-cells are also detected in type 2 diabetes, which 
enhances glycogenolysis, lipolysis, gluconeogenesis and ketogenesis, whilst inhibiting 
lipogenesis and glycolysis (Rosen and Spiegelman, 2006). Elevated concentrations of 
blood glucose result in an increased rate of glucose reabsorption in the kidney and 
progressive insulin resistance in target tissues, which switch to fatty acid metabolism 
(Poudel, 2013). Chronically elevated insulin production by the pancreas acts as a 
compensatory step to restore glucose homeostasis, and this along with chronic high 
glucose levels may have a toxic effect on islet function and lead to further worsening of 
hyperglycaemia. In concert with lipotoxicity resulting from elevated level of free fatty 
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acids,  these effects promote malfunction of pancreatic β-cells, islet hyperplasia and β-
cell apoptosis (Kitamura, 2013).  
In summary, the  pathogenic processes of type 2 diabetes  are characterised by a gradual 
decline of glucose homeostasis as a result of disruption to multifactorial metabolic 
pathways (Holst and Gromada, 2004). Thus, insulin resistance in peripheral tissues, 
increased glucose production in the liver, and eventual pancreatic β-cells failure results 
in hyperglycaemia which plays a key role in type 2 diabetes pathophysiology. Other 
corollaries of type 2 diabetes are cardiovascular disease, hypertension, stress, and 
metabolic syndrome (DeFronzo et al., 2013). 
 
 
 
 
Figure 1-12 Type 2 diabetes is characterized by three pathophysiological abnormalities. 
Impaired insulin secretion, peripheral insulin resistance and excessive hepatic glucose production. 
Adapted from (DeFronzo et al., 1992). 
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1.7.4 Dermatological complications of type 2 diabetes, obesity and ageing  
Obesity is the most major risk for insulin resistant, and the development of type 2 
diabetes, which is further stressed by chronological age, and other contributing factors 
such as cardio vascular disease, smoking, sedentary life style, unhealthy diet and if left 
uncontrolled, it may affect nearly all the body organs system (Yosipovitch et al., 2007). 
The skin largest organ in the body. Therefore, the majority of individuals suffering from 
type 2 diabetes will experience skin complications of varying severity during their 
lifetime (Baloch et al., 2008). Likewise, obesity and ageing is associated with a range of 
cutaneous complications. There are very common dermatological disorders associated 
with type 2 diabetes, which include (but are not limited) to necrobiosis lipoidical 
diabeticorum (NLD), granuloma annulare, diabetic dermopthy, acanthosis nigricans, 
vitiligo, psoriasis, lichen planus, and microangiopathy, which in conjunction with 
neuropathy lead to foot ulcers, delayed wound healing and infection (LeRoith et al., 
2004, Van Hattem et al., 2008). The appearance of some of these lesions may provide 
early signs of  type 2 diabetes, notably acanthosis nigricans, lichen planus, skin tags, 
and dermopathy, which are seen in hyperglycaemia or/and euglycemic dysfunction 
(Rasi et al., 2007, Baloch et al., 2008, Thoenes, 2012). Skin manifestations are 
commonly described in both types of diabetes mellitus, and there are no distinctive 
classifications for dermatological complications related to type 2 diabetes. Thus 
grouping them under the following headings will give a better understanding of clinical 
dermatoses or complications associated with this disease (Table 1.3). 
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Skin lesions associated with type 2 DM Cutaneous infection associated with type 
2 DM 
Pruritus Fungal 
Acanthosis nigricans Bacterial 
Diabetic thick skin Viral 
Cutaneous  Xanthomas Cutaneous manifestations related to 
diabetic complications 
Diabetic dermopathy Macroangiopathy 
Skin tags Microangiopathy 
Rubeosis faciei Diabetic neuropathy  
Diabetic  bullae Diabetic foot  
Lichen planus Antidiabetic therapy complications 
Granuloma  annulare Sulphonylurea-related skin lesions  
Diabetic xerosis Insulin lipo-atrophy 
Vitiligo Insulin lipo-hypertrophy 
Acquired perforating  dermatoses  
Necrobiosis  lipoidica diabeticorum   
 
Table 1-3 Classifications of cutaneous manifestations associated with type 2 diabetes.  
Adapted from (Baloch et al., 2008, El-Khalawany and Mahmoud, 2014). 
 
However, it is still enigmatic whether the cutaneous complications are caused  directly 
by the pathogenesis of type 2 diabetes or it is merely an epiphenomenon of metabolic 
interference of various metabolic disorders such as obesity, CVD, metabolic syndrome  
(Baloch et al., 2008, Berlanga-Acosta et al., 2012). Studying early markers of diabetes 
in human subjects is difficult for both ethical and practical reasons: people may not 
wish to know they are prediabetic, and routine biopsy is difficult to justify. This is 
confounded by heterologous skin presentations. Therefore, mouse models of obesity 
and diabetes are widely used to study human disease, but relatively little evaluation of 
diabetic associated murine skin pathology have been performed, other than studies of  
impaired wound healing (Trousdale et al., 2009). Whilst many attempts have been  
undertaken by researchers to model a variety of human skin diseases such as fibrosis, 
psoriasis and cancer in mice using transgenic or environmental models, xenografting, or 
30 
 
other forms of genetic manipulation of target genes, progress is limited (Wagner et al., 
2010, Khavari, 2006).  Animal models are attractive surrogates for human diseases with 
the ability to manipulate, and control the environmental and the genetic variables, 
allowing detailed histopathological and molecular studies to be performed. However, 
one must take account  the anatomical differences between humans and mice (Table 1.4 
and Figure 1.13). One key difference is that mouse skin is much thinner than human 
skin, which complicates the preparation of good histology sections, particularly in the 
diabetic state (Al-Habian et al., 2014). Thus, obtaining good mouse skin histology is a 
key factor in achieving meaningful morphological analysis (Treuting and Dintzis, 
2011). Critically, in vivo models also provide a system for evaluating therapeutic 
remediation of diabetic phenotypes. The most common histological and molecular 
findings of skin layers in obesity, type 2 diabetes, and ageing are summarised in (Table 
1.5, 6,  and 7).  
 
Figure 1-13 Comparison of skin histomorphology from human and mouse stained with H&E.  
Mouse skin layers (B) are thinner and less distinctly separated than in human skin (A). In particular, the 
two dermal layers (papillary and reticular) clearly seen in human skin (A). Images were captured by an 
Aperio ScanScope scanner at 5x magnification. 
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Human Mouse 
Epidermal 
layers  
Relatively thick, with 
distinct layers 
(particularly the stratum 
spinosum can be seen to 
be composed of multiple 
layers of keratinocytes) 
Thinner, with less discrete layers  
Keratohyalin 
granules 
Consist of filaggrin in 
human interfollicular 
epidermis 
Consist of filaggrin and loricrin proteins. 
Epithelial 
architecture 
Rete ridges present No rete ridges 
Dermis  
Thick, good distinguish 
between papillary and 
reticular dermis 
Thinner, lesser discrimination between 
papillary and reticular dermis 
Vasculature  
Highly   vascularised Poorly vascularised compared to human 
dermis 
Apocrine 
sweat glands 
Present in axilla, 
inguinal, and perianal 
skin regions 
Not present in mouse skin, extensive in 
mammary glands 
Hypodermal 
thickness 
Consistent between body 
sites 
 Variable with age, body site, and murine 
strains 
Biomechanical 
properties 
Thick, relatively stiff, 
adherent to underlying 
tissues 
Thin, compliant, loose. 
Table 1-4  Summary of the key differences between human and mouse skin. 
 Modified from (Wong et al., 2010, Treuting and Dintzis, 2011).
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 Human epidermis Mouse epidermis Ageing mammalian 
epidermis 
Reduced keratinocyte 
proliferation  
(Terashi et al., 
2005) 
(Sakai et al., 2003, 
Lamers et al., 
2011) 
(Rook et al., 1986) 
Hyperkeratosis  (Lowe, 2009) 
(Levy and 
Zeichner, 2012, 
Plascencia Gómez 
et al., 2014) 
(Grice et al., 2010) (Bitter, 2000) 
Impaired epidermal 
barrier function   
(Lowe, 2009) (Taylor et al., 
2011) 
(Ghadially et al., 
1995b) 
Atrophy (Sakai et al., 2005) (Taylor et al., 
2011) 
(Waller and 
Maibach, 2005) 
Increased rate of infection  (Levy and 
Zeichner, 2012, 
Bandaru et al., 
2013) 
 
(Bandaru et al., 
2013) 
(Scheinfeld, 2005) 
Irregular pigmentation  
 
(Levy and 
Zeichner, 2012) 
(Salton et al., 
2000) 
(Mine et al., 2008) 
Delayed wound 
epithelialisation 
(Schmidt and 
Horsley, 2013) 
(Frank et al., 2000) (Bennett et al., 
2008) 
Table 1-5 Reports describing common epidermal features in diabetic and ageing epidermis. 
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Human 
dermis 
Murine 
dermis 
Ageing 
mammalian 
dermis 
Reduction in Type I/III 
collagen synthesis  
(LeRoith et al., 2004, 
Lateef et al., 2004) 
(Lerman et al., 
2003a, Schmidt and 
Horsley, 2013) 
(Mine et al., 2008, 
Varani et al., 2006a) 
Mine et al., 2008) 
Loss of collagen organisation (LeRoith et al., 2004, 
Ren et al., 2013) 
(Osman et al., 
2013a) (Morris et al., 
2013) 
(Mine et al., 2008)  
Increased MMP expression (LeRoith et al., 2004, 
Lateef et al., 2004) 
(Morris et al., 2013)  
(Ibuki et al., 2012) 
Morris et al., 
2013) 
(Mine et al., 2008) 
Increased RAGE expression/ 
glycation 
(LeRoith et al., 2004, 
Nawale et al., 2006) 
  (Giacco and 
Brownlee, 2010) 
Ibuki et al., 2012) 
(Nawale et al., 2006) 
Changes in inflammatory cell 
infiltration 
 (LeRoith et al., 
2004, Bandaru et al., 
2013) 
(Maruyama et al., 
2007) 
(Bennett et al., 2008) 
Microvasculature 
complications 
 (LeRoith et al., 
2004, Nawale et al., 
2006) 
(Maruyama et al., 
2007, Kanasaki and 
Koya, 2011) 
Decreased. (Nawale 
et al., 2006) 
Elastic fibre disorganisation/ 
loss of elasticity 
(LeRoith et al., 
2004)  (Ye et al., 
2010, Ezure and 
Amano, 2011) 
(Ezure and Amano, 
2011) 
(Rook et al., 1986, 
Lavker et al., 1987) 
(Mine et al., 2008) 
Fibrosis (LeRoith et al., 2004, 
Osman et al., 2013a) 
Not reported (Osman et al., 2013a, 
Watt and Fujiwara, 
2011) 
Flatting of DEJ Not reported (Taylor et al., 2011) (Mine et al., 2008, 
Janovska et al., 2013) 
Altered fibroblast shape (Schmidt and 
Horsley, 2013) 
(Langevin et al., 
2005) 
(Varani et al., 2006a) 
Table 1-6 Reports describing common features in diabetic and ageing dermis. 
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Human 
subcutis 
Mouse 
subcutis 
Ageing 
mammalian 
subcutis 
Loss of elasticity  
(Lowe, 2009) (Ezure and Amano, 
2011) 
(Sherratt, 2009) 
Altered collagen deposition (Van Hattem et al., 
2008) ( Lowe, 
2009) 
(Khan et al., 2009)  (Sherratt, 2009) 
Increased MMP expression (O’Hara et al., 
2009) 
(Ibuki et al., 2012) (Sherratt, 2009) 
increased macrophage 
infiltration 
(O’Hara et al., 
2009) 
(Xu et al., 2003) 
(Trayhurn, 2013a) 
(Tchkonia et al., 
2010) 
Increase  fat cells size and 
number 
(Goossens, 2008) (Xu et al., 2003, 
Ezure and Amano, 
2011) 
(Watt and Fujiwara, 
2011) 
Vascular dysfunction  (Van Hattem et al., 
2008) (Goossens, 
2008) 
(Ibuki et al., 2012) (Nawale et al., 
2006) 
Increase in pro-
inflammatory cytokines 
(particularly TNFα and IL-
6 ) 
(Tchkonia et al., 
2010) 
(Xu et al., 2003) 
(Trayhurn, 2013a) 
(Tchkonia et al., 
2010) 
Adipocyte necrosis and or 
apoptosis   
(Tchkonia et al., 
2010) 
(Murano et al., 
2008).(Khan et al., 
2009) 
(Tchkonia et al., 
2010) 
Table 1-7 Reports describing common features in diabetic and ageing hypodermis 
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In summary, a range of cutaneous pathological changes are associated with insulin 
resistance and type 2 diabetes complications such as delayed wound healing, diabetic 
foot ulcers, neuropathy, and vascular problems (Van Hattem et al., 2008). Many 
attempts to investigate mechanisms of skin complications in murine models of insulin 
resistance and diabetes have been reported (Seitz et al., 2011). It is, however, 
noteworthy that not all secondary diabetic cutaneous signs can be modelled accurately 
in the mouse due to physiological and anatomical variation. Nevertheless, it is likely 
that there exist many common mechanisms at the cellular and molecular levels in 
diabetic human and mouse skin. Furthermore, using either genetically altered mouse 
models of obesity, insulin resistance (notably Lepob/Lepob mice lacking leptin) and  
diabetes (leprdb/leprdb mice lacking the leptin receptor), or environmental models 
(dietary induced obesity  [DIO])(Seitz et al., 2011) will allow more effective analysis of 
the various stages of skin disease, which are not practicable (or ethical) in human 
subjects.   
 
1.8 Hypothesis and aims of the thesis  
 
Previous studies of peripheral lesions in metabolic disease include insulin resistance, 
obesity, and type 2 diabetes mellitus have focussed on the role of hyperglycaemia, 
glycation (in particular the formation of advance glycation end products), hypoxia, 
adipose tissue-driven inflammation and cytokine action as drivers of disease pathology 
(Van Hattem et al., 2008, Barrientos et al., 2008, Seitz et al., 2011). Keratinocytes and 
fibroblasts have active insulin-dependent glucose transport systems (Shen et al., 2000, 
Howard et al., 1979). The integrity of the skin is maintained by a continuous 
programme of renewal, and it is possible that progressive insulin resistance and 
hyperglycaemia will have a profound effect on cutaneous homeostasis and function. 
Herein, I seek to use animal models of human disease in order to investigate the 
complex mechanisms underlying cutaneous changes associated with insulin resistance 
and type 2 diabetes(Wong et al., 2010).  
 
My first hypothesis is that insulin resistance itself plays an important role in 
dermatological changes. I tested this hypothesis in a pre-diabetic (insulin resistance), 
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and hyperinsulinaemic (diabetic) animal model by evaluating skin phenotypes in 
paraffin sections of tissue derived from environmental C57BL/6 mice maintained on a 
high fat diet, genetic models of obesity and insulin resistance (Lepob/Lepob), and 
models of type 2 diabetes (leprdb/leprdb). I sought to achieve this by using a range of 
special histological stains to evaluate structural changes in the skin. This work was 
extended by the use of immunohistochemical (IHC) methods with antibodies 
recognising a range of key proteins including markers of proliferation (PCNA), 
epidermal maturation (K14, involucrin, profilaggrin), endothelium (CD31) and immune 
infiltration (CD68). 
 
Dermal damage, and overall skin fragility in insulin resistant and obese murine models 
is associated with an expansion of subcutaneous adipose tissue (Ibuki et al., 2012) and it 
was notable from my work that the tissue layer adjacent to the expanded subcutis (i.e. 
the reticular dermis) sustained the greatest damage, which is consistent with chronic 
exposure to locally produced adipokines in human studies (Khan et al., 2009). Thus my 
second hypothesis is that chronic exposure to paracrine inflammatory signals released 
from an expanded subcutis underlies some of the peripheral effects of insulin resistance 
or type 2 diabetes on mouse skin compartments. In this regard, measuring the systemic 
(plasma), and local (subcutaneous adipose tissue) cytokines production was undertaken 
to elucidate their contribution to dermatological sequelae related to insulin resistance 
and type 2 DM. My third hypothesis is that insulin-resistant dermal fibroblasts are 
impaired in their ability to secrete and organise collagen. Therefore, their function from 
fibroblasts isolated from Lepob/Lepob and normal C57BL/6 animals was assessed. The 
receptors for both insulin-like growth factor1 and insulin are highly expressed by both 
basal keratinocytes and dermal fibroblasts (Hodak et al., 1996). Their chronic activation 
resulting from hyperinsulinaema may have pathological consequences. Thus, evaluating 
insulin receptor expression in isolated dermal fibroblasts would help in investigating a 
role for local insulin resistance in type 2 diabetes skin lesions. By using a range of 
histological techniques, IHC, and in vitro methods, I sought to achieve the following 
aims: 
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1) Rigorous evaluation of histological differences in skin isolated from different mouse 
models of insulin resistance and diabetes. 
2) Assessment of cutaneous molecular characteristics associated with increasing insulin 
resistance via immunohistochemistry analysis of some cutaneous maturation and 
function biomarkers.  
3) Investigation of a role for adipokine signalling in skin damage. 
4) Evaluation of insulin signalling mechanisms in cutaneous fibroblasts. 
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2.1 Animals models and diet  
Over the last decade several animal models have been used to investigate the metabolic 
syndrome. Rodents are commonly used models to study human disease in part through 
their similarity in mammalian anatomy, their genome is well characterised, their fast 
reproduction rates (making them cost effective), and the wide availability of biological 
markers and assays (Spence, 1999) make them attractive research tools. Various mouse 
models have been developed to study obesity and type 2 diabetes, including genetically 
modified; transgenic or polygenic models, and environmental models for example 
streptozotocin treatment, partial pancreatomy, or exposure to a high fat diet 
(Buckingham et al., 2012).  
 
Male C57BL/6, Lepob/Lepob, Leprdb/Leprdb and Misty mice were purchased from 
(Charles River, Manston, UK) at 5-6 weeks of age. All experiments were conducted in 
accordance with the University of Buckingham Home Office licence and ethical review 
process. Animals were housed in solid-bottomed, sawdust-filled cages with access to 
tap water and fed a standard chow diet (10% kcal fat, 70% kcal carbohydrates, 20% kcal 
protein; (Beekay Diets, New Brunswick, NJ, USA)) or a high fat diet ( 40% calories are 
provided by fat) (Western diet, Special Diets Services, Witham, UK). The fat in the 
high fat diet was derived predominantly from milk (other source: corn oil, cholesterol) 
while the source of fat in the chow diet was soybean oil.  Mice were maintained at a 
controlled temperature of 23±1˚C, on a 12 hour light-dark cycle (7.00 until 19.00 
hours). 
2.1.1 C57BL/6  
The C57B/6 mouse (here after referred to as wild type (wt/wt), or lean mice) inbred 
strain was used in this study (Garcia-Menendez et al., 2013). The C57BL/6 mouse was 
used for the diet induced obesity (DIO) and ageing models.  
2.1.2 Lepob/Lepob  
C57BL/6 Lepob/Lepob (here after referred to as ob/ob or insulin resistance model). 
These mice lack circulating leptin because they are lacking a functional leptin gene. 
Leptin is a key regulator of satiety and energy homeostasis, and these mice show post-
natal weight gain and progressive insulin-resistance (moderate hyperglycaemia with 
compensating hyperinsulinemia) (Clee et al., 2005). Feeding ob/ob mice a 40%-60% 
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high fat diet ( here after referred to as ob/ob HFD) results in an increase in body weight, 
glucose intolerance and progressive insulin insensitivity (Kennedy et al., 2010, Koch et 
al., 2014).  
2.1.3 Diet induced obesity model  
The diet induced obesity model (DIO) was produced in C57BL/6 wild-type animals 
maintained on a high fat diet (in which 40% or more of their calories are provided by 
fat) from 6-7 weeks of age for a total of 45 weeks feeding. DIO mice become obese and 
are mildly insulin resistant (but not diabetic), allowing for the investigation of the early 
effects of insulin resistance (Wargent et al., 2013). 
 
2.1.4  Mouse models of ageing (old) 
This model was introduced in C57BL/6 wild-type animals maintained on a chow diet 
until 20 months of age.  
2.1.5 C57BlKS/J (misty) 
The C57BLKS/J strain (here after referred to as KSJ or Misty) is closely related to 
C57BL/6, but the strains are phenotypically distinct. C57BLKS/J with a leptin knockout 
receptor will be homozygous for the diabetes Leprdb/Leprdb. The Misty strain was used 
as the control strain for Leprdb/Leprdb (Mao et al., 2006) .  
2.1.6 Leprdb/Leprdb  
Leprdb/Leprdb (here after referred to as db/db or diabetic mouse) mice fail to respond to 
leptin. A dysfunctional leptin receptor in db/db in mice on the C57BlKS/J background 
results in excessive, rapid post-natal weight gain, obesity, glucose intolerance and 
insulin resistance, accompanied with a deterioration in pancreatic islet function from 6-7 
weeks of age leading to hyperglycemia and hyperinsulinemia and frank diabetes. This 
strain shows impaired wound healing, and is thus considered a good model to study the 
associated complications of type 2 diabetes on skin function (Trousdale et al., 2009). 
2.2 Physiological measurements 
2.2.1 Body weight 
The body weight of the mice was measured weekly. Each animal was placed in a small 
bowl on an electronic scale (Adventurer TM Pro, Ohaus Corporation, Pine Brook, 
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USA). Readings were taken over a 5 second period and averaged by the scales in order 
to allow for the animal‘s movements. 
2.2.2 Body composition  
Body fat content, lean mass, and bone density were measured by the Dual Emission X-
ray Absorptiometry (DEXA) densitometer (LUNAR PIXImusTM, LUNAR Europe 
N.V, Brussels, Belgium). DEXA passes two X-ray beams through the subject and 
measures the amount of X-ray absorbed by the tissue. One beam is of high intensity and 
the other of low intensity, so the relative absorbance of each beam is an indication of the 
density of the tissue it has passed through. The higher the tissue density, the greater is 
the reduction in X-ray intensity. The DEXA densitometer was calibrated for bone 
mineral density and percent fat content by scanning a ‘phantom mouse’ supplied with 
the machine. The phantom mouse measurement for bone mineral density and percent fat 
must be within 2% of the expected quality control values in order to proceed with 
animal scans. Prior to the measurement of body composition, mice were weighed and 
anaesthetised with an isoflurane/nitrous mix (Isoba, Schering-Plough Limited, Welwyn 
Garden City, UK), (1.5% flow with 1 litre/minute N2O and 0.5 litre/minute O2) and 
transferred ventral side down onto a specimen tray whilst being maintained under 
anaesthesia. Mice were positioned on the DEXA densitometer so that the entire body 
and base of tail were measured in the scan. The DEXA scanning of each animal was 
performed and finalised by image acquisition and analysis using the PIXImus2
TM
 1.46 
software (GE Medical Systems, Bedford, UK). 
2.2.3 Blood glucose  
Blood glucose measurements were determined using the Inﬁnity™ Glucose (Oxidase) 
Liquid Stable Reagent (Thermo Fisher Scientific Inc., Middletown, USA). 10µl of 
blood drawn from the tail vein was mixed with 390µl of haemolysis reagent (50mg/l 
digitonin, 100mg/l maleimide) before 20µl was transferred to a 96-well plate in 
duplicate. A set of glucose standards (at 5.56, 16.67 and 44.4mmol/l) were included. 
180µl Trinders reagent (Thermo Fisher Scientific) was added to each well before 
incubation for 30 minutes in the dark. Absorbance at both 505 and 575nm were 
measured using a spectrophotomer (Spectramax, Molecular Devices, CA, USA). A 
linear regression calculation from the glucose standards provided glucose 
concentrations using Prism 5.0 (GraphPad
TM
 Software, LA Jolla, CA, USA).  
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2.2.4 Plasma Insulin   
Mice were fasted for 5 hours and blood was collected into EDTA coated tubes (Sarstedt, 
Nümbrecht, Germany) and plasma prepared by centrifugation for 5 minutes at 3000g in 
a microfuge.  Plasma insulin was measured using a 96-well  ELISA  kit  mouse insulin 
enzyme-linked immunosorbant assay ELISA (Crystal Chem., Illinois, USA) according 
to the manufacturer’s recommendations (sensitivity 0.1ng/ml,  CV≤10%).  Prior to the 
first reaction, 5μl of the plasma samples and mouse insulin standards (0-10ng/ml) were 
dispensed in duplicate onto a microplate coated with the mouse anti-insulin monoclonal 
antibody. 95μl of guinea pig anti-insulin antibody was added and the plate was 
incubated for 16 hours at 4°C. Following this three washes with phosphate buffered 
saline with tween 20 (PBS-T) (PBS-0.01% Tween-20) was carried out to remove 
unbound antibodies, the mouse anti-insulin monoclonal antibody/guinea pig anti-insulin 
antibody complex was detected by the addition of the horseradish peroxidase (HRP) 
labelled anti-guinea pig antibody (100μl). Prior to the enzymatic reaction, after 3 hours 
incubation at room temperature and five washes with PBS-Tween-20, to each well 
3,3‘,5,5‘-Tetramethylbenzidine (TMB) substrate solution (100μl) was added. After 30 
minutes incubation in the dark, the reaction was stopped by adding 1N sulphuric acid 
(10μl) to each well. The absorbance was measured at wavelengths of 492nm (measuring 
wavelength) and 630nm (subtracting wavelength). The insulin concentration in each 
sample was interpolated from a standard curve generated in Prism 5.0 (GraphPad
TM
 
Software, LA Jolla, CA, USA) using the standard concentrations and corresponding 
absorbance values. 
2.2.5 Preparation of adipose tissue conditioned medium (ACM)  
At the time of dissection approximately 0.2g of epididymal and subcutaneous fat from 
lean, ob/ob, db/db, misty were collected from each of three mice into 24 well plates 
(Sigma Aldrich, Gillingham, UK) containing pre-warmed Krebs-Ringer-HEPES buffer 
pH7.4 and 1% endotoxin free bovine serum albumin (Sigma-Aldrich, Gillingham, UK). 
Adipose tissue samples were then transferred into a fresh plate containing 0.5ml of 
DMEM/F-12 and Ham‘s medium (1:1) supplemented with L-glutamine, 15mM HEPES 
and 0.5% BSA (Gibco, Life Technologies, Paisley, UK) and chopped into small pieces. 
The samples were incubated at 37ºC using a plate shaker for 90 minutes at 450rpm 
(Heidolph Titramax, Germany). The culture medium was collected and frozen at -80ºC 
prior to analysis of secreted cytokines.  
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2.2.6 Mesoscale    
The Meso Scale Discovery
 TM
 (MSD
TM
 MesoScale Discovery, Gaithersburg, USA) 
technology uses chemiluminescent detection of substances in either single or multiplex 
assays, where one or more analytes are detected during one immune-based assay. It  
involves  the  use  of  Sulfo-Tag (N-Hydroxysuccinimide) NHS ester- labelled detection 
antibodies which emit light under the electrochemical stimulation of an electrode 
attached to the surface of the microplate well (Gowan et al., 2007). The plate is analysed 
in a Sector Imager 2400 reader (MesoScale Discovery, Gaithersburg, USA). During the 
measurement, a voltage applied to the plate electrodes causes the labels bound to the 
electrode surface to emit light. The instrument measures the intensity of emitted light as 
a quantitative measure of the cytokines present in the sample (Figure 2.1). 
 
 
 
Figure 2-1 Principle of the immunoassay with 7- spot microplate. 
In each spot different cytokines are detected.  Antigen binds to the primary antibody on the working 
electrode and the antigen-antibody complex is detected by a Sulfo-Taq labelled antibody. Adapted from 
Meso Scale Discovery, Gaithersburg, USA. 
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Cytokine levels were measured in plasma and subcutaneous or epididymal adipose 
conditioned medium from wt/wt, ob/ob, misty, and db/db mice, at 3 months and 20 
months of age. Specific cytokines were measured in conditioned medium prepared from 
skin compartments isolated from both the hypodermis and the outer layers of the skin 
(comprising the dermis and epidermis) in chow-fed wild-type and in ob/ob mice. 
Cytokine levels were quantified using the MesoScale™ ultra-sensitive mouse pro-
inflammatory 3 and 7-plex assay measuring MCP1, RANTES, KC, IFN-γ, IL-1α, IL-6, 
IL-10, IL-12, GMCSF and TNF-α. Antibodies for the specific protein targets are coated 
onto 7 spots (or electrodes) in the same well. Plates were run as per manufacturer‘s 
recommendation, briefly, a blocker solution (150μl) was added into each well of the 
microplate. The plate was incubated at room temperature on a shaker for 1 hour 
(Heidolph Titramax, Heidolph Instruments GmbH &Co, Schwabach, Germany) at 300–
1000rpm and then washed with PBS-0.05% Tween. Diluent (40μl) and either sample 
(25μl) or a serially diluted mouse standard (0-10000pg/ml) was then dispensed in 
duplicate into each well. The plate was incubated under the same conditions for a 
further two hours and then washed. The anti-mouse goat polyclonal secondary has a 
unique sulpho tag, and 25μl was added, with a further incubation for 1 hour. After 
washing, read buffer (150μl) was dispensed into each well and the plate was analysed in 
the Sector Imager 2400 reader.  
2.3 Histology methods  
2.3.1 Tissue preparation and fixation   
The dorsal area of each mouse was shaved using electrical clippers prior to the 
dissection of the skin samples. Skin from each mouse was sliced into small pieces 5x10 
mm (to allow for better penetration of fixative), and then placed into histological 
cassettes (VWR International Ltd, Milton Keynes, UK) prior to fixation for 3 days in 
10% neutral buffered formalin (10% NBF) (BDH, VWR International Ltd, Lutterworth, 
UK) at room temperature. This fixation method was used historically with all mouse 
models in our laboratory, including in this study, but has later been revised as described 
in detail in Chapter 4. 
2.3.2 Tissue processing 
Cassettes were transferred to a Leica TP1020 tissue processor (Leica Microsystems, 
Milton Keynes, UK) for automated dehydration, clearing and wax impregnation using 
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the protocol detailed in Appendix 1. This processing protocol was routinely used for 
processing of the skin samples but has been revised in Chapter 4. 
2.3.3 Embedding 
Skin tissue samples were embedded using an embedding station (Leica EG1150H) for 
30 minutes in a mould in the correct orientation to prepare paraffin blocks. Skin 
specimens were oriented in warm (60C) metal histological cassettes filled with hot 
(65C) paraffin wax (Leica, Milton Keynes, UK), so that sections were taken at an angle 
perpendicular to the epidermis. This was followed by transfer to a cold plate (Leica EG 
1150C). Once the paraffin had solidified, the mould was filled with more molten wax 
and the base of the histological cassette was placed on top to create a support, which 
was subsequently filled with more wax. Blocks were kept on the cooling plate for one 
hour before separating the paraffin blocks to ensure complete solidification. 
 
2.3.4 Sectioning 
After the blocks had hardened, a Leica RM 2125 rotary microtome was used to cut 4m 
thick sections. A room temperature of 15C was maintained, to minimise softening of 
the wax and reduce sectioning artefacts, and sections were cut at an angle of 45°. 
Sections were then transferred to a Leica HI1210 water bath at 40C, and floated onto 
positively-charged 76x26mm microscope slides (Star Frost, Waldemar Knittel 
Glasbearbeitungs, Germany) before drying on a hot plate (RA Lamb, Eastbourne, UK) 
at 35C for several hours. Finally, the slides were dried overnight at 37C.  
2.3.5 Tissue macro arrays (TMA) construction 
The tissue macro arrays (TMA) technique is a high throughput analysis technique used 
to achieve experimental uniformity (less variability) (Kampf et al., 2012). A 12x4mm 
core multiple tissue array was used to study the four mouse models in triplicate, and 
representative tissue from each mouse was presented on a single slide from four 
fixatives to evaluate the duration and fixative choice for later experiments. The TMA 
block was made up from 12 regular paraffin blocks of skin samples or multiple mouse 
tissues (brain, brown adipose tissue (BAT), epididymal fat, heart, pancreas, skin, 
kidney, liver, small intestine, soleus muscle, lung, and spleen. Briefly, a 12 steel tube 
custom mould (Figure 2.2A) was used to match the punch pen diameter of 4mm to 
create the recipient block with 12 cores.  After keeping the 12 donor blocks, and one 
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recipient block at 37C for 3-5 minutes to soften samples were obtained from each 
paraffin-embedded biopsy specimen by using 4mm punches merged to the 12 holes 
recipient paraffin block as seen in (Figure 2.2 C) with maintaining the embedding 
orientation to the recipient block. The TMA blocks were flattened by keeping them in 
the oven at 37C for 20 minutes upside down on a glass slide and then applying gentle 
load or pressure in order to achieve full adherence and integration to the recipient block. 
The TMA block was attached to a glass slide and placed on a cooling plate prior to 
sectioning and staining (Figure 2.2 D). 
 
Figure 2-2 Tissue macro arrays (TMA) construction steps. 
Custom mould (A), recipient block (B). A single TMA was created containing tissue from 3 different 
mice (columns), each was treated with the four different fixatives (rows) (C); recipient, arrayed paraffin 
block and multiple tissue arrayed slide (C and D). 
 
2.3.5.1 TMA sectioning procedures  
The hard cutting surface of the TMA blocks was as a result of the heterogeneity of 
multiple samples from different models and different mouse tissues. Thus it required 
many attempts to achieve good sectioning outcomes which included; sectioning at low 
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temperature, frequent blade changing, chilling blocks on ice and tissue paper soaked 
with softening agents for 2-5 minutes (see formulation in Appendix 4).  
2.3.6 Special histological stains 
Four µm paraffin sections were stained using a variety of histological stains informative 
for cutaneous organisation. The initial steps for all the histochemical stains and 
immunohistochemistry involved de-waxing the slides in an oven at 60˚C  for 15 minutes 
followed by rehydration (Histo-Clear
TM
 II, National Diagnostics, UK) twice for 2 
minutes each, then in graded ethanols (100%, 90%, 70%; each for 1 minute for each 
step, with a final rinse under running tap water). Staining was then carried out using 
solutions for each staining as described below. At the end of each staining procedure, 
sections were dehydrated using graded ethanols (100% and 90%; 30 seconds each), 
Histo-ClearTM II (30 seconds) and then mounting in VectaMount
TM
 permanent 
Mounting Medium (Vector Laboratories, Peterborough, UK) and coverslipping. 
2.3.7 Morphology stain 
2.3.7.1   Haemotoxylin and Eosin (H&E) 
Haematoxylin and Eosin stain is the most common histologic stain used to study the 
general morphology of any tissue. Haematoxylin is a basic dye with affinity for nucleic 
acids (blue), while Eosin Y stains the cytoplasmic elements (pink) and the red blood 
cells (red). It is prepared from 7g/L Haematoxylin Solution, Harris Modified and Eosin 
Y, 0.5% (w/v) in acidified 90% ethanol. Routine H&E staining was performed 
according to Gamble (Gamble, 2008) (Appendix 6). Briefly, slides were immersed in 
Harris’ haematoxylin for 8 minutes followed by rinsing in water, 30 seconds in 1% HCI 
in 70% ethanol (v/v) (differentiation), 1 minute rinsing in water, 30 seconds in 0.1% 
(w/v) sodium bicarbonate (blueing), 5 minutes rinsing in water and then in eosin Y 
0.5% (w/v) in acidified 90% ethanol for 3 minutes. 
2.3.8 Connective tissue stain 
2.3.8.1 Masson Trichrome 
The Masson Trichrome stain is a very common connective tissue stain which 
distinguishes collagen fibres (blue) from muscle fibres (red) and cell nuclei (black). It 
can also indicate the collagen content in the tissue (Yamamoto et al., 2012). The 
Masson trichrome stain kit (Sigma, HT15) contains aniline blue solution, Biebrich 
scarlet-acid fuchsin solution, phosphotungstic acid and phosphomolybdic acid. This kit 
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was used according to the manufacturer’s recommendation, briefly slides were 
incubated in preheated Bouin’s solution for 15 minutes, followed by Weigert’s iron 
haematoxylin solution (5 minutes),  Biebrich scarlet-acid fuchsin (5 minutes), dipped in 
phosphotungstic/ phosphomolybdic acid solution and aniline blue, with a final wash in 
0.5% (v/v) acetic acid. A running tap water rinse was carried out between each step. 
 
2.3.8.2 Herovici  
Herovici’s stain for young and mature collagen was adapted from Herovici (Herovici, 
1963). This stain consists of Weigert’s iron haematoxylin solution, Herovici solution 
(50ml solution A (100ml Picric acid [saturated aqueous]), 10ml acid fuchsin, 1% (w/v) 
aqueous solution, 50ml methyl blue (0.05% (w/v) aqueous), 10ml glycerol and 0.5ml 
saturated aqueous lithium carbonate. The first step of the protocol was nuclear staining 
with an acid-resistant nuclear stain (Weigert’s iron haematoxylin) for 1 minute followed 
by a 2 minute incubation in Herovici staining solution (50ml Solution A (100ml Picric 
acid [saturated aqueous], 10ml acid Fuchsin, 1% aqueous solution), 50ml methyl blue 
(0.05% aqueous), 10ml glycerol, 0.5ml saturated aqueous lithium carbonate) followed 
by rinsing in tap water  (Friend, 1963). Slides were then immersed in 1% (v/v) acetic 
acid for 1 minute. 
 
2.3.8.3 van Gieson 
The elastic stain kit (Sigma, HT25) is also known as Verhoeff Van Gieson stain 
(Pieraggi et al., 1985). This kit was used to study elastic fibres which stained nuclei 
(black), and collagen (red) and other tissue elements (yellow). This kit is composed of a 
working elastic solution (20ml Haematoxylin solution, 3ml ferric chloride solution, 8ml 
Weigert’s iodine solution and 5ml deionised water) and a working ferric chloride 
solution (3ml ferric chloride and 37ml deionised water). The Van Gieson counter stain 
solution (acid fuchsin, 0.05% (w/v) in 95% saturated picric acid solution) was used 
according to the manufacturer’s recommendation.  Firstly, slides were incubated in 
elastin stain solution for 10 minutes. After rinsing in tap water, slides were 
differentiated in ferric chloride solution followed by a tap water rinse. Slides were 
transferred to 95% ethanol for 1 minute and then incubated in Van Gieson stain for 2 
minutes (Hayashi et al., 2004). 
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2.3.8.4 Picrosirius 
The Picrosirius stain contains Sirius red (Direct Red 80) and Sirius Red 0.1% (w/v) in 
saturated picric acid (see Appendix 7). Collagen fibres are stained to different degrees 
with this stain depending upon their thickness from green (thin), yellow, orange, to red 
(thick) under crossed polar microscopy as they align parallel to the transmission axis of 
the filter (Rich and Whittaker, 2005). This stain was performed as described previously 
(Junqueira et al., 1979, Sweat et al., 1964, Puchtler et al., 1973). Briefly, slides were 
incubated in 0.1% (w/v) of direct Red 80, which was prepared in saturated picric acid 
for 1 hour at room temperature, followed by differentiation in 0.5% (v/v) acetic acid 
(Junqueira et al., 1979). 
2.3.9 Elastic fibres and immune cells stain 
2.3.9.1 Giemsa and orcein (G and O) 
This stain was used to identify immune cell infiltration, and in particular mast cells 
(dark purple) and elastic fibres (black) (Harikumar et al., 2014)(see Appendix 8). Slides 
were incubated at room temperature in 0.5% (w/v) Orcein solution for 10 minutes. After 
rinsing in tap water for 10 minutes, the slides were incubated in 1ml Giemsa stock 
solution (diluted in 45ml H2O) for 1 hour at 50ºC in a water bath. Giemsa solution was 
prepared by dissolving 7.36g Giemsa in 500ml warm glycerol (~50ºC) for 30 minutes 
with occasional mixing, cooling and 500ml methanol added. The solution was filtered 
before use and stored at room temperature (Pinkus, 1944, Pinkus and Hunter, 1960). 
After rinsing in tap water for 5 minutes, slides were incubated in 0.4% (95% 
ethanol/eosin Y solution) for 2-3 minutes until the collagen fibres stained pink (as 
observed by microscopy). 
2.3.10 Basement membrane and glycogen deposition 
2.3.10.1 Periodic acid Schiff 
The periodic acid Schiff (PAS) stain kit (Sigma, 395B) contains Haematoxylin Solution 
(Gill No.3), periodic acid solution and Schiff's reagent. This kit was used according to 
the manufacture’s recommendation. It is a very common stain used to identify non-
enzymatic glycation (when glucose binds to the amino groups of proteins without 
enzymatic action). Schiff’s reagent interacts with glycol and leads to the formation of 
aldehyde groups (appearing as red-purple) which mostly occurs in the basement 
membrane and to a lesser extent in collagen fibres (Singh et al., 2014). Slides were 
incubated in periodic acid reagent for 5 minutes, followed by a tap water rinse and 
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incubation in Schiff’s reagent for 15 minutes. The slides were then rinsed in water and 
counterstained with Harris’ haematoxylin. 
2.3.11 Chromogenic immunohistochemistry (IHC) 
 A list of all antibodies used in this thesis are listed in (Appendix 5), herein only the 
antibodies with positive signal are shown in the method section. An evaluation of 
antigenicity was performed using IHC with antisera raised against the following 
proteins: CD68 (SC-9139 Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), CD31 
(Cellworks, Caltag Medsystems Ltd, Buckingham, UK Cat No ZHA-1225), rabbit anti-
involucrin (1/50 dilution; PRB-140C; Covance, Maidenhead, UK), rabbit anti-keratin 
14 (K14) (1/500 dilution; stock: 1mg/ml; PRB-155P; Covance), RAGE IHC antibody 
ready to used (IW-PA1069 IHC World, LLC, Woodstock, USA) and mouse anti-
proliferating cell nuclear antigen (PCNA) (1/100 dilution; P8825; Sigma), Hypoxia-
inducible factor 1-alpha HIF1-α (1/50 dilution; Santa Cruz, USA). Tissue sections were 
deparaffinised and hydrated (Table 2.1). Prior to antibody incubation, endogenous 
peroxidases were inactivated by treatment with 3% hydrogen peroxide in methanol (v/v) 
for 10-30 minutes, followed by a wash in PBS-T containing 0.1% (v/v) Triton X-100 
(PBS-T). A 15-30 minute 5% goat serum block in PBS preceded incubation with 
primary antibodies for 90 minutes at RT (all diluted in PBS). Subsequently, slides were 
incubated with species-appropriate HRP-conjugated secondary antibodies (all used at 
1/200 dilution in PBS for 1 hour). After washing in PBS-T, slides were developed using 
chromogenic detection (DAB Peroxidase (HRP) Substrate (Vector Laboratories, 
Peterborough, UK)) and counterstained with Harris’ haematoxylin for 8 minutes 
followed by rinsing in water, 30 seconds in 1% HCI in 70% ethanol (v/v) 
(differentiation), 1 minute rinsing in water, 30 seconds in 0.1% (w/v) sodium 
bicarbonate (blueing), 5 minutes rinsing in water, then dehydrated and cleared as routine 
for special stains, and mounted in Vectashield™ hardset Mounting Medium (Vector 
Laboratories, Peterborough, UK). 
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Table 2-1 Immunohistochemical chromogenic detection. 
  
STAGE REAGENT DURATION NOTES 
1 Xylene 2x 2 min Dewaxing 
2 100% EtOH 2x1 min Rehydration 
90% EtOH 1 min 
3 0.3% H2O2 (in methanol, 
optional) 
20 min Blocking of the 
endogenous peroxidise 
activity. 
4 PBS-T 3 min Wash 
5 Pressure cooking in 
citrate buffer (optional) 
10 min Antigen retrieval 
6 PBS-T 3 min Wash 
7 Running tap water 1 min Rinse 
8 5% serum block in PBS-T 20 min Blocking 
9 1 antibody at empirically 
determined dilution 
60 min to overnight 
(RT to 4°C) 
First layer 
10 PBS-T 3 min Wash 
11 2 antibody (HRP 
labelled) (1/200 dilution). 
30 min (RT) Second layer 
12 PBS-T 3 min Washing 
13 Chromagen 2-10 min (determine 
empirically) 
Detection 
14 Running water 1 min Rinse 
15 Dehydrate, clear and 
mount 
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2.3.12 Immunofluorescence  
Some of the biomarkers investigated in this study have been tested using fluorescence 
IHC. In this method the antibody-mediated antigen interaction can be visualised by 
florescence (FITC, TRTC) tagged secondary antibodies. This protocol has fewer steps 
than for the IHC enzymatic method because there is no need for a substrate to activate 
the enzyme (blocking endogenous and enzyme activation steps were omitted). Instead, 
organic fluorophores are conjugated to the secondary antibody which can then be 
detected under a fluorescent microscope. Different antigen retrieval (AR) methods 
(Table 2.2) were applied with some antibodies to unmask the antigen site for antibody 
binding action. Briefly, after the dewaxing and rehydration steps, the sections 
underwent blocking nonspecific background staining by a 15-30 minute incubation with 
the 5% serum from the species, used to create secondary antibodies (2ºAb). Then slides 
were incubated for 1 hour at RT with the primary antibodies (diluted according to 
manufacturer’s recommendation or optimised to the optimal dilution), before incubation 
in FITC or TRTC-conjugated anti- IgG anti-sera for 30 to 60 minutes at RT following a 
PBS-T wash. After a second wash, slides were mounted in VectaShield™ Mount 
containing the nuclear stain DAPI (Vector Laboratories) and viewed using the 
fluorescence Nikon microscope (Nikon Eclipse 80i, Nikon Corporation, Japan).
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STAGE REAGENT DURATION NOTES 
1 Incubator To melt the wax heat at 60 
ºC in the oven. 
15 to 30 min 
2 Rehydrate 
tissues 
2x Histoclear (2 min), 
100%, 90%, 75% EtOH (1 
min each), running water. 
 
3 0.1% trypsin Enzymatic or heat antigen 
retrieval in the pH 6-9 
solution. 
30 min, 10 
min 37 ºC 
/120 ºC 
4 0.2% glycine in 
PBS, tap water 
rinse 
5min RT to Stop enzyme, 
cooling slides for 10 mins. 
0.2% 
glycine in 
PBS, rinsing 
5 
Optional 
PBS-T Wash Rinse RT 
6 5% serum in 
PBS 
Block stage. Use serum 
from the species used to 
create 2ºAb. 
20 min RT 
7 1ºAb in PBS / 
2% serum 
Dilution: according to the 
manufacturer’s 
recommendation 
1h.30.min 
RT 
8 PBS-T  3 min 
9 2ºAb in PBS / 
2% serum 
FITC or TRITC-conjugated 
anti- IgG anti-sera at 1/400 
dilution. 
1 hr RT 
10 PBS-T  3min 
11 Mount Use hard setting mounting 
media with DAPI. 
 
Table 2-2 Immunofluorescence protocol. 
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2.3.13 Antigen retrieval methods  
Poorer immunostaining occurs with formalin-fixed tissues as compared to frozen 
sections, due to the cross-linking of proteins (antigens) during the fixation process. This 
can render the epitopes (antibody-binding locations) of antigens inaccessible to many 
antibodies (epitope masking), preventing detection by several immunohistochemical 
methods. A number of methods were assessed to unmask antigens, including enzymatic 
treatment (e.g. trypsin), heat-based methods in citrate buffer of varying pH (using a 
microwave) or a combination of pressure and heating (steamer or pressure cooker). The 
process of protein cross-linking is progressive i.e. the longer the fixation time, the 
stronger the cross-linking. This is enhanced by increasing the temperature, which also 
leads to a reduction in immunochemical detection (Webster et al., 2009). Antigen 
retrieval was performed as described below. Briefly, sections were de-waxed (by 
placing the slides for 5 minutes in the oven) and rehydrated. Sections were then treated 
with 0.1% trypsin (PBS/ tween 20) for 30 minutes at 37C, followed by 5 minutes in 
0.2% glycine/ PBS-T to stop the enzymatic action and then processed according to the 
standard IHC protocol (as discussed above).The different antigen retrieval methods 
included; 
 
2.3.13.1 Microwaving   
A 800-watt microwave oven was used to preheat 400–600ml of citrate buffer to 95˚C 
before incubation of the de-waxed and rehydration of the slides. Sections were then 
maintained at 95˚C for 10 minutes (ensuring that the buffer covered all the sections). 
Slides were allowed to cool in the buffer for a minimum of 30 minutes before washing 
in PBS-T prior to IHC. 
 
2.3.13.2  Steaming   
A steamer filled with 1l of citrate retrieval buffer (pH 6.0), was preheated to 80˚C, and 
then the slides were placed in a metal jar filled with the buffer, and heated for 30 
minutes, followed by cooling for 15 minutes. 
 
2.3.13.3 Pressure cooking   
The citrate buffer was preheated to 120˚C (10 minutes on a hotplate) before immersing 
the sections in a metal rack and securing the pressure cooker lid. Once the cooker had 
reached the full pressure (approximately 5-10 minutes) the pressure cooker was placed 
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in an empty sink after releasing the pressure valve and cold water was run over the 
cooker for 3-5 minutes. Slides were left to cool for an additional 5 to 10 minutes after 
opening the lid before IHC staining. 
 
2.4 ScanScope imaging protocol  
All chromogenic IHC, and most of the histology stained sections were scanned by a 
digital scanner (CS2, Aperio, Vista, USA) under x40 magnification. Images scanning 
the entire tissue were saved as ‘Cis’ files, viewed and analysed using ImageScope™ 
software. This software provides powerful viewing analysis tools to scan the entire slide 
with high resolution images and various image analysis options (Olson, 2013). The 
operation and calibration steps were followed according to manufacturer’s 
recommendations. Briefly, a series of critical calibration steps were carried out using the 
Aperio Scanscope, and some illustrative figures referring to the screen shots of these 
calibration steps shown below. 
 
 In the five options of the first window (Start, Scan area, Focus Points, Calibrate, Scan) 
which influence the image results (as seen in Figure 2.3), there options have to be 
adjusted to give a better image quality. In the scan area window option, choosing (20x 
doubled magnification, with narrow stripes) gave better images quality (particularly 
with big specimens). However, choosing 40x doubled magnification with wide stripes 
was not applicable when scanning multiple tissues (TMA) to generate good resolution 
of whole samples. 
 
The number of focus points, and the location of the blue point into the clear area out 
from the focus point rectangle will affect the clarity of the scanned tissue and 
background noise ratio (Figure 2.4 and 2.5 respectively). Before running the analysis for 
the whole slide after setting these parameters, one has to get quick snapshots and review 
them, making sure they are clear from air bubbles, debris, and that the focal point is 
located correctly by visualizing clear tissue with less background staining density 
(Figure 2.6). By following these steps high quality images were obtained which 
improved the analysis of skin structure (Figure 2.7). 
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           Figure 2-3 Schematic for the Imgescope™ software showing the scan area options setup. 
The image was scanned at 20x magnification and narrow strips option.
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             Figure 2-4 Scanning and calibration optimizing steps with the Aperio Imagescope™ software.  
Setting up the focus points (circle) inside the calibrated area, and locating the blue diamond point (arrow) 
outside the scanned rectangle in a clean background. 
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               Figure 2-5 The scanning process.  
 Applying the narrow strips option from a skin sample scanned with the Aperio Imagescope™ software.   
The image was scanned at 20x magnification. 
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                 Figure 2-6 Snapshot review of a human skin sample at 1x magnification.  
        This step was used to evaluate the calibration setting. 
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 Figure 2-7 Human skin stained with G&O and scanned with the Aperio Imagescope™ software at       
1x and 10x magnification. 
This software enhances the analysis of skin morphology structure with the ability to discern the 
particular skin components (left panel) as well as the general structure. 
2.5 Image capture and analysis  
Whole-slide images were captured with an Aperio ScanScope CS scanner (Aperio, CA, 
USA) and additional fluorescent IHC images as well as picrosirius red birefringence 
and fluorescent eosin under bright-field and cross-polar were captured using a Nikon 
TEi inverted microscope equipped with cross-polar optics (Nikon, Kingston, UK) and a 
QImaging CCD camera operated by Nikon NIS imaging software (version 4.10.01). 
Eosin fluorescence and other stains were assessed with the Nikon TEi instrument using 
a Nikon C-FL Epi-Fl TRITC Filter Block (excitation wavelength 547nm, emission 
wavelength 572nm; Barrier Filter BA605/55). The grading of special stains and IHC 
images were completed with an ordinal scale Table 2.3. 
 
 
 61 
 
 
Grading scale for especial stains and IHC images 
Grade index Specific criteria 
- (poor) There is a lack of consistency and a disruption of key features as 
identified by the special stain, or lack of antigenic signal with 
IHC 
† (satisfactory) The main components highlighted by the special stain could be 
identified but a lack of consistency or disruption of features was 
still evident or variation in signal, both within and between 
samples in IHC 
†† (good) The desired features were identified following special staining or 
IHC, with consistency within and between samples 
†††(Best) indicates optimal staining consistency and feature visualisation 
for the individual special stain, or signal accuracy and strength in 
IHC 
Table 2-3 Qualitative description of IHC images.  
The scoring relates to the consistency of special stains or the level of IHC signal seen (rather than the 
general morphology of tissue). 
2.6 Preparation of dermal fibroblasts  
2.6.1 Explant culture of dermal fibroblast  
The explant method grows dermal fibroblasts out of a skin specimen. Briefly, dorsally 
shaved skin samples were wiped with 70% alcohol before dissecting and under sterile 
conditions pieces were washed gently in PBS after removal of the connective tissue. 
Then each sample was incubated in 0.3% trypsin for 60-90 minutes at 37°C in a water 
bath under continuous shaking (350 cycles/per minute). The epidermis and the 
remaining  connective tissue were removed and the dermal sheets were washed three 
times in PBS containing 1% penicillin/streptomycin prior to incubation in a petri dish 
with 10ml of DMEM supplemented with 10% bovine serum at 37C°/5% CO2 incubator 
for 3-6 days. 
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2.6.2    Enzymatic isolation of fibroblasts  
Dorsal skin was shaved, and wiped with 70% alcohol before dissecting a 4x4cm piece 
from each mouse model. Then the skin was incubated in 0.3% trypsin/2.5%/PBS for 50 
minutes under continuous shaking in a 37C water bath to aid epidermal dissociation. 
Each specimen was then transferred to a petri dish containing 5ml of 1% 
penicillin/streptomycin in PBS. Subsequently, using fine forceps, the dermis was peeled 
from the underlying subcutaneous fat (cleaning the dermis sheet from connective 
tissue). The dermal sheet was placed in a 20ml sterile tube containing 1ml PBS and then 
chopped into small (2-4mm) pieces prior to transferring 2.6ml of the cell mixture to 
10.4ml of type IV collagenase (0.5mg/ml Lot 089K862) in a 50ml tube. The contents 
were incubated for 5 minutes under continuous shaking in a 37C water bath and 13ml 
of ice cold complete DMEM, containing 10% foetal bovine serum added to stop further 
collagenase action. Fibroblasts were released by vortexing (1-2 minute) and debris was 
removed by passing the suspension through (80-100m) a nylon mesh. The suspension 
was divided into four 10ml tubes and centrifuged at 150g for 10 minutes at 4ºC. The 
supernatant was discarded and the pellets were resuspended in complete medium and 
seeded into collagen-coated tissue culture flasks (Cell Culture flask EZ flask collagen I 
coated, 25cm², Thermo Scientific Nunc). Fibroblasts were maintained in a 37°C/5% 
CO2 incubator over 5-10 days until the cells were 70-90% confluent (passage 1).  
Primary dermal fibroblast cell lines from 3 ob/ob mice and 3 age-matched wild-type 
controls were cultured and expanded in supplemented DMEM (Chapter 5) and used in 
experiments at passages 1-5. 
2.6.3  Western blotting   
Primary dermal fibroblasts were isolated from 12 week old, male, wt/wt, ob/ob, misty, 
and db/db as well as 20 month old wt/wt. Cells were lysed in 150μL RIPA buffer (see 
Appendix 9) containing protease inhibitors. Lysates were shaken at 4°C for 15 minutes 
before centrifugation at 14,000g for 15 minutes at 4°C. 30μg protein was subjected to 
10% SDS-PAGE before electrophoretic transfer onto nitrocellulose membranes. Blots 
were blocked in 5% BSA and probed with a polyclonal antibody to the insulin receptor 
β-subunit (IRβ, Cell Signaling Technologies, Danvers, MA, USA, 1:1000 dilution) 
overnight at 4°C. Following a one-hour incubation with an HRP-conjugated secondary 
antibody (goat anti-rabbit, 1:10000 dilution, Merck Millipore, Billerica, MA, USA), 
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blots were washed and developed with a chemiluminescent substrate (Supersignal West 
Pico, ThermoFisher, Rockford, IL, USA). Protein expression was quantified using 
GelquantTM software (DNR Bioimaging Systems Ltd, version 2.7.0) and expression 
relative to GAPDH calculated.  
2.6.4 Dermal fibroblast experiments 
2.6.4.1 Cell viability  
When dermal fibroblast cells reached the desired confluence, cell viability was 
measured by adding 0.4ml of the cell mixture to 0.1ml trypan blue with 0.01 ml of the 
mixture transferred to a haemocytometer. The percentage viable cells (with clear 
cytoplasm) to nonviable cells (blue cytoplasm) described cell viability (Strober, 2001). 
The dermal fibroblast cells viability were between 70-90%. 
 
2.6.4.2 Proliferation  
Proliferation was assessed using methylene blue uptake, as previously described 
(Olsson et al., 1982). Pre-confluent cells were assayed 2, 4, and 6 days post-plating. 
Cells were washed in PBS and fixed in 10% formaldehyde solution (v/v in PBS). After 
washing in borate buffer (10mM, pH8.4), cells were incubated with methylene blue (1% 
w/v, in borate buffer) for 10 minutes at room temperature. Cells were then washed 
under running water until no free dye persisted. After drying, methylene blue was eluted 
in 0.1N hydrochloric acid for 10 minutes at 50C and the absorbance OD630nm was 
measured. 
 
2.6.4.3 Collagen production  
Collagen synthesis was measured using a modified method of Heng et al (Heng et al., 
2006). Pre-confluent culture plates were washed 3 times in PBS and fixed with Bouin’s 
solution for one hour at room temperature before thorough rinsing in running water and 
air-drying overnight. Cells were stained for one hour at room temperature in picrosirius 
solution (1mg/ml Direct Red 80 in saturated picric acid) with gentle agitation. Any free 
dye was removed with 4 washes in 0.01N HCl, before plates were dried for 20 minutes 
at 70ºC. Incorporated dye was eluted in 0.1N NaOH with mild agitation for 30 minutes 
and the OD at 550nm determined by spectrophotometry. Values were normalised 
relative to total protein content measured using Bradford reagent (Bio-Rad  Laboratories 
Ltd. Bio-Rad House Maxted Road) according to the manufacturer’s recommendations. 
Briefly, the protein standards, 0.1-1.4mg/ml was prepared using bovine serum albumin 
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(BSA). Then 5l of the protein standards and cell lysates were added to separate wells 
in a 96 well plate in duplicates, and 5l of 1% Triton-X-100 was added to the blank 
wells. 250l of Bradford reagent was then added to each well and mixed. Samples were 
incubated for 30 minutes and read at 595 nm.  
 
                                           A sample x C standard 
Protein (mg/ml) =        ------------------------------ 
                                               A standard 
Where A is absorbance at 595nm and C is concentration of standard mg/ml. 
 
2.6.4.4 Senescence- associated β-galactosidase assay  
Pre-confluent cells were washed twice in PBS and fixed for 15 minutes at room 
temperature in phosphate buffer (pH 7.3) containing 5mM EGTA, 2mM MgCl2 and 
0.2% glutaraldehyde. Following 2 washes in 2-3 ml of 0.1M phosphate buffer 
containing 2 mM MgCl2, 1 mg/ml X-gal (in 0.1M phosphate buffer, 2mM MgCl2, and 
5mM potassium ferrocyanide) was added and the cells were incubated overnight at 
37C before thorough washing in PBS and analysis. Cells were visualized under a light 
microscope and the proportion of blue positively stained (senescent) cells was counted 
according to Bimri et al. The percentage area of β-galactosidase positive-cells was 
determined in 8 fields, from replicate cultures using VIS image analysis software 
(VisioPharm, Hoersholm, Denmark). 
2.6.5 Statistical analysis  
Statistical analysis was performed using GraphPad Prism™ 5 software (La Jolla, USA). 
All results are expressed as mean ± standard error of the mean (SEM) with a p<0.05 
considered as statistically significant (*p<0.05, **p<0.01, ***p<0.001). Statistical 
differences were determined using an unpaired two-tailed Student‘s t-test or one- or two 
way ANOVA with a post-hoc Dunnett’s test or followed by a Bonferroni post-test for 
selected data unless otherwise stated. 
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3 Chapter 3: Skin Histology of Mouse 
Models of Obesity and Type 2  Diabetes 
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3.1 Introduction 
The majority of individuals diagnosed with type 2 diabetes mellitus will experience skin 
complications during the natural history of their disease, ranging from relatively benign 
epidermal manifestations, such as acanthosis nigricans, diabetic thick skin, through to 
potentially harmful delays in wound healing, and diabetic foot ulcers (Romano et al., 
1998, Baloch et al., 2008). Addressing these sub clinical changes at the molecular level 
in order to understand the cutaneous complications and its pathogenesis in humans is 
difficult as there are many contributing factors in this disease and the skin presentation 
is complex. Furthermore there is a notable lack of skin donor availability, homogeneity 
as well as clear ethical constraints. These confounders have directed the researchers to 
rely on alternative experimental sources: including in vitro models, genetically 
engineered animal models, ex vivo, and xenotransplantation tools  (Guerrero-Aspizua et 
al., 2010) to unravel the sophisticated aetiology and pathways (Treuting and Dintzis, 
2011).  
 
Mouse skin has been well acknowledged as an essential tool to study human skin 
diseases, including skin cancer, dermatological lesions, infections, hair loss and wound 
healing (Avci et al., 2013). Wild-type mice exposed to calorie-rich diets, or genetic 
mutants that lack the satiety regulator leptin (ob/ob mice) or its receptor (db/db mice), 
are widely used in the study of type 2 diabetes. These models are associated with weight 
gain, increasing plasma glucose levels and progressive insulin-resistance, and in the 
case of db/db mice, the eventual deterioration in pancreatic islet function modelling 
end-stage human disease (Hummel et al., 1966, Surwit et al., 1988). These animals also 
display the compromised re-epithelialisation and chronic inflammation, characteristic of 
non-healing diabetic wounds in man, and therefore, are widely used in wound healing 
studies (Frank et al., 2000). There is a lack of full knowledge of pathological changes in 
mouse models of obesity and type 2 diabetes skin in the literature. This  might be due to 
the fact that mouse skin is much thinner, softer, and much more difficult to obtain good 
histological sections than human skin. Furthermore, the compressed anatomical 
structure in mouse skin (in comparison to human skin) characterised by thinner 
epidermis, poor vascularisation, the absence of retre ridges, clear boundary between 
reticular, and papillary dermis present many disadvantages if one seeking exploring 
these phenotypes.  
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Likewise, the major challenge in detecting the pathological changes in these mouse 
models was achieving good histological sections. Particularly, loss of architecture 
during processing, and other artefacts which has implications for later downstream 
applications.  
3.2 Materials and methods 
3.2.1 Histology of diabetic mouse skin  
Dorsal skin sample from male from eight biological animal models; wt/wt, ob/ob, misty 
,db/db, DIO, lean (12 month), ob/ob with high fat diet, and ageing wt/wt at 20 month old 
(n=6).Three replicates from each mouse were cut into 5x10 mm and placed in plastic 
cassettes prior to be fixed in 10% NBF for 3 days at RT. Samples were processed for 
approximately 10 hours according to the long processing protocol (Appendix3). Then 
4µ paraffin embedded sections were generated using the softening agent (Appendix 4) 
prior to IHC analysis (as described in Chapter 2). A list of antibodies used in evaluating 
diabetic mouse skin phenotypes are detailed in (Appendix 5). Various procedures were 
employed including antigen retrieval, different primary antibodies (1Abs), and different 
incubation conditions to optimise the immunostaining results. Detailed below are the 
antibodies (which gave meaningful results), and the optimised dilutions and incubation 
conditions (Table 3.1). 
  
 68 
 
 
Antibodies 1ºAb / Antigen Retrieval (AR) 
PCNA 1:100 / 10 min pressure cooker/citrate buffer 
pH=6 
Involucrin 1:50 / trypsin-EDTA  
Profilaggrin 1:100 /10 min pressure cooker/ citrate buffer, 
pH6 
CD31 1:200/10 min pressure cooker/ citrate buffer, 
pH6 
CD68 1: 50 /10 min pressure cooker/ citrate buffer, 
pH6 
keratin 14 1:2000/10 min pressure cooker/ citrate buffer 
pH=6 
RAGE 1:500/ 10 min pressure cooker/ citrate buffer 
pH=6 
Table 3-1 Primary antibody dilution and antigen revival (AR) method. 
3.3 Results  
3.3.1 Murine models of obesity and diabetes  
Physiological measurements from various mouse models of insulin resistance, obesity 
and type 2 diabetes are described in Table 3.2. Ageing was associated with a small rise 
in fasting blood glucose in wt/wt animals, whilst those maintained on a high fat diet 
became mildly hyperglycaemic. Both genetically-obese models (ob/ob and db/db) 
showed hyperglycaemia. Circulating insulin acts to counter elevated plasma glucose and 
maintain a normoglycaemic state, and increased insulin levels were recorded in both 
obese (DIO) mice which were maintained on a high fat diet for 12 months, and in ob/ob 
mice. However, decreased insulin levels (even in the presence of high glucose levels) 
were measured in type 2 diabetic db/db animals.   
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Strain Age 
(months) 
Diet Weight (g) 
(mean 
+SEM) 
Glucose 
[mM] 
Insulin [pM] 
wt/wt 3 chow 26.6+/- 0.44 3.9+/-0.54 278+/-13 
wt/wt 12 chow 39.6+/-0.9 6.2+/-0.3 298+/- 48 
wt/wt 12 (DIO) 45% 
fat 
44.5+/-0.6 7.2 +/- 0.6 2730 +/- 300 
ob/ob 3 chow 46.5+/-5.5 8.7+/-3.3 4938+/- 1973 
ob/ob 3 45% 
fat 
52.6 +/- 4.2 10.7+/- 3.1 8800+/- 3852 
Misty 3 chow 23.9+/-1.4 5.4+/-0.5 114+/-18 
db/db 3 chow 45.3+/-3.6 14.8+/-2.6 1399+/-329 
Table 3-2 Body weight, fasting blood glucose and plasma insulin levels in murine models of 
obesity and type 2 diabetes. 
Mean values +/- SEM are shown from 6 animals per group. 
 
3.3.2 Cutaneous organizations in insulin resistance, obesity, and old mice 
models  
When comparing the morphological structure across these models I noticed that the 
structure of the dermis and subcutis changed with progressive insulin resistance, with 
the greatest disruption occurring in the dermis (Figure 3.1A). An increase in 
subcutaneous fat deposition relative to age-matched chow fed controls (12 months old) 
characterised the skin of wt/wt mice maintained on a high fat diet (DIO) (Buettner et al., 
2007). Whereas tissue from ob/ob mice, which are a more severe model of obesity and 
insulin resistance showed both increased fat deposition and dermal erosion as compared 
to age-matched controls and this phenotype was exacerbated by a high fat diet as shown 
with H&E stained sections (Figure 3.1A). Complete loss of the reticular layer 
characterised tissue from ob/ob animals maintained on a high fat diet and the persisting 
sub-epidermal papillary dermis showed a loss of collagen integrity. Picrosirius staining 
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effectively demonstrated normal collagen organisation, and the well-organised 
“basketweave” of thick fibres characteristic of young lean skin, which was 
progressively lost with hyperinsulinaemia (Figure 3.1B). Loss of organisation was also 
seen to a lesser extent with age. 
 
 
Figure 3-1 Skin compartments and collagen changes from different mouse models.  
Representative images of H&E and PS stained sections from six mice per each group .(A) lean mice 
(wt/wt), and mouse models of obesity (DIO), insulin resistance (ob/ob) and age (12 month) with H&E 
and(B) with PicroSirious (under crossed-polar microscopy). Bright-field images were captured at 10x 
original magnification, and 50x under crossed-polar images. 
 
3.3.3 Skin compartmental depth and body composition  
Histological sections of skin from lean, insulin-resistant and ageing mice were used to  
measure dermal depth (Figure 3.2). Skin from 3 month old chow fed animals was 
characterised by a tightly packed dermis overlying a subcutis comprising one to two 
layers of adipocytes (Figure 3.2.A). In DIO mouse skin a slight increase in the 
subcutaneous layer (not significant) was not accompanied by a loss of dermis at 12 
month of age (Figure 3.2.B). Fat deposition increased 3.6 fold in 12 month-old mice 
exposed to a high fat diet, when compared to lean controls at same age. However, while 
an increased space between collagen fibres characterised the dermis, there was no 
significant change in dermal depth (Figure 3.2I). Similar to previous reports, increased 
insulin resistance is a feature of ageing (Gkogkolou and Böhm, 2012, Osman et al., 
2013a), and a slight reduction in dermal depth was recorded in wild-type mice 
maintained on chow at 20 months of age relative to 3 month wt/wt (Figures 3.2D and 
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3.2I). Insulin resistant ob/ob skin showed a 2.4 fold reduction in the size of the dermal 
compartment relative to controls, accompanied by a 6.3 fold subcutaneous expansion 
relative to wild-type controls (Figures 3.2E and 3.2I). This phenotype was exacerbated 
in ob/ob mice maintained on a high fat diet, and these animals displayed a 4.8 fold 
decrease in the dermis and an 8.8 fold adipose layer expansion relative to chow-fed 
wild-type controls (Figures 3.2F and 3.2J). Diabetic db/db animals displayed a 1.8 fold 
reduction in dermal depth and an 11 fold increase in adipose deposition compared to 
lean misty mice (Figures 3.2G, 3.2H and 3.2K). A significant increase in body weight, 
fat mass and % fat mass from 3 month old ob/ob and db/db as compared to their age 
matched controls was observed when measuring the body composition by DEXA (Dual 
Energy X-ray Absorptiometry) (Figure 3.3). 
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Figure 3-2. Cutaneous phenotypes in animal models of insulin resistance. 
H&E stained paraffin sections representative images from 4-6 animals  maintained on chow diet at 3 
months (A) or 12 months without (B) or with fat diets (C), and from 20 month old mice on chow (D). 
Tissue from 3 month old ob/ob maintained on either chow or high fat diets are shown in E and F 
respectively. Finally, I studied tissue from 3 month old misty controls (G) and age matched db/db mice 
(H), both maintained on chow. Scale bars = 100µM. I also quantified the dermal depth in (I), which 
revealed a significant loss of dermis with only ob/ob maintained on high fat diets. Dermal fat depth in 
showed a significant increase in ob/ob and db/db skin  (J), which was exacerbated by a high fat diet.  
Significance was assessed by 1-way ANOVA with a post-hoc Dunnett’s test. *p<0.05, ** p<0.01; 
***p<0.001.    
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Figure 3-3 Body composition of mouse models of obesity and diabetes, and age. 
By using  DEXA (Dual Energy X-ray Absorptiometry)  body weight, lean and fat mass, as well as the 
percentage of fat mass were measured from 6 animals at 3 month old wt/wt, ob/ob, misty, db/db, and 20 
month old wt/wt (OLD) models. Significance was assessed by 1-way ANOVA followed by Dunnett's 
post-test. *p<0.05,; ***p<0.001, ****p<0.001.  
 
3.3.4 ECM structure and immune infiltration  
The most abundant components of the extracellular matrix (ECM) of mouse skin are 
collagen fibres and elastic fibres to a lesser extent (Watt and Fujiwara, 2011). In wild 
type mouse skin, fine elastic fibres were difficult to discern from the relatively thick 
adnexal fibres in Giemsa and Orcein stained dermis (Figure 3.4A). Bundles of elastic 
fibres were observed in the upper layers of the dermis at 12 months of age, with an 
increased disorganisation in mice exposed to a high-fat diet. I did not observe any 
elastic areas in the skin from older mice, suggesting that localised elastosis may be a 
relatively stochastic phenomenon, rather than being specifically age-related. The 
considerable loss of dermis in the genetic models made it extremely difficult to assess 
the organisation of elastic fibres but no evidence of significant elastosis was detected.  
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Giemsa is an effective stain for immune cells, and mast cells are readily identified by 
their abundant cytoplasm that contains vivid purple-staining granules. Small numbers of 
mast cells are normally resident in the skin, but I did not observe a change in numbers 
in any of the models investigated. I did, however, observe an increase in CD68-positive 
macrophages in the dermis of 20 month old mice compared to young lean wt/wt mice 
(4-fold, p=0.04; Figure 3.7), but no significant change in any other state. Overall, there 
was no obvious significant evidence of inflammation in this study, nor was there 
evidence of angiogenesis in the CD31 stained sections in these models (Figure 3.7). 
 
wt/wt(3M) wt/wt(12M) DIO(12M) ob/ob(3M) ob/ob HFD wt/wt(20M) 
 
 Figure 3-4 ECM organisation . 
Representative images of 4-6 animals per each group. Tissues were stained with O&G (A), picrosirius 
(B), Herovici (C) and PAS (D) and viewed under bright-field, with the exception of cross-polar 
picrosirius images. (A) Elastic fibres appear dark purple/black, collagen rose pink, nuclei are dark blue, 
cytoplasm stains light blue and mast cells are characterised by purple cytoplasmic granules (difficult to 
discern at this magnification). Disorganised elastic fibre bundles can be seen in 12 month old animals. 
Scale bar =100µM. (B) shows the collagen basket-weave, revealed by picrosirius staining and cross-polar 
imaging. Scale bar =50µM. (C) Herovici staining identifies immature collagen as blue fibres and mature 
collagen as red fibres. Scale bar =50 µM. (D) PAS staining highlights glycoproteins, predominantly in 
basement membranes and endothelial walls. Scale bar =100µM. 
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The birefringent property of picrosirius-stained collagen revealed a “basket-weave” 
conformation in young lean skin when viewed under polarised light (Figure 3.4.B) 
(Junqueira et al., 1979). The fine papillary and thicker reticular fibres meet 
approximately at the level of the sebaceous gland (seen as dark spaces) in picrosirius 
stained sections. Some relaxation of the basket-weave occurred in wild type chow-fed 
animals at 12 months of age, which was exacerbated by exposure to a high fat diet. 
Moreover, a loss of deeper reticular fibres was apparent in the latter group. A further 
loss of reticular fibres was detected in ob/ob mice, which was exacerbated in db/db skin. 
Strikingly, ob/ob animals maintained on a high fat diet retained only a thin layer of 
papillary dermis, which adopted a flattened, rather than basket-weave configuration. 
The deeper reticular dermis was all but lost in these tissues. Skin from an extreme-aged 
model also showed regions of basket-weave loss in the papillary dermis, as well as 
erosion of thicker reticular dermis. 
  
Fiona Watt et al used Herovici’s polychrome to discern mature collagen fibres (red 
fibres) from immature fibres (blue fibres) (Collins et al., 2011a). This technique 
identified a layer of blue-staining collagen adjacent to the basement membrane in lean 
mice (Figure 3.4C). With increasing age, this pattern became discontinuous, and in the 
high fat-fed model, the blue layer was difficult to discern. The blue-staining layer was 
maintained in chow-fed ob/ob mice (albeit qualitatively reduced compared to controls), 
whereas exposure of these mice to a high-fat diet led to a loss of immature collagen 
fibres. In the extreme-aged model, collagen synthesis appeared to be discontinuous, and 
generally associated with epidermal ridges. PAS staining identified basement 
membranes and vasculature (Figure 3.4D). It is known that collagen and elastin in 
hyperglycaemic state undergo very slow non-enzymatic protein cross-linking and form 
heterogeneous group of protein-bound moieties called  advance glycated end products 
(AGEs) which cause various complications in both diabetes and ageing (Nawale et al., 
2006).  Despite the increased levels of plasma glucose found in models of type 2 
diabetes, increased glycation (except old mice skin) was not a prominent feature of any 
of the models studied. This confirmed  by the lack of expression of RAGE  IHC from 
the latest skin samples, and (Figure 3.6 left panel) shows a representative image from 
db/db skin(n=6). In contrast, the positive reaction of PAS materials (Figure 3.5), and 
RAGE immunoreactivity (Figure 3.6) were seen in the diabetic pancreas of db/db mice 
as evidence of glycation. 
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Figure 3-5 Representative image for positive PAS stain in diabetic pancreas. 
PAS positive materials were detected in the pancreatic islet of diabetic mice (n=3), and blood vessel wall 
(arrows) from db/db mouse. Image was captured at 20x. 
 
Figure 3-6 Representative images for expression of IHC with RAGE antibody. 
Representative image in the left panel shows lack of expression RAGE IHC signal in skin from db/db 
animals (n=6). In the right panel refers to representative image of pancreas section from db/db mice (n=3) 
was stained with anti-RAGE antibody. The RAGE receptors were prominent in outer layer of the islet, 
where the alpha cells are localised.  Image was captured at 20x. 
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3.3.5 Epidermal differentiation markers 
Filaggrin expression normally decorates the upper spinous and granular epidermal 
layers, acting as an anchor for the assembly of keratin filaments in barrier formation 
(Dale and Holbrook, 1987). The expression of its precursor, profilaggrin, in normal and 
insulin-resistant states, as a marker of epidermal differentiation was detected (Figure 
3.7), however, no gross changes in profilaggrin were seen in either DIO mice, or in 
chow-fed ob/ob or db/db mice relative to lean controls. Consistent with these results, no 
gross alterations were seen in the expression of  involucrin, which is an earlier marker 
of epidermal differentiation, (Figure 3.8) (Gudjonsson et al., 2007). Interestingly, a 
qualitative reduction in PCNA immunoreactive cells was detected only in the most 
extreme obese group (high fat-fed ob/ob animals). Whilst no little changes were seen in 
the expression of the basal keratin K14 across any investigated models, with the 
exception of the high-fat fed ob/ob animals, which showed a lower level of 
immunoreactivity, although staining, remained continuous throughout the compartment. 
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               wt/wt (3M)        ob/ob (3M) ob/ob HFD wt/wt (20M) 
 
     Figure 3-7 Macrophage infiltration, angiogenesis and epidermal maturation. 
Representative images from 4-6 animals per each group. Macrophages were identified by CD68 
expression in 4μM paraffin sections prepared from wt/wt mice at 3 month (M) old, age-matched ob/ob 
mice on chow and a high fat diet (HFD), and in 20 month old wt/wt Scale bar =50 µM.  Endothelial 
cells were identified by CD31 immunoreactivity. Epidermal development was assessed by expression 
of filaggrin (decorating the outer stratum corneum), PCNA (mitotic cells, mainly located in the basal 
layer) and K14 (identifying basal keratinocytes). Images were captured at 20x magnification. 
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Figure 3-8 Involucrin as an early marker of epidermal differentiation immunoreactivity. 
(A) wt/wt mice at 3 month old; (B) age-matched ob/ob mice on chow; and (C) on a high fat diet; (D) 
wt/wt mice, 20 month old. Representative images from 4-6 animals per each group. Images were captured 
at 20x magnification. 
3.4 Discussion  
Murine models of type 2 diabetes provide essential tools to unravel the aetiology of this 
disease. These models are used to study cutaneous disorders in increasingly 
hyperglycaemic and hyperinsulinaemic states (Lee-Kubli et al., 2014, Biessels et al., 
2014). This chapter provides an evaluation of histological differences in mouse models 
of obesity and type 2 diabetes mellitus as well as a characterisation of cutaneous 
maturation and function through investigating various cutaneous markers. 
 
The skin is an insulin-sensitive tissue (Shen et al., 2000) and in this study I described 
specific patterns of skin damage in animal models of obesity and type 2 diabetes, the 
most notable of which was the degradation of the deeper layers of the dermis. This 
attrition was accompanied by the loss of regular collagen organisation, which has 
implications for the physical integrity of the skin and its capacity for repair. In 
particular, the reticular layer of the dermis, adjacent to an expanded adipose depot, 
suffered the greatest insult, and this layer was all but lost in the most extreme phenotype 
(ob/ob animals maintained on a 60% fat diet). Moreover, the “basket weave” of the 
remaining papillary dermis adopted a more laminar organisation, coupled with a 
reduction in dense irregular fibrillar collagen topography. This is associated  with 
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reduced mechanical strength, and consistent with a recent study (Delaine-Smith et al., 
2014). Thus, insulin-resistance might be associated with the compromised ability of 
dermal fibroblasts to secrete and assemble collagen.  
These pathological consequences previously were assumed to be the result of direct 
glycosylation of proteins exposed to hyperglycaemia (glycation, or browning) as the 
underlying cause of peripheral disease, but I have shown that tissue damage predates 
hyperglycaemia in DIO and old animals. This is, perhaps, unsurprising if one considers 
that many of the changes seen in diabetes are also seen (albeit in a less severe form) in 
ageing. This was supported by low expression of the receptor of advanced glycation end 
products (RAGE) antibody (Figure 3.6 left panel) in the skin from mouse models of 
obesity, type 2 diabetes and ageing (by applying IHC protocol with RAGE antibody as 
described in 2.3.11 and Table 2.1 in general method chapter). However, in agreement 
with other studies, the  onset of advanced glycated end products, and positive the PAS 
staining in the diabetic pancreas suggests that the rate of glycation and oxidation 
reaction in skin is very slow and might only be presented in long term diabetes and 
ageing (Nawale et al., 2006). In accordance with previous studies, in ageing skin; the 
cutaneous collagen degradation, elastosis, and abnormal vasculature (slight CD31 and 
PAS up regulation diagnosed in our ageing mice skin) might result from collagen 
proteins cross-linking (glycation) (Nawale et al., 2006). 
Changes in collagen organisation may reflect either the loss of thick fibres, revealing 
underlying collagens, or a more general loss of collagen integrity (or both). More 
interestingly, dermal layers show discrete responses to increasing insulin resistance, 
evidenced in the increasingly laminar organisation of papillary dermis and the loss of 
reticular dermis, as well as differences in elastin deposition. In particular, loosely 
packed collagen and altered elastin deposition characterises skin from diabetic animals 
compared to their controls suggesting that progressive loss of fibroblast function is 
inevitable in insulin resistant states. Thus, it is possible that in vitro studies of the 
dermal fibroblasts from ob/ob mice may provide a deeper insight into the dermal loss 
mechanism. Obesity and insulin resistance in humans is closely associated with ectopic 
fat deposition (Snel et al., 2012), particularly, the deep enlarged subcutaneous adipocyte 
that is considered as independent predictor for IR (Marinou et al., 2014).  I observed an 
increase in both the size and the number of subcutaneous adipocytes in obese mice that 
correlated with a reduction in dermal tissue. Moreover, dermal erosion was extended to 
a loss of connective tissue in the adipose layer itself (the hypodermis). Elevated 
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adipokine signalling secreted from subcutaneous fat is emerging as a potential mediator 
of insulin-resistance (Karastergiou and Mohamed-Ali, 2010), thus it is possible that 
chronic exposure of fibroblasts to adipokines underlies their impaired function. 
Furthermore, peripheral damage in type 2 diabetes is traditionally considered to arise 
from prolonged exposure of tissues to elevated levels of reactive glucose molecules, but 
chronic hyperinsulinaema, inflammation or hypoxia could also promote such damage 
(Aronson, 2008, Singh et al., 2014). 
 
Why an increase in circulating adipokines characterises obesity remains unclear, 
although it was speculated that inflammation, and hypoxia arising from the relatively 
poor vascular supply within enlarged fat deposit could be the cause (Trayhurn and 
Wood, 2004). Macrophages are the most predominant immune cell in the inflammatory 
processes associated with obesity and diabetes; but no gross changes were seen in our 
insulin resistant and diabetic models using G&O staining (Drozdowski and Mehregan, 
2005). Although there was little evidence of frank inflammation, as demonstrated by 
IHC analysis of CD68 (Chen et al., 2008) in this study elevated levels of CD68 
expression were detected only in 20 month old mouse skin. Furthermore, by using HIF-
1α IHC detection (as mentioned in general chapter method 2.3.11 and according IHC 
protocol detailed in Table 2.1) there was no evidence of hypoxic condition in skin of 
mouse models used in this study, and no evidence of angiogenesis was seen (i.e. no 
changes in CD31 expression in our models with slight up regulation exception in ageing 
animal).  
 
I also investigated skin integrity in ageing, as all tissues acquire some degree of insulin 
resistance over time (Varani et al., 2000), and I observed that many histological features 
of ageing, for example loss of collagen organisation and synthesis (Varani et al., 
2006b), as well as abnormal elastic fibres in mid and lower dermis correlate with 
collagen degradation in these mouse models of obesity and diabetes (Seitz et al., 2011). 
A deeper understanding of the mechanisms underlying the commonality between 
insulin-resistant and ageing states (reviewed in (Seitz et al., 2011), and  is essential to 
elucidate the  appearance of an “accelerating ageing“ skin  phenotypes in mouse models 
of obesity and diabetes.  
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In contrast to the dermal and subcutaneous layers, I found little change in epidermal 
maturation (via profiling epidermal differentiation markers) with increasing insulin 
resistance. However, there was some disruption in the organisation and integrity of the 
epidermis with increasing insulin resistance. In particularly, only the most insulin-
resistant mouse models (ob/ob mice fed on high fat diets) showed a negative impact of 
differentiation through reduction in PCNA and K14 IHC expression. This was 
surprising as even relatively young ob/ob mice maintained on a chow diet are known to 
show impaired wound re-epithelialisation (Goren et al., 2006). Thus, the disrupted 
glucose homeostasis in insulin resistant states may have a greater effect on keratinocyte 
activation and migration, fibroblasts (in secreting, and remodelling ECM) and 
angiogenesis dysfunction (Berlanga-Acosta et al., 2012). Nevertheless, the epidermis 
may be a more protected site, perhaps as a consequence of higher cell densities (damage 
to the relatively sparse dermal fibroblast population will have a disproportionate 
outcome), or perhaps deleterious adipokines stimulation is mitigated by distance. 
However, severe insulin resistance is associated with impaired epidermal 
differentiation, and dermal disruption evidenced in the increasingly laminar organisation 
of papillary dermis and the loss of reticular dermis.  
 
Although this study provided distinctive knowledge of many pathological sequelae of 
cutaneous damage in mouse models of obesity, type2 DM and ageing via histological, 
and IHC evaluation of skin structure and function, there were many histotechnological 
difficulties throughout this analysis. Mouse skin is very thin and the loss of architecture 
during processing has implications for downstream applications. In particular, obtaining 
good histology from diabetic mouse skin was the biggest challenge. However, detecting 
cutaneous phenotypes in mouse models of obesity and type 2 DM was difficult and 
required a deep understanding of the contributing factors and parameters that may affect 
the skin morphology, structure and quality that might confuse these phenotypes or cause 
misleading artefacts. Thus, by taking these issues to consideration, I went on to revise 
some histology methods in order to improve, and minimise artefacts of mouse skin 
morphological and IHC analysis in the next chapter.   
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4 Chapter 4: Optimising Histological 
Analysis of Normal Mouse Tissues 
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4.1 Introduction 
It is well known that mouse skin is a useful tool to study human cutaneous diseases such 
as skin cancer, dermatological lesions and infections, hair loss and wound healing  
(Avci et al., 2013). This has been facilitated in part by innovation in both in vivo and ex 
vivo techniques such as histopathology, and cellular and molecular biology. Great care 
must be taken when translating data from mouse models of human disease to diagnose 
or elucidate mechanisms disease, or when investigating the effect of pharmaceuticals on 
specific pathogenic processes, by applying highly evaluated analysis protocols 
(Treuting and Dintzis, 2011). Histological analysis is a cornerstone of skin disease 
diagnosis, and the stratified nature of the skin presents many technical problems in the 
preparation of sections of acceptable quality. Furthermore, histological artefacts may be 
exacerbated in pathological states that compromise cutaneous integrity. Therefore, extra 
care must be taken when selecting the conditions, particularly fixative type, to ensure 
that meaningful conclusions may be drawn (Al-Habian et al., 2014). Although many 
reports describe the use of mouse skin to reveal insights into aspects of human 
pathology, it remains a challenge to find a standard protocol that retains the complex 
structure of mouse skin effectively. Researchers often report the use of human skin 
histology protocols when analysing mouse tissue and this is not necessarily acceptable 
when one considers the anatomical differences between human and mice. For example, 
mouse skin is thinner than human skin, thus it is much harder to achieve good sections. 
Moreover, this is exacerbated if tissues are compromised, for instance skin structure 
from obese and diabetic models shows a thickened subcutis and reduced dermis. Thus, 
getting acceptable sections from these models was extremely difficult, and many skin 
tissues were lost during preparation, and I spent a considerable amount of time adapting 
the best sectioning methods and conditions. Systematic analysis of histological methods 
in mouse are limited, and it is possible that fixatives that may provide outstanding 
morphology results could interfere with, for example, immunodetection techniques 
(Treuting and Dintzis, 2011).  Problems related to incomplete fixation, or improper 
processing, cannot be remedied at a later stage, thus this is a crucial point when 
studying valuable tissues. Therefore, fixative and processing protocols must be decided 
upon at the outset (Srinivasan et al., 2002). The total impact of a particular fixative on 
tissue should be assessed after processing, sectioning and staining in order to 
demonstrate the adequacy of a specific fixative for any staining protocol (Taylor et al., 
2002). 
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The term ‘fixation’ refers to chemical modification of a biological tissues to prevent 
autolysis and putrefaction. It is very important to understand the mechanism of fixation 
prior to histological or IHC applications. Fixation also helps in making the cellular 
elements more resistant to the rigorous processes of staining, and preserves antigenicity 
from cross-linking. Various types of fixation techniques are available to preserve tissue 
elements, and one must be aware that ineffective fixation (including over-fixation) may 
irreversibly degrade specimens and result in artefacts. Moreover, fixation not only 
causes chemical modification to stop degradation or bacterial decomposition, but also  
helps in the immobilisation of antigens and the arrest of other cellular processes (De 
Paul et al.). Thus, it is very important to understand the chemical actions of a fixative on 
tissues before embarking in any histopathology research (Treuting and Dintzis, 2011). 
Not all fixatives used in histopathology laboratories have similar properties. 10% 
neutral buffered formalin (NBF), a non-coagulating fixative, has been used widely for 
many decades, and continues to be the first choice for many pathologists (Grizzle, 
2009b). However, the negative effects of 10% NBF include its propensity to mask 
antigenic sites, degrade certain antigens, promote tissue shrinkage and reduce nuclear 
detail. Moreover, the performance of NBF is inconsistent when a range of stains is 
compared (Howat and Wilson, 2014). Hence, selecting the appropriate processing 
conditions, particularly the fixative type and fixation time must be carefully considered 
to ensure that meaningful conclusions may be drawn. In this study, I sought to compare 
the ability of 10% NBF to preserve and retain cutaneous morphology and antigenicity 
with respect to three widely- used fixatives: Bouin’s solution, zinc formalin (ZnF) and 
alcoholic formalin (AF) (Treuting and Dintzis, 2011) under various conditions to 
determine the optimal fixation methods for mouse skin histology. Time and temperature 
also play a key role, and I investigated each fixative with respect to these parameters. 
For example, 10% NBF  has  a  propensity  to mask  antigenic  sites,  degrade  certain  
antigens, promote tissue shrinkage, and reduce nuclear detail, and all these actions 
depend on cofactors such as time (which can determine the insufficient or sufficient 
cross-linking of polypeptide chains), and temperature (this reduces the time of action by 
increasing penetration) (Al-Habian et al., 2014). The literature provides little insight in 
to optimal fixation times in mouse skin tissue, and in most researchers fix for 24-72 
hours with little consideration of ambient temperature and tissues thickness (Srinivasan 
et al., 2002). 
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Therefore, this chapter will focus on optimizing normal mouse skin histology methods 
through revising fixation and processing protocols. Skin sections from mouse models 
used in Chapter 3 were prepared according to existing best practice for skin in my 
laboratory were relatively good (10% NBF fixation for 3 days, followed by using 
routine processing protocols (Appendix 1), albeit at the cost of time in sectioning . I 
faced many problems in sectioning skin samples prepared under these condition, 
including folding and losing some parts of specimens (mainly from the loose packing of 
the dermis), and maintaining the organised adipocyte structure. On occasion there was a 
lack of clarity after staining the skin sections, possibly due to residual fixative. All these 
issues reduce the chance of getting good sections from paraffin blocks, and will 
influence to a certain extent histopathology analysis outcomes. Since the skin samples 
used in this thesis were collected from a variety of in vivo experiments, it was not 
feasible (or ethical) to repeat the entire study to revise the fixation and processing 
protocols. For this reason, from this point on I describe the optimisation histology 
protocols for prospective diabetic mouse tissue analyses. Firstly, before revising the 
fixative choice, I sought to compare the existing processing protocol with two 
customised ones, as dehydration, clearing, and wax infiltration play a critical role in 
maintaining tissue structure (Renshaw, 2007). To increase histological analysis 
throughput, and to minimise technical variation, I made use of tissue macroarrays (as 
described in the previous methods chapter). Various mouse organs were used to assess 
the efficiency and generalisability of different processing protocols. Secondly, I 
evaluated methods using normal mouse skin in order to achieve robust morphology and 
IHC analysis using a range of histological stains and the immunohistochemical analysis 
of key cutaneous proteins, as described in Chapter 3. Finally, I went on to evaluate  
fixation in either 10% neutral buffered formalin (NBF), alcoholic formalin (AF), 
Bouin’s solution and zinc formalin (ZnF) under different temperatures and time.  
4.2 Methods and results 
4.2.1 Optimised processing of mouse tissues 
4.2.1.1 Histological evaluation of processing time 
Several critical variables need to be considered before processing specimens, including 
the type and concentration of dehydrating and clearing agents, paraffin infiltration, and 
operating temperature. For instance, specimens during processing may shrink by 20- 
30% of the original volume (Krekel et al., 2012). The skin tissues obtained with the 
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processing protocols previously used in my laboratory were relatively soft (particularly 
the fatty skin samples). This was most likely as a consequence of the alcohol 
dehydration steps and the subsequent clearing agent action. Thus, I evaluated histology 
results with an existing skin processing protocol, and customized long and short 
processing protocols with skin tissues fixed in 10% NBF for 3 days (detailed protocols 
are presented in Appendices 1, 2, 3). In order to investigate applicability not only to 
mouse skin but also to other mouse organs, I initially evaluated the influence of a new 
long processing protocol (described in detail in Appendix 3), as well as the protocol 
previously described, on the histological features of various mouse organs in tissue 
arrays. 
The rationale was to maintain good epidermal, dermal and adipocyte integrity, when 
faced with sectioning fatty, fragile diabetic mouse skin. The short protocol was found 
not to be effective as tissues remained very soft, and difficult to cut. For that reasons, 
typical sections are not shown here. The extended processing protocol yielded sections 
that were much easier to cut compared to the standard protocol, and better maintained 
integrity, as shown in Figure 4.1.  
 
To investigate the consistency of the new processing method, I sought to evaluate a 
range of mouse tissues. In order to minimize artefacts between experiments, I arrayed 
all mouse tissues on one slide (using a tissue macro arraying technique). Briefly, 12 
different organs were collected from 3 month old wt/wt male mice (liver, small 
intestine, brain, lung, epididymal fat, kidney, heart, spleen, soleus muscle, skin, brown 
adipose tissue, and pancreas). Samples were fixed in 10% NBF for three days at room 
temperature, followed by processing with standard and extended protocols, prior to 
embedding in macroarray blocks. 
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Figure 4-1 H&E staining of tissues with standard and extended processing protocols. 
Representative images for each condition (n=-4-6). Wt/wt skin tissue processed with routine processing 
(A), and a longer processing protocol (B). The skin structure was typically improved with the extended 
protocol. Images were captured with the Aperio Scanscope at 5x original magnification. 
 
4.2.1.2 Staining and IHC 
Routine H&E staining and CD31 immunostaining was used to assess morphology and 
antigenicity respectively (Pusztaszeri et al., 2006). CD31 identifies endothelium in all 
tissues, therefore, it represents a useful generic marker. It was outside the scope of this 
thesis to assess a broader range of antibodies. Whole-slide images were captured using 
an Aperio Scanscope CS scanner as discussed in Chapter 2. Chromogenic staining is 
shown when a larger field of view was informative. In some cases, CD31 
immunofluorescence results are shown, in cases where more consistent results were 
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achieved compared to chromogenic staining. Fluorescent images were captured using a 
Nikon Eclipse 80i microscope equipped with fluorescent optics. 
 
Various difficulties were associated with the routine protocol as discussed above 
(notably a hard cutting surface, tearing and reduced adhesion of sections to slides), 
which led to folding or tearing of tissues as seen in (Figure 4.2). 
 
In general, microtomy was easier when the long processing protocol was used, 
providing consistent anatomical structure with reduced disruption in all of the mouse 
organs following an assessment by H&E staining (Figure 4.3). Sectioning 12 
heterogeneous tissues was much easier when using the softening agent (as described in 
the general methods chapter). A key feature of the extended protocol was the removal of 
formaldehyde from the first step in order to reduce over-fixation. However, IHC signals 
were generally weak without antigen retrieval.  
 
4.2.1.3 Antigen retrieval 
Reduced immunostaining is more likely to occur with formalin fixed tissues compared 
to cryosections due to cross-linking of proteins (antigens) during the fixation process. 
This can render the epitopes (antibody-binding locations) inaccessible to antibodies (a 
process known as epitope masking), preventing detection by immunohistochemical 
methods. A number of methods were applied to unmask antigens, including enzymatic 
treatment (trypsin), heat-based (microwave) methods in citrate buffer of varying pH, or 
a combination of pressure and heating (using a domestic vegetable steamer or pressure 
cooker) (Figure 4.4). While pressure cooking revealed the strongest signal, it did lead to 
variable background with chromogenic detection. For this reason, fluorescent detection 
is shown in subsequent experiments. 
 
The process of protein cross-linking is progressive i.e. the longer the fixation time, the 
stronger the cross-linking. This is exacerbated by increasing temperature, which also 
leads to a reduction in immunochemical detection (Webster et al., 2009). Enzymatic 
digestion by trypsin is a common method to uncover antigenic sites, however, for some 
antigens trypsin digestion could produce false positive results as a consequence of over 
digestion, or false negatives could result from insufficient retrieval of the antigenic site.  
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Figure 4-2 H&E staining of tissues prepared using the standard processing protocol. 
12 different issues from 3 month old male wt/wt mice were processed using the routine processing 
protocol. Morphological features of many tissues were disrupted (tissue folding and loss). Representative 
images from three mice. Images were captured with the Aperio Scanscope at 15x original magnification. 
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Figure 4-3 H&E staining of tissues prepared with an extended processing protocol. 
12 different tissues from 3 month old male wt/wt mice were processed using a long processing protocol. 
Representative images from three mice. Images were captured with the Aperio Scanscope at 15x original 
magnification. 
 
The results depend on digestion time and enzyme concentration, and these need to be 
adjusted for individual antibodies, and fixation time and type. For other retrieval results, 
temperature and pH must be optimized to produce acceptable, and consistent IHC 
staining. Other factors, such as section thickness, dewaxing, and rehydration of tissues 
yield certain nuclear antigens may require longer treatment. Moreover, the IHC protocol 
choice (chromogenic or fluorescent) can favour particular antibodies. I found that 
immunofluorescent detection of CD31 expression with heat-induced antigen retrieval by 
pressure cooking in citrate buffer provided the most consistent signal/ noise ratio across 
a range of tissues (Figure 4.5).   
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Figure 4-4 Antigen retrieval methods to reveal CD31 immunoreactivity in wt/wt skin with chromogenic 
detection. Representative images for each condition (n=-4-6) 
No qualitative differences were observed in CD31 immunodetection between skin specimens fixed in 
10% NBF for 3 days, and retrieved with enzymatic treatment with trypsin (B), microwaving (C), and 
steaming (D). Pressure cooking did enhance antigen retrieval outcomes, although there was some increase 
in tissue disruption and background (A). Images were scanned using the Aperio Scanscope at 10x 
magnification. 
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Figure 4-5 Representative images of immunofluorescent detection of CD31 expression in mouse 
tissues.  Representative images for each condition (n=3) 
Sections were fixed in 10% NBF for 3 days and processed with the long processing protocol without antigen 
retrieval (-AR) and with antigen retrieval (+AR). Antigen retrieval consistently reveals CD31 staining in 
endothelium.  Images were captured at 20x original magnification.  
 
Tissue loss from slides is an issue in histology, made worse by relatively harsh antigen 
retrieval during IHC. Figure 4.6A shows H&E stained TMAs with tissues prepared with 
the standard protocol. Use of the extended protocol promotes tissue adherence, even 
following heat-based antigen retrieval (Figure 4.6B). 
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Overall, the extended processing protocol improved the histology of multiple tissue 
types compared to the routinely used one. Thus, I went on to assess this protocol on 
CD31 IHC across different organ arrays. 
 
Without antigen retrieval, the IHC signal for CD31 was inconsistent across tissues. 
With heat induced antigen retrieval, signals were improved in pancreas, heart, kidney 
and brain, with a small improvement in skin (which gave a good signal without 
retrieval). Weak signal were achieved in heart and muscle, suggesting that these tissues 
could be relatively over-fixed. Rather than go on to vary the numerous parameters 
relevant to processing, I was satisfied that the extended protocol provided a significant 
advantage over the previous method across a range of tissues. I then sought to focus on 
skin, and investigate the effect of different fixatives on histological analysis, starting 
with 10%NBF. In particular, I wanted to investigate the relationship between fixative 
and a broader range of downstream histological techniques. 
  
 
Figure 4-6 Loss of sections from organ tissue arrays prepared with standard and extended processing 
protocols.  Representative images for each condition (n=3) 
A) H&E stained TMA with tissue prepared using the short protocol. Missing tissues are circled. B) CD31 
immunostained TMA showing retention of tissue, even following antigen retrieval. Image were captured 
using the Aperio Scanscope at 1x magnification. 
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4.2.2 Effect of fixation time and temperature 
4.2.2.1 Tissue Preparation 
Three male wt/wt mice were obtained at 5-6 weeks of age and maintained on a chow 
diet. At 3 months of age the dorsal skin was shaved and 5cm by 5cm pieces of skin 
specimens were dissected from three separate animals and sliced into multiple 5mm x 
10mm x 2mm thick samples.  Skin samples from each of three different mice were 
prepared in triplicate and placed in a histological cassette prior to fixation. Skin samples 
in each fixative were treated with 3 different conditions: 1) short fixation time (6 hours) 
at room temperature; 2) short fixation time (6 hours) at 40˚C; and 3) long fixation time 
(32 hours) at room temperature. All tissues were then processed using to the extended 
processing protocol described above. Three TMAs were created, one for each fixation 
condition as described in Chapter 2 (Figure 4.7). Each TMA had three biological 
replicates of mouse skin fixed with each fixative.  
 
 
Figure 4-7 Tissue macroarray overview 
Recipient Block (left diagram) consists of four replicated skin samples from each mouse fixed with four 
different fixatives (rows), and three biological replicates from different mice (columns).The four samples 
were generated from single piece of mouse skin embedded in a   donor block.  Hole with 4mm punch 
biopsy from   Donor skin. 
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4.2.2.2 Effect of short fixation time at RT and 40˚C with 10%NBF 
H&E staining revealed improved morphology in  skin fixed with 10%NBF for 6 hours 
at 40˚C compared to RT (Figure 4.8).  For example, dermal collagen organisation 
disruption seen in skin samples fixed at RT (Figure 4.8 A) can be contrasted with the 
tightly-packed organisation seen when tissues were fixed at a higher temperature 
(Figure 4.8B). Consistent detection of PCNA immunoreactivity in skin is difficult, and 
this antibody was used as a sensitive test of antigenicity, and good signals were obtained 
when fixation was performed at both temperatures for short periods of time (Figure 4.9). 
Notably, no antigen retrieval was required. 
 
Figure 4-8 H&E staining of wt/wt skin fixed for 6 hours in 10%NBF at RT and 40˚C. 
Dermal collagen structure was typically characterised by many spaces when skin tissue was fixed at RT 
in 10%NBF (A) in comparison to fixation at 40˚C (B). Images were captured at 5x magnification with an 
Aperio scanner. Representative images for each condition (n=3)   
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Figure 4-9 PCNA immunoreactivity in wt/wt skin  
Tissues were fixed for 6 hours in 10%NBF at 40˚C (A) and at RT (B). .  Representative images for 
each condition (n=3). Images were captured using a 40x objective lens. 
 
4.2.2.3 Effect of short fixation with 10%NBF at 40˚C to long fixation at RT 
 
Having established that 6 hours at 40˚C gave good results, I went on to compare tissue 
preservation achieved with longer fixation (32 hours) at room temperature. It has been 
suggested that fixation up to 48 hours provides a good compromise between effective 
tissue preservation and antigenicity (Grizzle, 2009a). For pragmatic reasons, I selected 
32 hours to allow for consistent timing in tissue preparation and transfer to the 
processor. An initial finding was that extended fixation time was associated with a hard 
cutting surface, tissue loss and over-staining (Figure 4.10). Better morphology, reduced 
shrinkage, and better contrast were associated with shorter fixation (Figure 4.11). 
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Figure 4-10 Disrupted organisation in H&E stained wt/wt skin with 32 hour fixation. 
A typical image is shown. .  Representative images for each condition (n=3). Image was captured at 20X 
original magnification. 
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Figure 4-11 Effect of fixation time. 
Better histology of skin tissues fixed at 40˚C for 6 hours in 10%NBF are shown in A, compared to 32 
hours fixation (B).  Representative images for each condition (n=3).  Images were captured at 10x.  
   
4.2.3 Reduction of endogenous peroxidases  
Any changes in fixation will influence histology and immunostaining outcomes, and 
IHC methods must be optimised empirically  (Moelans et al., 2011). Both direct and 
indirect approaches were used to detect target antigens, through either chromogenic or 
fluorescent means (as described previously in Chapter 2). While I described quenching 
endogenous peroxidases earlier, I had to re-evaluate these methods in light of shorter 
fixation times when chromogenic IHC methods were used.  
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Endogenous peroxidases may react with chromogenic substrates and contribute to 
background signals that may compromise subsequent analysis. A solution of 3% 
hydrogen peroxide is commonly used to block such endogenous peroxidases. Skin 
tissues were incubated in 3% H2O2 v/v in methanol for 30 and 60 minutes prior to a 3 
minutes PBS-T wash and incubation with ImmPact DAB substrate (Vector 
Laboratories) for 5minutes at RT in order to determine appropriate conditions.  
It was noteworthy that skin fixed for 6 hours required a longer incubation period (up to 
one hour) to block the endogenous peroxidase activity as shown in Figure 4.12B. In 
comparison, a 30 minutes incubation with 3% H2O2 was enough to reduce the non-
specific substrate deposition with long-fixed tissues (Figure 4.12A).  
 
Figure 4-12 Endogenous peroxidase reduction skin from wt/wt mouse skin. 
Sections fixed in 10% NBF for 32 hours (A), and 6 hours (B) were evaluated with and without blocking. 
In particular, high levels of endogenous peroxidise persisted with short fixation (upper panel B, arrow). 
Images were captured at 10x original magnification. . Representative images for each condition (n=3) 
 
4.2.4 Optimisation of primary antibody concentrations  
 A range of cutaneous antigens were investigated by IHC. Again, primary antibody 
concentrations had to be titred in light of adapted fixation protocols (table 4.1). 
Secondary antibodies were either FITC or TRTC conjugated for immunofluorescent 
detection. All were used at a 1:200 dilution in PBS-T containing 2% relevant serum. 
Routinely, primary antibodies incubations were performed for one hour at either RT 
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with short fixed tissues, or with varying conditions with longer fixation. Generally, long 
fixed skin samples required more optimisation compared to short fixation. In contrast, 
the short fixed samples retained good antigenicity with all biomarkers used in this 
study, with  lower primary antibody concentrations, fewer optimisation steps, and more 
importantly, without the need for antigen retrieval (Figure 4.13). 
4.2.5 Antigen retrieval  
Without antigen retrieval, immunoreactivity of most biomarkers was weak with fixation 
for 32 hours. To unmask the cross-linking of proteins, I used various antigen retrieval 
methods including enzymatic antigen retrieval and heat induced retrieval using pressure 
cooker and microwaving. A summary of optimal dilutions of primary antibodies and 
best antigen retrieval methods is shown in Table 4.1. 
 
Antibody Primary antibody 
dilution/incubation 
6hr fixation 
Primary antibody 
dilution/antigen 
retrieval/incubation 
32hr fixation 
involucrin 1:500/1hr at 37
0
C 1:100/ trypsin-EDTA/ 1hr at 
37
0
C 
profilaggrin 1:500/overnight at 4
0
C 1:200/10 min microwave in 
citrate buffer pH6 / overnight at 
4
0
C 
keratin 14  1:2000/1hr at RT 1:500-1000/10 min pressure 
cooker in citrate buffer pH6/1hr 
at RT 
PCNA 1:400/overnight at 4
0
C 1:200/ 10 min pressure cooker in 
citrate buffer pH6/ overnight at 
4
0
C 
 
Table 4-1 Optimised primary antibody dilutions, incubation conditions and antigen retrieval 
methods. 
No antigen retrieval was required to give a good signal with all antibodies used when a 
short fixation time was used (Figure 4.13). With long fixation, antigen retrieval was 
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required to obtain signals with involucrin, profilaggrin and PCNA. K14 yielded a robust 
signal under all conditions. 
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Figure 4-13  IHC detection of cutaneous markers. 
Representative images of wt/wt skin sections fixed in 10%NBF for 32 hours without antigen retrieval 
(AR, left panel), and with AR (centre panel), and for 6 hours at 40°C without AR (right panel). .  
Representative images for each condition (n=-4-6). Images were captured at 50x original magnification. 
 
Overall, 6 hours fixation in 10%NBF at 40°C gave better results than 32 hours fixation 
at RT. However, I was still not satisfied that I was achieving optimal results and wished 
to investigate other fixatives, in the first instance using 32 hour incubations.  
4.2.6 Effect of fixatives type on histologicalanalysis 
4.2.6.1 Special Histological Stains 
4µm TMA paraffin sections were stained using a variety of special histological stains to 
evaluate cutaneous organisation as described in Chapter 2.  
 
4.2.6.2 Preservation of Morphology 
H&E staining is routinely used to make a general assessment of tissue organisation. 
Basic haematoxylin in the presence of a mordant (aluminium) distinctively stains the 
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acid content of the cell, giving nuclei a bluish-purple colour. Eosin stains cytoplasm and 
connective tissue varying shades of pink. Whole-slide image evaluation confirmed large 
variation in hue and intensity when identical tissues were stained following preparation 
with different fixatives (Figure 4.14). Bouin’s, AF and ZnF fixation led to superior 
preservation of skin morphology with limited shrinkage of the tissue compared to 10% 
NBF fixation and this was particularly revealed in the separation of collagen fibres, seen 
in (Figure 4.14A-D). Despite the maintenance of overall skin morphology, Bouin’s 
fixative led to disruption of nuclear detail and tissue were brittles while sectioning 
(Figure 4.14.B), whilst ZnF was associated with a reduced intensity of colour hue 
(Figure 4.14D). Overall AF fixation most effectively preserved skin morphology 
(Figure 4.14C), sharpness of nuclear detail (Figure 4.14C, inset) and contrast in colour. 
I also studied skin morphology revealed under eosin auto-fluorescence, a technique that 
provides increased resolution relative to bright-field microscopy (Kiernan, 1990). In this 
way, collagen fibres were easily discerned from other tissue components (for example 
the epidermis) with all fixatives, but this distinction was most apparent with AF and 
ZnF fixation (Figure 4.14E-H). The use of these two fixatives yielded enhanced clarity 
in resolving fibre bundles compared to the commonly used 10% NBF fixation.  
 
 
Figure 4-14  H&E stained sections of mouse skin prepared with four different fixatives. 
Top panel images were captured under bright-field microscopy and the lower panels show matched 
images obtained under eosin auto fluorescence. Inset images illustrate nuclear detail (top panel) or 
collagen fibre resolution (lower panels). A, E: 10% NBF; B, F: Bouins’ solution; C, G: AF; D, F: ZnF. 
Images are representative of three experiments, and were captured at 60X original magnification (inset 
180X magnification). .Representative images for each condition (n=4-6) 
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4.2.6.3 Basement membranes and vasculature  
Periodic acid oxidises polysaccharide moieties to create aldehyde groups whose reaction 
with Schiff reagent yields a deep red/magenta colour. Therefore, PAS staining readily 
identifies glycoproteins such as those constituting basement membranes and blood 
vessel walls, but it should be noted that both of these structures are much thinner in 
mouse than in human skin. Under normal conditions, PAS-stained collagen appears 
light pink, thus good contrast is extremely important in discriminating skin features. 
However, weak staining was obtained with both 10% NBF and ZnF fixation and typical 
PAS staining of NBF-fixed material is shown in Figure 4.15A. Better results were 
obtained when either Bouin’s or AF fixed tissues were examined; with which sufficient 
contrast to discriminate basement membranes and blood vessels was obtained (typical 
PAS staining of Bouin’s fixed material is shown in Figure 4.15B). 
 
Figure 4-15 Representative images of normal skin with PAS and G&O stained sections. 
PAS (A and B) and G&O stained specimens (C and D) in mouse skin processed with different fixatives. 
A and C were fixed in 10% NBF, panel B was fixed in Bouin’s solution and panel D was fixed in ZnF. 
Red arrows highlight the basement membrane distinguished in PAS staining; green arrows indicate fine 
elastic fibres (C); black arrows indicate purple granule-bearing mast cells (D) identified with G&O 
staining.  Representative images for each condition (n=4-6). Images representative of skin from three 
different animals is shown. Images were captured at 15x magnification. 
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4.2.7 Elastic fibres and immune cells 
Giemsa is composed of a mixture of methylene blue, azure B and eosin, and provides an 
excellent stain for identifying leucocytes in blood smears, as well as red blood cells and 
platelets (García and Bruckner, 1988, Garcia and Standards, 2000). In particular, 
methylene blue has metachromatic properties in that a reaction with mast cell granules 
yields a colour (purple) other than the colour of the dye itself (blue). Orcein is a 
synthetic dye that identifies elastin. I used a combined G&O stain for multiple skin 
feature identification and found that although Bouin’s fixation yielded excellent 
discrimination of mast cells, it was to a lesser extent capable of identifying elastic 
fibres. However, both 10% NBF and ZnF fixation gave good discrimination of mast 
cells (arrowed, Figure 4.15C and D), and better discrimination of elastic fibres 
compared to other fixatives. 
4.2.8 Collagen fibre organisation 
The polychromatic Herovici stain distinguishes young, newly formed collagen fibres, 
which appear blue, from the mature, dense collagen fibres, which appear red, making 
this stain very useful in the investigation of collagen organisation and dynamics. 
Possibly due to tissue shrinkage induction obtained with Bouin’s (and to some extent 
with ZnF), blue fibres were difficult to discern in skin preserved with either of the 
fixatives used. However, use of both 10% NBF (Figure. 4.16 A) and AF fixation 
(Figure. 4.16B) revealed distinct blue and red stained collagen fibres. 
Picrosirius red (PS) is a strong anionic dye that enhances the normal birefringent 
property of collagen (Constantine and Mowry, 1968). Under cross-polar microscopy, 
collagen fibres show a “basket-weave” conformation and fibres of different size and 
type may be discriminated by hue (Montes and Junqueira, 1991). Fixation with AF and 
ZnF, and to some extent 10% NBF (Figure.4.16C), revealed a distinct collagen basket-
weave structure in these images. However, AF fixation yielded the broadest spectrum of 
colours compared to the other fixatives (Figure 4.16D), thus AF may be preferred  to 
distinguish thick type I collagen fibres (red or orange) from thin type III fibres (yellow 
or green) if this type of collagen discrimination is required (Ren et al., 2013). Bouin’s 
was not an effective fixative to reveal structure under cross-polar microscopy. PS, van 
Gieson (VG) and Masson’s trichrome (MT) staining are commonly used histological 
stains for collagen identification (Manne et al., 2013). Collagen was readily identified 
with all stains and all fixatives, but I could not readily discriminate fine murine elastic 
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fibres under any of the conditions used (Figures 4.16E and F). However, in tissues fixed 
in 10% NBF, Masson’s trichrome revealed thick red-staining reticular fibres, while finer 
fibres appeared blue (Figure 4.16E). Red staining is generally associated with 
erythrocytes, muscle, cytoplasm and cross-linked keratins, but in this case tightly-
packed collagen bundles also stained red, as did keratins in the cornified layer of the 
epidermis (Bancroft and Gamble, 2008b).  
 
Figure 4-16 Collagen fibre organisation with different stains. 
The collagen fibres were identified using Herovici (A, B), picrosirius (C, D), Masson’s trichrome (E) and 
van Geison stains (F) in mouse skin processed with different fixatives. Representative images are shown 
for 10% NBF fixed specimens (A, C, E, and F) and AF (B, D).  Representative images for each condition 
(n=4-6). Images representative of skin from three different animals and captured at 20x original 
magnification. 
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4.2.9 Immunostaining 
In order to assess the effects of different fixatives on antigen recognition, I evaluated the 
detection of three key epidermal proteins by applying IHC: involucrin, K14, and PCNA. 
Cytoplasmic involucrin expression decorates the cornified layers of the epidermis 
(Crish et al., 1993), K14 is expressed at high levels in the cytoplasm of basal 
keratinocytes (Moll et al., 2008), whilst nuclear PCNA localisation characterises 
proliferating cells of the (predominantly) basal layer of the epidermis (Furukawa et al., 
1992). 
 
K14 immunoreactivity was detected in all skin specimens irrespective of the fixative. 
The detection of this antigen was most easily discerned with ZnF fixation (Figure 
4.17A) but was also effectively discerned with Bouin’s fixative (Figure 4.17 B). 
Involucrin antigenicity was retained to some extent with 10% NBF and AF fixation 
Figure 4.17C), whilst the signal was weak in ZnF fixed skin, and diffuse when Bouin’s 
solution was used. Antigen retrieval with trypsin-EDTA digestion led to an 
improvement in ZnF fixed skin specimens (Figure 4.17 D). 
 PCNA antigenicity was both weak and inconsistent in 10% NBF fixed tissue (Figure 
4.17E). The level of background signal also varied between fixatives, most noticeably in 
ZnF and Bouin’s fixed skin. The best signal to noise ratio was achieved with AF 
fixation (Figure 4.17F). However, when tissues underwent antigen retrieval in citrate 
buffer with heat, PCNA antigenicity was improved relatively with all fixatives. 
  
109 
 
 
Figure 4-17 Immunodetection of K14 (A, B), involucrin (C, D) and PCNA (E, F) in mouse skin 
prepared with different fixatives. 
Specimens were fixed with AF, and Bouin’s without antigen retrieval (A, B,), and AF (C), and ZnF with 
antigen retrieval (D) , and 10%NBF without antigen retrieval (E) and ZnF with heat-mediated antigen 
retrieval (F). Representative images for each condition (n=4-6). Images representative of skin from three 
different animals were captured at 20x magnification.  
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 The previous results  were  quantified and scored according to the consistency of 
special stains or the level of IHC signal (rather than the general morphology of tissues 
as described in table 2.3 in general methods) and summarized in Table 4.2 and 4.3. In 
summary, no single fixative provided optimal results with both histological and IHC 
analysis and each fixative have a particular advantage or disadvantage. Therefore, I 
went on to evaluate skin preservation and antigenicity with the four fixatives using the 
short fixation time in a subset of conditions as it is beyond the scope of this thesis to 
systematically evaluate every possible parameter.  
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Fixatives 10% NBF     Bouin’s         AF      ZnF 
H&E 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 H
is
to
lo
g
y
 s
ta
in
s 
 
† Tissue shrinkage  †   ††   †††   
the separation of collagen fibres, seen in eosin auto-fluorescence  
PAS †† Fair contrast  
 
†††  †††  † Weak discrimination  
 Sufficient contrast to discriminate basement membranes and 
blood vessels was good with AF 
G&O ††† Good discrimination 
of both mast cells and 
elastic fibres 
†† excellent discrimination of 
mast cells, it was poor at 
identifying elastic fibres 
† Good 
observation of   
(immune cell) 
††† good discrimination of 
both mast cells and 
elastic fibres  
VG ††  -  †  -  
 Difficult to detect  fine murine elastic fibres under any conditions 
MT †††  ††  ††  †  
Good collagen  and cross-linked keratins identification  
Herovici †† Good discrimination 
blue and red  
 
† blue fibres were difficult to 
discern 
†† Good 
discrimination 
blue and red 
†† blue fibres were 
difficult to discern 
PicroSirius  †† Distinct collagen 
basket-weave. 
- Poor distinction  ††† Good distinct 
collagen basket-
weave  
†† Distinct collagen 
basket-weave. 
Table 4-2 Summary of special staining for 32 hour fixation.Key for grade index - (poor) † (satisfactory†† (good) †††(Best) 
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10% NBF Bouin’s         AF   ZnF 
Involucrin 
IH
C
 
† Good antigenicity  - Weak †† Good antigenicity - Antigen retrieval 
with trypsin-
EDTA Figure  
K14 †  - Epidermal 
shrinkage resulting 
in the loss of 
keratinocyte nuclear 
detail. 
††
† 
 ††  
PCNA - weak inconsistent  - Weak inconsistent. †† Best signal to 
noise ratio was 
achieved with AF 
fixation  
- Antigen retrieval 
with heat 
improved (for all) 
Table 4-3 Summary of IHC results for 32 hours fixation. Key for grade index - (poor) † (satisfactory†† (good) †††(Best) 
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4.2.10 Comparison of four fixatives for short and long time 
Normal skin samples exposed to the four fixatives for 6 hours at 40°C were evaluated 
using some of the histological stains and antibodies described earlier. Overall, the 
microscopic evaluation of skin morphology with H&E staining following fixation at 
40°C for six hours in all solutions was characterised by better structure, reduced 
shrinkage, and better contrast compared to sections from skin samples fixed for 32 
hours at room temperature (Figure 4.18).  Particularly, AF achieved good morphology 
with fewer artefacts with short fixation (Figure 4.18 C) when compared to other 
fixatives at longer time (Figure 4.18G). Longer fixation was consistently associated 
with artefacts such as poor contrast, tissue shrinkage, abnormal collagen fibre 
organisation, lack of nuclear details and compromised epidermal structure. Another 
advantage of short fixation was enhanced antigenicity, exemplified in K14 
immunostaining, with only AF not showing evidence of over fixing by 32 hours (Figure 
4.19).  
 
 
Figure 4-18 H&E staining of wild-type mouse skin with four fixatives. 
Top panels, skin fixed for 6 hours at 40°C, and lower panel skin samples fixed for 32 hours at RT: A, E 
10% NBF, B, F Bouin’s, C, G AF and D, H ZnF. Lower panel, fixation for 32 hours at RT. The 6 hour 
fixed skin samples were characterised by better contrast with which to discern the skin layers. AF fixative 
with short (C), and long fixation (G) improves overall morphology. Representative images for each 
condition (n=4-6). Images were captured at 10x magnification using the Aperio scanner. 
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Figure 4-19 Representative images of K14 immunohistochemistry after 6 hours (40°C) and 32 hour 
fixation in various solutions. 
     Representative images for each condition (n=4-6). Images were captured 20x magnification. 
 
PCNA IHC results were also consistently better with short fixation (especially 10% 
NBF and AF) compared to long fixation. (Figure 4.20). Best results were obtained with 
short AF staining. This is could be as a consequence of the chemical properties of the 
various formulations, notably pH, osmolality, and coefficient of diffusability. For 
example, the diffusability for ethanol (1.0) is higher than that for 10%NBF (0.79) 
(Bancroft and Gamble, 2008c). Thus, it very important to be aware of these parameters, 
and the nature of the tissue under study, when selecting fixative for any study (Treuting 
and Dintzis, 2011). 
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Figure 4-20 Representative images of PCNA immunohistochemistry after 6 hours (40°C) and 32 hours 
fixation in various fixatives. 
     Representative images without the use of antigen retrieval are shown. Representative images for each 
condition (n=4-6). Images were captured at 20x    magnification. 
 
All fixatives used in histopathology have different chemical properties and 
characteristics. Therefore, there is no universal fixative for all tissues due to the fact that 
certain fixatives might be appropriate for specific tissue components or certain IHC 
applications. The sectioning procedures and overall morphology of normal mouse 
tissues obtained using the four fixatives with six hour incubations at 40°C were better 
than those achieved using longer conditions when comparing the morphology of mouse 
skin using a range of histological stains. As well as revealing the expression of key 
cutaneous proteins, I found that prolonged tissue exposure to any of the four fixatives 
(32 hours) will increase the masking of antigen’s epitopes, so requiring antigen 
retrieval, which can promote tissue damage. However, AF and 10% NBF fixed tissues 
tolerate this reasonably well. With short fixation, both AF, and 10% NBF provided 
good retention of morphology and structure of normal skin with special histological 
staining. AF was more effective in maintaining antigenicity for the cutaneous markers 
investigated in this study. 
 
However, the rationale of these experiments was to identify optimal conditions for the 
histological evaluation of tissues including fragile mouse skin. I went on to study the 
effect of AF fixation on diabetic mouse skin organisation with a selective range of 
histology stains, compared with the method used in Chapter 3. 
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4.2.11 Histological analysis of diabetic mouse skin fixed with AF  
Mouse skin tissues from three male wt/wt, ob/ob, db/db, and misty animals were fixed 
for 6 hours at 40°C before processing with the long processing protocol (Appendix 3). 
Three biological replicates from each model were used to establish TMAs to ensure 
consistency between skin sections, and minimise artefacts that might confuse 
downstream analysis of skin phenotypes in obese and insulin resistant mouse models. 
 
4.2.11.1 Sectioning diabetic mouse skin from different fixations 
 TMA sections skin fixed in 10% NBF for 3 days (the previous standard) were 
compared to tissues fixed in AF for 6 hours at 40°C. A hard cutting surface, missing or 
folded regions, as well as artefact including abnormal nuclei, collagen deposition, and 
adipocyte architecture were only associated with TMA obtained from the 10%NBF 
fixed tissues Figure 4.21 4.22, and 4.23) 
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Figure 4-21 Gross organisation of TMA sections with old and revised histological methods. 
Skin TMAs prepared from different mouse models at 3 month of age (wt/wt, ob/ob, db/db and misty) are 
shown. Typical structure obtained with fixation in 10% NBF for 3 days is shown in upper panel. 
Improved section quality achieved by fixation in AF for 6 hours is shown in the lower panel.  
Representative images for each condition (n=4-6). Images were captured at 1x magnification with the 
Aperio Scanscope.   
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Figure 4-22  H&E stained sections of mouse skin. 
Skin samples fixed in 10%NBF for 3 days: wt/wt skin (A), misty (B), ob/ob (C) and db/db (D).  
Representative images for each condition (n=4-6). Images were captured at 10x magnification with the 
Aperio scanner 
 
While it was possible to achieve good sections using the method described earlier, this 
was at the cost of sectioning time, and the need to cut more sections due to tissue loss. 
In future studies, the use of AF fixation gives consistent morphology, with considerable 
time saving in preparation (Figure 4.23). Moreover, the contrast achieved with H&E 
staining was very good. 
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Figure 4-23 Different mouse models skin fixed in AF and stained with H&E. 
Tissue organisation following AF fixation: wt/wt skin (A), misty (B), ob/ob (C) and db/db (D).  
Representative images for each condition (n=4-6). Images were captured at 10x magnification with the 
Aperio scanner 
4.3 Discussion  
It is critical in histopathology that researchers are aware of the range of fixatives and 
processing parameters that may impact the tissue’s morphology under investigation 
(Srinivasan et al., 2002). This is more difficult in mouse tissues as histology texts focus 
on human material, which tends to be more robust than murine counterparts (Glasø and 
Hovig, 1987), and extra care must be taken to avoid protein denaturing or masking due 
to poor or over fixation (Srinivasan et al., 2002, Treuting and Dintzis, 2011).  Problems 
are exacerbated when tissue integrity is impacted by a pathological state, and to my 
knowledge there are no methods that describe preserving diabetic mouse skin tissue. 
These models are characterised by an expanded subcutis (and cutting fatty tissue is 
difficulty) and a loosely packed dermis. 
 
One of the aims of this thesis is to identify cutaneous pathology in mouse model of 
diabetes. Tissue processing is central to this, and the choice of fixative is, therefore, 
  
120 
 
crucial if one is to preserve fine cutaneous structures (Glasø and Hovig, 1987, Al-
Habian et al., 2014). Also fixation has various affects at the molecular level that can 
retain or destroy key structural details, and  mask some antigens (Treuting and Dintzis, 
2011). In most pathology laboratories, formalin based processing protocols (particularly 
10% NBF) are considered the first choice fixatives (Tang et al., 2013, Khan et al., 2009, 
Kunder et al., 2007). Previous studies have considered the influence of fixatives on 
mouse skin with particular respect to the immunoreactivity of  various  antibodies 
(Mikaelian et al., 2003). However, to my knowledge no previous studies have 
investigated time and temperature systematically (and certainly no use was made of 
TMAs) for both histology and IHC experiments. The Table 4.4 provides a brief outline 
of the steps relevant to developing optimal mouse skin histology and IHC methods and 
problems solving process. 
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PROBLEM SOLUTION OUTCOME 
Brittle sections Adapt 
processing 
Improved sections 
Inconsistent 
staining 
Improved special staining 
Antigen 
masking 
Unmasking still required 
Throughput 
low preparing 
TMAs 
Softening agent Reduced loss of tissue and good TMA 
histology 
Tissue 
disruption with 
antigen 
unmasking 
Evaluate 
antigen retrieval 
methods 
Inconsistent IHC and tissue damage 
Inconsistent 
IHC 
Adapt fixation 
time 
Reduced fixation improves antigenicity 
Lack of 
contrast with 
special staining 
Evaluate 
fixative type 
Consistent staining with 10% NBF. 
Improved staining with AF 
Poor signal/ 
noise ratio 
with IHC 
Evaluate 
antibody 
conditions and 
detection 
methods 
Unambiguous IHC 
Loss of 
diabetic skin 
tissue 
organisation 
Short fixation in 
AF, long 
processing 
protocol 
Retention of diabetic skin integrity 
Table 4-4 Optimisation of diabetic mouse skin histology and IHC 
Fixation time is very important and tissues are routinely exposed to fixative for one 
hour per millimetre depth using non-coagulative fixatives (Medawar, 1941, Bancroft 
and Gamble, 2008d). Other studies  have recommended  25 hours to fix a 4x4x4 mm 
piece of mouse tissue (Treuting and Dintzis, 2011).  Therefore, the size of skin samples 
is one of the major factors in the fixation process, and the use of thin skin slices in this 
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study ensures effective penetration and faster action of fixatives. However, when using 
10% NBF, fixation is not complete until cross-linking has occurred and so samples are 
usually left for at least 24 hours to ensure complete fixation (Tellyesnicsky, 1926, 
Baker, 1958). Thus, thin specimens might be fixed sufficiently in 10% NBF in 5- 6 
hours, and rapid fixation is acceptable as long as histochemical staining is effective 
(Bancroft and Gamble, 2008c). However, increasing the ambient temperature of fixative 
enhances its action. This is supported by recent studies on  Bouin’s, AF and ZnF, which 
demonstrated that fixation is completed by 6 hours  at 37°C (Coscia et al., 2014, 
Elzabbal et al., 2013), and that skin is effectively fixed after 18 hours at room 
temperature. Whilst under-fixation is associated with tissue degradation and 
underperformance in histological assays, over fixation is associated with problems 
including loss of antigenicity (Werner et al., 2000, Bancroft and Gamble, 2008a). 
However, I observed no “edge effects” with either  special staining or IHC that might 
indicate incomplete tissue fixation with any fixatives employed with different 
conditions in this  study, whereas long fixation was associated with over-staining and 
tissue shrinkage and  limited retention of cutaneous antigens and loss of nuclear detail, 
as reported previously (Ananthanarayanan et al., 2005). For IHC analysis of skin 
tissues, I would recommend AF as this provided a good signal to noise ratio and the 
robust retention of antigenicity. These findings are intriguing as 10% NBF is the most 
widely used fixative in histology laboratories (Grizzle, 2009b). In agreement with 
previous studies, ZnF enhanced staining and nuclear details, but I saw no deleterious 
effects of alcohol on nuclear or cytoplasmic detail, as has been previously suggested 
(Eltoum et al., 2001, Rolls, 2012). 
 
My rationale for evaluating mouse skin histology was informed by two considerations; 
firstly, the widespread use of mouse as a disease model and secondly, that this tissue 
provides a challenging experimental environment that has yet to be assessed 
systematically for histological artefacts arising from fixation. Mouse skin is thinner and 
more fragile than human skin, and so loss of architecture during processing has 
implications for downstream applications. In particular, obtaining good histology from 
diabetic mouse skin (the most fragile) such as maintaining subcutaneous adipocyte 
architecture and the discrimination of components such as fine elastic fibres presents a 
considerable challenge. Moreover, this study provides many insights via comparison of 
the effects of processing protocols and fixatives under two different conditions (time 
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and temperature) on the detection of cutaneous features. Finally, I suggest that these 
observations are applicable to tissue derived from a variety of tissues, and are relevant 
to human material when considering downstream applications. A summary of key 
technical steps and the main findings of this study provide guidelines for preparing skin 
samples from mouse models of insulin resistance (ob/ob), obese (DIO), and diabetic 
(db/db) for prospective histological and IHC analysis. These are listed in (Table 4.5). 
 
Tissue 
harvesting  
Shave the skin and cut into 2-5x5-10mm slices before fixation  
Pre-fixation Use fresh fixative with the correct tissues to fixative’s volume 
ratio (1 to 20)  
Fixative Alcoholic formalin for 6 hours at 40°C (histology) or (IHC) 
works well across a range of experiments. 
Processing  Use extended processing protocol with fresh reagents, without 
delay in starting or removing from the processor  
Sectioning  Use TMAs, softening agent, and keep the temperature in the 
sectioning  room below 15°C 
IHC  Consider utility of both chromogenic and fluorescent methods. 
Investigate different chromogens and fluorescent labels 
(FITC, TRITC). Short fixation may remove need for antigen 
retrieval.   
Antigen 
retrieval  
Retrieval with trypsin preserves tissue structure, but may not 
suffice. More aggressive heat-based methods disrupt tissue, 
but 10 minutes of pressure cooking in citrate buffer at pH6 
was satisfactory. 
Primary 
antibody  
Short fixation times may allow for reduced primary antibody 
concentrations and better signal to noise ratios. 
Investigate incubation time and temperature. 
Table 4-5 Recommended guidelines for diabetic mouse skin histology and IHC application 
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5 Chapter 5: Cytokine Profiling and Dermal 
Fibroblast Culture 
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5.1 Introduction 
There is growing evidence in the literature about the relationship between white adipose 
tissue metabolism, insulin resistance, diabetes, hypertension, and cardiovascular disease 
(Bjørndal et al., 2011, Trayhurn and Wood, 2004). Fat distribution, adipose gene 
expression profiles, adipokine secretion and lipolytic capacity are among the major 
determinants of metabolic disease (Snel et al., 2012). For example,  the metabolic 
activity of white adipose tissue varies depending upon its location, with visceral adipose 
tissue (VAT) having a higher metabolic activity, mitochondrial and free fatty acid 
(FFA) content, and sensitivity to insulin stimulated glucose uptake than subcutaneous 
fat depots (Bjørndal et al., 2011, Goran and Alderete, 2012b). Both systemic and local 
inflammatory agents impact peripheral tissue function, and I wanted to investigate an 
association with cutaneous pathophysiology in the models described in this thesis. 
 
Using the range of histological techniques developed in the previous chapters, I 
investigated different cutaneous phenotypes including dermal damage, disorganisation, 
and increased fat accumulation in animal models of insulin resistance, type 2 diabetes, 
and ageing. Interestingly, I was able to distinguish subcutaneous (the deep layer) from 
subdermal fat (the superficial layer) in mouse skin. There are several terms used for the 
third layer of the skin, which is located beneath the dermis. These terms include the 
hypodermis, subcutaneous adipose tissue (SAT) and subcutis, and are used in both 
humans and mice (Avram, 2004, Trottier et al., 2008). However, there is emerging 
evidence that that the SAT in humans can be anatomically divided into two distinct 
layers by Scarpa’s fascia; the superficial subcutaneous adipose tissue (panniculus 
adiposus), and a deeper subcutaneous adipose tissue (panniculus carnosus) (Abu-Hijleh 
et al., 2006). Recently, the deeper layer of SAT has been linked to features of insulin 
resistance, unlike the superficial layer which acts more likely as  a buffering fat depot 
for excess energy intake (Marinou et al., 2014). In this chapter, I chose to investigate the 
upper layer as other researchers have recently shown that the more superficial fat layer 
(also called the intra dermal layer) influences whole body physiology, potentially via a 
thermoregulatory response (Kasza et al., 2014). Other researchers were able to 
differentiate the dermal adipose tissue in mature mouse skin from deeper subcutaneous 
tissue (Wojciechowicz et al., 2013). However, I found that the more superficial layer 
was difficult to discern in young adult mice, but that it could be discerned in obese 
models. The topography is displayed in Figure 5.1, showing the location of sub-dermal 
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fat, which lies above the muscle layer, and the deeper subcutaneous fat layer, which is 
beneath the dermal facia and muscle in mature and obese mouse skin. It is likely that 
each layer has distinct physiological and biochemical properties, but physically isolating 
each fat layer was very difficult. In the first instance, I looked at the inflammatory 
cytokine profile of plasma (which is considered to be relatively non-inflammatory) and 
epididymal fat depots (a visceral depot, also considered to be relatively protective), both 
of which contribute to some extent to peripheral diabetic pathophysiology in insulin 
resistant and ageing states. I then went on to look at the local cytokine profiles of the 
skin compartments (including both adipose depots) in wild type and ob/ob mice as there 
is evidence that deeper subcuticular adipose depots have a relatively pathogenic effect. 
To my knowledge, however, no group is yet to report the biochemical properties of the 
divisions of this depot. 
 
Figure 5-1 Mouse skin adipose tissue layers. 
The topography of mouse skin sub dermis above the panniculus carnosus layer, was distinguishable from 
the deep SAT (beneath panniculus carnosus layer) in 20 month B, db/db C, and ob/ob D and was difficult 
to discern in 3 month old wt/wt mice skin stained with herovici in A, B ,and C, and H&E in D. .  
Representative images form three mice. Images were scanned Aperio
TM
 Scan Scope and captured at 10x 
magnification. 
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An understanding of the mechanisms underlying the disruption of dermal collagen 
structure and function in murine models of obesity and type 2 diabetes will provide 
insight into human disease. Previous in vitro studies of dermal fibroblasts have 
identified impairments related to fibroblast function arising from reduced vasculature, 
and the local inflammatory impact of adipokines (Lerman et al., 2003b, Schmidt and 
Horsley, 2013). These effects may provoke downstream cascades of altered ECM 
remodelling (Berlanga-Acosta et al., 2012). I wanted to investigate if fibroblasts from a 
model of insulin resistance (ob/ob mice) maintained a “diabetic” phenotype if 
maintained ex vivo by studying proliferation, collagen synthesis, and senescence. I also 
wanted to evaluate if insulin signalling mechanisms were impacted by determining the 
expression in the β-subunit of the insulin receptor, which is known to be down-
regulated in insulin resistant and ageing states. 
 
Previous studies have shown that insulin resistance in various adipose tissues from 
obese subjects (both subcutaneous and visceral fat) influences systemic insulin 
sensitivity via both paracrine and endocrine mechanisms (Virtanen et al., 2002, Khan et 
al., 2009). Therefore, my hypothesis was to investigate the possible relation between 
dermal damage and local or systemic cytokine action from expanded fat depots by 
profiling candidate cytokines from both adipose tissue and plasma of mouse models of 
obesity, type 2 DM and ageing. 
5.2 Methods 
5.2.1 Optimisation of dermal fibroblast culture protocol  
 Methods to culture dermal fibroblasts were described in detail in the general methods 
chapter, but preparing viable cells from ob/ob mice proved challenging, and herein I 
highlight some important technical considerations. Culture methods for primary dermal 
fibroblasts in both human and rodents are well established (Takashima, 2001, Seluanov 
et al., 2010). However, these are not optimised to produce fibroblasts of impaired 
function, and yields of ob/ob fibroblasts were low. As access to ob/ob fibroblasts was 
limited, I initially optimised methods using wt/wt cells. Two methods (explants and 
isolation of cells following enzymatic digestion) were assessed using young, lean wt/wt 
mouse skin to maximise yields of dermal fibroblasts. I found explant methods to be 
unsatisfactory, producing a very low number of dermal fibroblast after 48 hours in 
culture. By day 6, growth had consistently ceased (Figure 5.2). 
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Figure 5-2 Explant culture of dermal fibroblasts from wt/wt mouse. 
A typical skin explant releasing few cells after 2 days is seen in panel A. By day 6, there was little 
evidence of proliferating fibroblasts (B). Images captured under phase contrast at 10x original 
magnification 
 
The second technique used enzymatic digestion of skin to release fibroblasts followed 
by seeding in culture flasks, as described by Takashima (Takashima, 2001). This 
requires the removal of extraneous tissue such as hair and fat. Table 5.1 summarises the 
key factors investigated to improve collagenase treatment. 
 
Collagen type Type II or type IV 
Concentration 0.5 and 1.0% 
Incubation time/ temperature 5min-30 minutes (RT), or on 4ºC 
Shaker speed 200 or 350 cycles per minute 
Substrate Collagen coated plates 
Table 5-1 Critical parameters in primary dermal fibroblast culture 
There was relatively difference in yields obtained with collagenase type, concentration 
or incubation conditions (not shown). The most dramatic improvement was found with 
shaker speed (Figure 5.3). Enzymatic incubation at 200 cycle per minute yielded a 
relatively intact dermal sheet from which many fibroblasts were released (indicated by 
pellet size (Figure 5.3.B) in comparison to over-digested dermal sheet under 350 cycle 
per minute (Figure 5.3 A).  The other critical parameter was the use of collagen-coated 
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flasks, which promoted cell attachment and growth (Figure 5.4). In this way, I was able 
to prepare viable cultures of both wt/wt and ob/ob fibroblasts. 
 
 
Figure 5-3 Preparation of dermal fibroblasts.. 
A. The higher shaking speed (350 cycles per minute) resulted in an over-digested dermal sheet. The arrow 
in (A) top panel highlights damage. Panel B shows an intact sheet resulting from the slower shaking 
speed. The lower left panel shows that very few cells were recovered with high shaker speed (arrow), in 
comparison to 200 cycles per minute (lower right panel). 
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Figure 5-4 Use of collagen coated flasks to promote dermal fibroblast attachment and proliferation. 
Representative images from normal dermal fibroblasts from three mice. Cells were cultured in collagen coated flasks 
(row A), and non-coated flasks (row B) at days one and 5 in culture. Images were captured at 10x original 
magnification. 
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5.3 Results 
5.3.1 Plasma cytokine levels 
Cytokine levels were quantified in plasma obtained from young (3 month old) lean 
wt/wt and ageing (12 month old wt/wt), KS/J (misty), ob/ob and db/db mice (all at 3 
months of age and maintained on chow diets; (Table 5.2). A 2.4 fold up-regulation in 
TNFα was seen with age, but not in insulin-resistant ob/ob or diabetic db/db plasma. 
Furthermore, IL10 and IL12 showed 2.3 and 2.0 fold increases respectively in old mice 
in comparison to young. Both MCP1 and RANTES were up-regulated significantly 
(*p<0.01, **p<0.001) in ob/ob animals only compared to controls (3.2 and 1.7 fold 
respectively). Overall, there was no strong inflammatory profile in the plasma of ob/ob 
or db/db mice and only ageing mice showed a mild inflammatory profile.  
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Plasma 
cytokines 
pg/ml 
wt/wt  ob/ob Old  
Mean SEM Mean SEM Mean SEM 
IFN 3 2 7 6 5.8 2 
IL10 48 13 64 16 111 59 
IL12 128 5 108 5 267 128 
IL1-β 3 1 2.4 0.7 5.6 0.6 
IL6 38 12 28 5 79 36 
MKC 111 20 125 5 102 26 
TNF-α 2 1 3 0.5 4.8 0.9 
GMCSF 0.3 0.1 0.19 0.009 0.2 0.2 
MCP1 32 12 104* 3 21 4.8 
RANTEs 42 4 73** 6 5 2.2 
Plasma 
cytokines 
Misty( n=4) db/db( n=4)  
Mean SEM Mean SEM   
IFN 6 4 3 0.8   
IL10 58 19 81 7.2   
IL12 124 42 225 53   
IL1-β 4 1.2 5 0.9   
IL6 40 6 64 11   
MKC 125 29 137 35   
TNF-α 2 1.6 3 0.7   
GMCSF 0.8 0.4 1.1 1   
MCP1 53 16 51 12   
RANTEs 84 7.9 96 11   
   Table 5-2 Plasma levels of cytokines from3-4 animals per each group. Significant analysis 
was performed using unpaired two-tailed Student’s t-test for each parameter  
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5.3.2 Subcutaneous adipose conditioned medium  
 In Table 5.3 there was significant up-regulation in IFN39 fold, IL1β (17 fold), IL6 
(35 fold), TNFα (13 fold), and RANTEs (13 fold) in the conditioned medium from 
ob/ob mice compared to age-matched lean controls. While there was no distinct 
inflammatory phenotype in db/db and ageing models (with exception of IL12, IL6, and 
MCP1 in ageing)ob/ob SAT characterised by higher level of various cytokines.. 
SC  
cytokines 
pg/ml 
wt/wt ob/ob Old 
Mean SEM Mean SEM Mean SEM 
IFN 0.3 0.06 14*** 2 1.7 0.2 
IL10 661 88 2760 887 529 135 
IL12 56 15 1042 98 155 19 
IL1-β 3 0.4 53 7 12 6 
IL6 633 44 22207*** 5735 2634 254 
MKC 1843 247 47947 3042 6655 798 
TNF-α 55 7 726*** 141 75 13 
GMCSF 1 0.3 26 2.7 3 2 
MCP1 246 40 6816 522 932 190 
RANTEs 38 7.9 394 155 19 6 
SC 
cytokines 
Misty db/db  
Mean SEM Mean SEM   
IFN 1.7 0.2 0.4 0.02   
IL10 238 62 210 62   
IL12 229 99 N/A N/A   
IL1-β 7 3.2 2 0.5   
IL6 1246 275 465 135   
MKC 2939 822 1465 384   
TNF-α 32 6.4 32 10   
GMCSF 1.8 1 4 4   
MCP1 286 150 387 78   
RANTEs 192 92. 66 53   
Table 5-3 Cytokine profile from subcutaneous adipose conditioned medium (ACM) from4 
animals per each group. Significant analysis was performed using unpaired two-tailed 
Student’s t-test for each parameter 
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5.3.3 Epididymal adipose conditioned medium 
Table 5.4 shows the cytokine profile from epididymal fat isolated from young (3 month 
old) lean wt/wt, and ageing (12 month old), KS/J, ob/ob and db/db mice (3 month of age 
on chow). There was a significant up regulation in MCP-1 with 47 fold induction, and 
MKC, TNF-α, and GMCSF (18, 7.4, and 40) fold induction respectively from ob/ob 
mice compared to their lean age-matched controls. Slight changes in db/db and ageing 
epididymal fat cytokines profile were detected in IL6, MkC, TNF-α, and MCP1mainly 
in ageing. 
Epididymal 
cytokines 
pg/ml 
wt/wt ob/ob Old 
Mean SEM Mean SEM Mean SEM 
IFN 1.4 0.91 12 2.9 2 1.6 
IL10 1819 231 2710 636 689 0.3 
IL12 107 22 1298 174 24 2.2 
IL1-β 6.8 3.7 55 7 6 0.9 
IL6 1117 262 17203 2135 2866 2.5 
MKC 2944 616 54496. *** 2857 9795 3.3 
TNF-α 90 6 668*** 106 114 1.2 
GMCSF 0.9 0.1 36*** 7 5 6.3 
MCP1 247 64 11738*** 1881 915 3.7 
RANTEs 70 11 207. 37 11 0.1 
Epidi  
cytokines 
Misty  db/db  
Mean SEM Mean SEM   
IFN 1.3 0.8 1.4 1.1   
IL10 421 228 864 2   
IL12 282 111 159 0.56   
IL1-β 8 2.8 6 0.8   
IL6 1939 1006 1583 0.8   
MKC 5944 3248 5224 0.8   
TNF-α 159 61 95 0.6   
GMCSF 4.7 2.9 4.8 1   
MCP1 645 376 607 0.9   
RANTEs 26.7 22 28 1   
Table 5-4 Cytokine profile from epididymal adipose conditioned medium (ACM) from4 
animals per each group. Significant analysis was performed using unpaired two-tailed 
Student’s t-test for each parameter 
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Figure 5-5   Illustrative figure for outer and inner layer separation in ob/ob skin.  
The dermis adipose tissue B from ob/ob mouse skin has been anatomically separated from the 
outer layer (epidermis and dermis) A and stained with H&E in image A, and B. Images were 
scanned Aperio
TM
 Scan Scope and captured at 10x magnification  
5.3.4 Comparing cytokines profile from different cutaneous layers in ob/ob 
mice  
Having established an inflammatory profile in SAT and VAT depots, I went on to 
investigate local levels of a subgroup of key cytokines (IL-10, IL-6, IL-1β, MKC, TNF-
α) in the skin layers of ob/ob mice compared to lean controls. I particular, I was able to 
micro dissect the dermal adipose layer in order to contrast the cytokine profile with that 
of deeper subcuticular fat analysed above (Figure 5.5). It was not possible to retain a 
cytokine signal upon the enzymatic separation of epidermis from dermis, and so these 
layers were profiled together. No changes were seen in plasma cytokine levels, while, a 
consistent reduction in levels of both anti-inflammatory (IL-10) and pro-inflammatory  
  
 Illustrative figure of inner and outer layers separati n  
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factors (IL-1β,IL6, TNF-α, and MKC) were down regulated in subdermal. A significant 
increase was seen in the non-adipose layers of ob/ob skin. Thus, local TNF action 
could be a critical mediator of cutaneous damage in insulin resistant states. The 
inflammatory profile of each compartment is summarised in Table 5.5.  
Cytokine 
pg/ml 
Plasma VAT SAT Subdermal 
fat 
Non-adipose 
Skin 
IL10 1.3 1.4 4 0.2 0.3 
IL6 0.8 15 35 0.3 0.5 
IL1-β 0.9 8 17 0.6 0.6 
MKC 1.2 18.5 26 0.3 0.2 
TNF-α 1.5 7 13 1 10 
Table 5-5 Summary of key cytokines in plasma, skin and adipose depots of ob/ob mice. Fold-
change values compared to control animals are shown. 
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Figure 5-6 Cytokine profiles from plasma and deferent skin compartment of ob/ob mice. 
 (A) Plasma cytokine levels were investigated in age-matched chow fed wild type wt/wt and ob/ob mice 
(n=4). Expression of individual cytokines in conditioned medium prepared by exposure to different skin 
compartments is shown in B-F. Significance was assessed by student unpaired t test, and *p<0.05, and ** 
p<0.01; ***p<0.001, ****p<0.0005. 
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5.3.5 Insulin receptor expression in normal and diabetic fibroblasts 
Western blotting analysis showed that the β-subunit of the insulin receptor is down-
regulated in dermal fibroblasts from db/db and 20 month old mice (Figure 5.7). An even 
greater suppression was observed in freshly-isolated 3 month old ob/ob fibroblasts, 
compared to age-matched wild-type controls. 
 
 
Figure 5-7 Insulin receptor (β-chain) expression in dermal fibroblasts. 
Dermal fibroblasts were isolated from lean C57Bl/6 at 3 month (12 week) and 20 month, along with 
KS/J, ob/ob and db/db mice (3 month of age on chow) is shown, normalised relative to GAPDH 
expression. Representative blots for each group are shown. Significance was assessed by 1-way 
ANOVA with post-hoc Dunnett’s tests to compare the groups in the C57BL/6 background, and a 
Student’s unpaired t-test was used to compare the mice on a KS/J (misty) background. ** indicates 
p<0.01. All experiments were performed in triplicate (cells prepared from 3 different mice per group). 
 
5.3.6 Proliferation of wt/wt and ob/ob fibroblasts 
Dermal fibroblast cell morphology and growth in tissue culture was measured. The 
growth curves indicate that ob/ob fibroblasts had a reduced proliferative capacity 
compared to controls as shown in Figure 5.8. Representative images were captured at 
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days 2, 4, 7 showing a reduction in refractile, spindle shaped fibroblasts in ob/ob cells 
compared to controls (Figure 5.9). 
 
Figure 5-8 Proliferation of normal and insulin resistance fibroblasts. 
Growth curves were generated from wild type and ob/ob cell lines (n=3). Experiments were performed on 
cells from 3 different mice per group.* indicates P<0.001. 
 
  
Figure 5-9 Proliferation of normal and insulin resistant fibroblasts. 
Representative images from three phases of proliferation at day 2, 4, 7 from wt/wt and ob/ob dermal 
fibroblasts (n=3). Images were captured at 10x original magnification. 
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5.3.7 Collagen production by wt/wt and ob/ob fibroblasts 
Total collagen deposition was assessed by picrosirius uptake once cultures reached 
confluence. Deposition was found to be reduced by 38% (P<0.001) in ob/ob fibroblasts 
relative to age-matched lean controls as seen in Figure 5.10. 
 
Figure 5-10 Collagen production by wt/wt and ob/ob mice fibroblasts . 
Quantitative measures of collagen deposition normalised to total cellular protein using a picrosirius assay 
(***p<0.0001) (n=3). 
5.3.8  Senescence in wt/wt and ob/ob fibroblasts 
Elevated β-galactosidase expression is a feature of senescent cells (Tchkonia et al., 
2010), and levels were assayed in primary fibroblast cell lines prepared from lean and 
ob/ob mice (Figure 5.11). Quantitative histomorphometry revealed that β-galactosidase-
positive cells accounted for 1.1% (SEM +1.0) of the total surface area in confluent 
wt/wt cultures, in contrast to ob/ob derived fibroblasts in which 11.6% (SEM + 2.4) of 
the surface area stained blue.  
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Figure 5-11 Senescence assay in normal and insulin resistant fibroblasts. 
Typical fields of β-galactosidase stained wt/wt (left panel), ob/ob primary dermal fibroblasts (right 
panel) (n=3) are shown at 10x original magnification. Cells with blue staining cytoplasm prevalent in 
the right panel are senescent. 
 
5.4 Discussion 
The skin is an insulin sensitive tissue, and so the integrity of skin will be impacted by 
insulin resistance and obesity  (Shen et al., 2000). In the healthy state, collagen 
comprises 50-70% of the skin’s connective tissue, with dermal collagen organisation 
presenting as dense perpendicular “basket-weave” like bundle of fibres to provide 
mechanical strength (Delaine-Smith et al., 2014). In Chapter 3 I discussed patterns of 
skin damage seen in animal models of IR and obesity. Specifically, the reticular layer of 
the dermis, adjacent to the expanded subcutaneous fat layer, was progressively degraded 
with increasing insulin resistance. Moreover, the reticular layer was all but lost in the 
most extreme obese phenotype, while the “basket-weave” organisation of the surviving 
papillary dermis adopted a predominantly “flattened” organisation in the most 
hyperglycaemic groups.  
 
There are a number of possible mechanisms to explain these pathological sequelae, 
including but not limited to: 1) intrinsic deficiencies in insulin signalling in dermal 
fibroblasts; 2) chronic exposure of insulin-sensitive fibroblasts to supra-physiological 
levels of insulin and glucose; and 3) chronic adipokine insult originating from an 
expanded subcutis. These mechanisms are discussed below.  
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The disappearance of the reticular layer relative to papillary dermis with increasing 
insulin-resistance may be as consequence of proximity to the subcutis, or intrinsic 
differences in papillary and reticular fibroblast physiology (reviewed in (Sorrell and 
Caplan, 2004b). Papillary fibroblasts display a faster rate of cell division compared to 
those in the reticular layer, and each compartment also secretes distinct collagens: 
mainly type III in the papillary layer, compared with type I in the reticular dermis (Rook 
et al., 1986). Parallel studies suggest that elevated glucose concentrations 
(hyperglycaemia) resulting from diabetes are associated with perturbed fibroblast 
physiology, ECM degradation, and impaired re-epithelialisation (Berlanga-Acosta et al., 
2012, Schmidt and Horsley, 2013). Traditionally, the peripheral tissue damage 
associated with diabetic states is assumed to result from the modification of proteins 
exposed to high levels of glucose (Kennedy and Baynes, 1984), but I found that the 
tissue damage in DIO mice at 12 months, and ob/ob mice (increased fat deposition and 
dermal erosion) occurred prior to the onset of frank diabetes. Furthermore, as discussed 
in Chapter 3, I did not observe evidence for increased collagen glycation in 
hyperglycaemic states (manifested as either RAGE immunoreactivity or PAS 
positivity).  
 
Previous studies of Lerman and colleagues, who investigated mechanisms of insulin 
resistance in dermal fibroblasts from young and adult db/db mice showed that a 
reduction in proliferation and collagen deposition was associated with endothelial 
dysfunction arising from hypoxic conditions rather than leptin deficiency (Lerman et al., 
2003a). This is consistent with my findings of compromised physiological function in 
ob/ob dermal fibroblasts, which showed a reduced proliferative capacity when 
compared to the age-matched lean controls. These ob/ob dermal fibroblasts also 
synthesise lower levels of collagen and were highly senescent in comparison to age-
matched wild type controls. However, there was no evidence of hypoxic condition in 
our models, in that no expression of the hypoxia marker HIF-1 was detected in paraffin 
embedded sections, and nor was their evidence of angiogenesis that hypoxia would 
promote.  
 
 Any perturbation in normal dermal fibroblast function will have myriad pathological 
sequelae, as these cells secrete all of the structural components of this compartment, 
including fibrillar type I and III collagens, elastic fibres and the enzymes that control 
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their turnover. These cells are also capable of releasing a range of the pro- and anti-
inflammatory cytokines that make a critical contribution to wound healing and, 
potentially, fibrosis (Falanga, 2005). Underlying the dermis is a layer of highly-
metabolically active adipose tissue, the subcutis, which acts as an energy store for 
excess energy intake (in the form of triglyceride) (Rook et al., 1986). An increase in 
subcutaneous fat in obese subjects is known to be linked to metabolic complications to a 
greater extent than visceral fat (Marinou et al., 2014). Indeed, SAT was associated with 
increased inflammatory cytokine release (notably TNFα and IL1β), which promote 
tissue damage (Trayhurn and Wood, 2004, Trayhurn, 2013b). Thus, exposure to 
cytokines released under hypoxic condition from the subcutis could impair adjacent skin 
function.  In my studies, deeper subcutaneous fat was characterised by the highest levels 
of pro-inflammatory factors (IL-1β, IL-6 and MKC, TNF-α) compared to other depots, 
and these cytokines may initiate inflammatory processes in the skin, and promote the 
secretion of other proinflamatory cytokines that could impair insulin sensitivity in 
dermal fibroblasts. 
 
The cells of the skin are insulin sensitive and any defects in insulin signalling could 
provoke further cutaneous complications, arising from a decrease in the number of 
insulin receptors, or from impairments in down-stream tyrosine kinase signalling 
cascades (Caro et al., 1986, Olefsky, 1976, Rook et al., 1986). Indeed, insulin receptor 
null mice show impaired insulin signalling, and disrupted keratinocyte and fibroblast 
function (LeRoith et al., 2004). LeRoith and colleagues also reported that the 
pathogenesis of dermatological complications in diabetes resulting from 
hyperglycaemia was linked to impaired insulin signalling, and remodelling the ECM. 
This might explain the reduction in the levels of the β1 subunit of the insulin receptor in 
both ob/ob and aged fibroblasts, and may indicate that acquired deficiencies in 
fibroblasts impair their capacity to produce collagen in insulin resistance and ageing.  
Elevated adipokine signalling is emerging as a mediator of insulin-resistance, possibly 
stimulated by hypoxia (Trayhurn, 2013a). Both adipocyte hypertrophy and hyperplasia 
characterise the expanded subcutaneous fat depots in mouse models of obesity and type 
two diabetes mellitus (Osman et al., 2013a). Moreover, insulin resistance and obesity 
are associated with chronic low-grade inflammation as a result of increased levels of 
pro-inflammatory cytokines including IL-1β, IL-6, IL-10, IL-12, TNF-α, MCP-1, 
RANTEs, which are secreted from both adipocytes and immune cells such macrophages 
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and lymphocytes that infiltrate adipose (Plambeck Hansen et al., 2010) 
(Ramachandrappa and Farooqi, 2011, Finucane et al., 2012). My studies of plasma 
cytokine levels suggest a lack of systemic inflammation in comparison to strong pro 
inflammatory profile from deep (SAT) and not in the superficial (sub dermal fat) ( as 
shown in table 5.5). While the SAT is a source of inflammatory cytokines, which are 
commonly associated with immune cells infiltrations. But these were not associated 
with the presence of monocytic infiltrates that the local release of pro-inflammatory 
cytokines such as IL-6 and TNF-α might elicit in the dermis. High local levels of TNF 
is known to promote insulin resistance, however, and this factor may drive impairment 
fibroblast function and dysregulated ECM remodelling. Elevated levels of circulating 
FFAs or cellular stress may also induce inflammatory processes (Trayhurn, 2013a).  It 
was suggested that enhanced production of chemo- attractive cytokines such as MCP-1 
by hyperplastic adipocytes leads to the recruitment of M1 macrophages to adipose 
tissue, in turn producing the majority of pro-inflammatory cytokines and stimulating the 
creation of reactive oxygen species (Wu et al., 2011). Pro-inflammatory macrophages 
form crown-like structures around necrotic or apoptotic adipocytes initiate the removal 
of non-functional cells (Murano et al., 2008). Other studies have shown that the 
stimulation of T helper (Th-1) lymphocytes by IFNγ  in adipose tissue leads to the 
generation of M1 macrophages (Wu et al., 2011). However, I did not see evidence for 
either increased macrophage infiltration or the presence of crown structures (other than 
a slight increase in macrophages in ageing only). Recent studies of human abdominal 
subcutaneous fat has shown that the deeper SAT layer possesses a more pro-
inflammatory, lipolytic, and lipogenic profile compared to more superficial SAT, and is 
strongly associated with obesity related pathology (such as insulin resistance and 
cardiovascular disease) (Marinou et al., 2014). Interestingly, in this study I confirmed 
that the deep SAT in the insulin resistant mouse had a more inflammatory profile than 
both the superficial (subdermal) depot and VAT (epididymal fat).  
  
This provides strong evidence about the influence of local inflammatory factors, rather 
than systemic effects, on skin in insulin resistant states. Dissecting the roles of cytokines 
is complex, for example, IL-10 is known to improve insulin sensitivity and counteract 
the pathological effects of IL-6, IL1-β, MKC and TNF-α (Lumeng et al., 2007, Esposito 
et al., 2003, Ha et al., 2014), but it is tempting to speculate that while the subdermal 
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layer has a protective effect (evidenced by the lack of immune cell infiltration), local 
TNF levels promote insulin resistance in dermal fibroblasts.  
Finally, although a relationship between insulin resistance and skin complications is 
well recognized, the mechanism underlying dermal pathogenesis remains poorly 
understood. This study shows that dermal damage in obese and diabetic states may 
occur as consequence of local factors that influence dermal fibroblast physiology. 
Exposure of healthy dermal fibroblasts to inflammatory cytokines in culture may yield 
useful insights into the contribution of adipose tissue to cutaneous damage. 
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6 Chapter 6: General Discussion and Future 
Work  
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6.1 General discussion  
Mouse models provide powerful tools for the investigation of many human skin 
diseases and associated mechanisms. This is made possible by both physiological and 
anatomical similarities between man and mouse, and the availability of genetic models 
carrying spontaneous or induced mutations  that model human disease (e.g. knockout or 
transgenic mice) (Wikramanayake et al., 2014). Great care, however, must be taken 
when translating data from mice in the elucidation of various human disease 
mechanisms. Another concern is that researchers must carefully validate experimental 
methods to ensure sensitivity and accuracy when investigating pathological phenotypes 
seen in mouse tissues to ensure the detection of subtle changes, and mitigate the 
influence of artefacts (Treuting and Dintzis, 2011). In pathology, for example, artefacts 
arising from incomplete fixation or improper processing protocols cannot be remedied if 
problems are seen at later histology stages, and so considerable thought must be given at 
the outset to experimental design (Srinivasan et al., 2002). My rationale for the rigorous 
evaluation of mouse skin histology was informed by two considerations; firstly, the 
widespread use of mouse as a disease model and secondly, the lack of standard 
histochemical protocols for mouse skin. This tissue provides a challenging environment 
for histopathogical investigation that has yet to be assessed systematically for 
histological artefacts arising from fixation (Al-Habian et al., 2014). Moreover, mouse 
skin is much thinner and more fragile than human skin, and so loss of architecture 
during histology procedures has implications for downstream applications. In particular, 
obtaining good histology from diabetic mouse skin (which is extremely fragile) 
presented a considerable challenge. Moreover, these problems were compounded as I 
decided to use a tissue macroarray approach that could increase throughput and reduce 
technical variation if it could be implemented across a range of mouse models. 
However, optimising histological methods to find effective fixation, processing, and 
IHC protocols for mouse skin was complicated, and many difficulties were faced during 
the sectioning and downstream analysis process, which necessitated constant rounds of 
refinement. My initial studies of skin phenotypes in a range of mouse tissues used skin 
material made available from investigation of other organs systems, and tissues were 
prepared using protocols standard in the laboratory at the time. These yielded adequate 
sections, but it was clear that further optimisation was necessary for prospective 
analyses. It was not feasible, or ethical to repeat the full range of mouse studies 
Therefore, I chose to evaluate the improved histological methods on a representative 
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subset of skin samples. These techniques more effectively preserved diabetic skin 
tissues, achieved better sections, and gave superior histological results for the 
characterisation of various skin compartments. This included the maintenance of good 
subcutaneous adipocyte architecture and the retention of collagen basket weave 
organisation (as seen in cross-polar imaging of picrosirius stained sections in Figure 6.1 
and Figure 6.2). The revised histological methods also improved other special stains by 
providing better discrimination of various skin components such as fine elastic fibres. 
The concept of this study was not to develop histological techniques as an end in itself, 
but rather to detect with sensitivity features associated with diabetic murine skin (Ibuki 
et al., 2012). Achieving consistent histology also facilitated the development of novel 
bioimaging techniques in parallel by colleagues in my laboratory, in particular those to 
count adipocytes (which requires the maintenance of fragile adipocyte cell membranes 
to ensure accurate counting), and the use of mathematical algorithms to quantify 
collagen basket weave in cross-polar captures of picrisirius stained tissue, and so 
measure incremental changes in skin structure with ageing (Osman et al., 2013a) 
(Osman et al., 2013b). Colleagues were also able to develop methods to quantify 
collagen dynamics in Herovici stained images (Osman 2014, Proceedings of the 1st 
International Conference on Bioimaging, pp41-48).  
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Figure 6-1  Mouse collagen basket-weave structure prior to optimisation. 
Skin samples stained with picrosirious were captured using cross-polar microscopy at 20x original 
magnification. Loss of thicker reticular fibres can be seen in ob/ob mice (C) relevant to controls (A), and 
in db/db mice (D) relative to lean controls (B) (n=3)..  
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Figure 6-2 Improved collagen basket weave structure from mouse skin processed with the 
optimised techniques. 
Skin samples stained with picrosirious were captured using cross-polar microscopy at 90x original 
magnification. Greater retention of fibre structure can be seen in ob/ob mice (C) relevant to controls (A). 
Loss of reticular fibres and increasing loss of basket-weave is prominent in db/db mice (D) relative to 
lean controls (B) (n=3).  
 
Skin displays many pathological changes in type 2 diabetes, including various forms of 
dermopathy such as bullosis diabeticorum, necrobiosis liboidiea diabeticorum and 
scleroderma diabeticorum (Jelinek, 1993). However, the greatest clinical problems are 
impaired wound healing and diabetic foot ulcers.  
 
Cutaneous manifestations of type 2 diabetes must be considered in the context of other 
risk factors linked to this disease such as obesity, CVS defects, hypertension and 
peripheral neuropathy (Olcucu et al., 2014). For instance, impaired wound healing 
might be linked to reduction in blood supply as result of vasculature damage, and 
frequent cutaneous infections secondary to immune system disruption. Both of these are 
  
151 
 
exacerbated if protective action is not taken as a consequence of nerve damage. Type 2 
diabetes is chronic and multifactorial disease, involving complex interactions between 
genetic and environmental factors. Impaired skin homeostasis could arise from 
compromised cellular function during the insulin resistant state that predates frank 
diabetes and the associated abnormalities of metabolism such as dysregulation of 
glucose, insulin and lipids. Uncontrolled type 2 diabetes will lead to permanent, 
irreversible functional changes such as glycation of proteins, vasculopathy and 
neuropathy (Baloch et al., 2008). Thus, early diagnosis of diabetes is critical, even if its 
aetiology remains unclear. Many researchers rely on rodent models because of 
accessibility, shorter life-cycle, anatomical similarity, and similarity of genomes and 
gene regulatory pathways with humans in order to unravel the mechanisms of 
dermatological changes in insulin resistance, obesity, and type 2 diabetes 
(Wikramanayake et al., 2014). An improved understanding of these mechanisms may 
help in early diagnosis, before the frank (and damaging) progression of these 
complications, perhaps by an assessment of early cutaneous presentations. It could also 
provide a mechanism to evaluate innovative treatment strategies to remediate diabetic 
tissue damage.  
 
The skin is comprised  of insulin sensitive tissues (Shen et al., 2000), and in this study I 
describe specific patterns of skin damage in animal models of obesity, type 2 DM, and 
ageing (the latter provides a model of very mild insulin resistance). Unlike changes in 
the fat and dermis, epidermal homeostasis was sustained in our skin models, confirmed 
by the lack of quantitative changes of late differentiation markers of cornified cell 
envelope formation (profilaggrin and involucrin). A very slight down regulation of 
basal keratin K14 and the proliferation marker PCNA was only seen in the most obese 
group (ob/ob mouse maintained on high fat diets).  
 
The most striking finding was that the reticular layer of the dermis adjacent to an 
expanded subcutis, was progressively degraded with increasing insulin resistance. The 
reticular layer was all but lost in the most extreme obese phenotype, while the “basket-
weave” organisation of the surviving papillary dermis adopted a predominantly 
“flattened” organisation in the most hyperglycaemic groups. Peripheral tissue damage 
associated with diabetic states is assumed to result from the modification of proteins 
exposed to high levels of glucose (Kennedy and Baynes, 1984), but I found that tissue 
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damage in DIO mice predated hyperglycaemia, and I did not observe evidence for 
increased collagen glycation in hyperglycaemic states. There are a number of possible 
mechanisms that could explain type 2 diabetes complications, including: 1) primary 
endothelial dysfunction caused by hyperglycaemia, hypoxia, non-enzymatic 
glycosylation of proteins (glycation) and cytokine insult to the cutaneous vascular 
system; 2) loss of fibroblast function associated with acquired insulin resistance; 3) 
chronic exposure of fibroblasts to elevated levels of insulin and glucose;  4) chronic 
cytokine exposure; 5) oxidative stress; and 6) hypoxia, all of which will impact the 
dermal compartment and ECM remodelling. Although I did not investigate reactive 
oxygen species in this study, or identify an effective IHC marker of matrix 
metalloproteases, Ibuki et al reported that diabetic skin fragility in obese mice (seen in  
disrupted dermal collagen organisation and impaired tensile strength) correlates with a 
dramatic increase in oxidative stress and MMP expression originating from the 
expanded subcutaneous adipose tissue (Ibuki et al., 2012). 
 
Much commonality exists between insulin-resistant and ageing states. Loss of fibrillar 
collagens in ageing (as result of an increase in matrix metalloprotease [MMP] activity) 
has long been known (Varani et al., 2000), while Varani et al also reported that the 
well-organised collagen structure characteristic of young human subjects (aged 18 to 29 
years) becomes disrupted in skin from older subjects (mean age greater than 80) (Varani 
et al., 2006b). Moreover, other reports have detailed the appearance of parallel collagen 
bundles and disorganised elastin in the papillary dermis (Nawale et al., 2006). Varani et 
al also reported a 75% reduction in collagen synthesis by fibroblasts derived from 
ageing individuals (which is a greater reduction compared to my observations in ob/ob 
mice), consistent with inherent differences in fibroblast physiology contributing to 
impaired skin phenotypes. Fibroblasts are commonly studied in ageing, and Schneider 
showed in 1979 that those isolated from a young cohort (20 to 35 years of age) were 
less senescent and faster growing than those isolated from an older group of individuals 
(aged 65 years or more), also mirroring my observations in ob/ob mice derived dermal 
fibroblasts, which showed an accelerating age phenotype (i.e. senescent, low 
proliferation, reduced collagen synthesis profile and irregular morphology) (Schneider, 
1979). It is tempting to speculate, therefore, that one mechanism underlying the age-
related decay in cutaneous function is that of increasing insulin-resistance, a process 
common to all insulin sensitive tissues including the skin (Shen et al., 2000). Glycation 
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is the non-enzymatic reaction between reducing sugars, such as glucose, and proteins, 
lipids or nucleic acids, and has been implicated in various pathological changes in 
humans including age and diabetes (Nawale et al., 2006, Gkogkolou and Böhm, 2012). 
Indeed, the peripheral tissue damage in diabetic states is generally assumed to result 
from the modification of proteins exposed to high levels of glucose (Kennedy and 
Baynes, 1984). I investigated this phenomenon with PAS staining, which identifies 
oxidised sugar moieties in various tissues including basement membranes and blood 
vessel walls (which are known to have a glycoprotein component). Neither this, nor 
immunostaining for advanced glycation end-products (AGE) highlighted frank 
glycation of collagen. In the absence of collagen glycation, one cannot ignore the 
impact of hyperglycaemia on endothelial cell function, ECM physiology and 
downstream remodelling cascades in diabetic skin (reviewed in (Seitz et al., 2011)). 
Furthermore, it is well known that  hyperinsulinaema and AGEs in diabetic animal 
correlate positively with the production of  ROS via the reduced form of nicotinamide 
adenine dinucleotide (NADH),  which is likely to play an important role in the 
development of type 2 diabetes and the promotion of vascular damage (Kaneto et al., 
2010). In the diabetic models studied herein, local rather than systemic pro-
inflammatory cytokines are more likely to impact ECM physiology as the deeper 
subcuticular fat layer appeared to be the source of inflammatory cytokines, rather than 
plasma. Interestingly, the more superficial dermal fat layer might serve as protective 
barrier from increased levels of cytokines in subcutaneous layer. In contrast, the highest 
levels of TNFα were seen in the deeper subcutaneous layer, and this cytokine could 
promote insulin resistance, possibly amplified by agonistic interaction with AGE/RAGE 
and the generation of ROS (Wu et al., 2011).  
 
Inflammatory cytokines, free fatty acids (FFAs) and high glucose concentrations can 
also attenuate insulin signalling in endothelial cells and stimulate formation of 
superoxide and hydroxyl reactive groups (Kolluru et al., 2012). Disrupted fibroblast and 
endothelial cell function in diabetic mouse skin could also impact epidermal 
homeostasis (Schmidt and Horsley, 2013), and this may explain mild alterations in 
epidermal markers in very obese mice (i.e. ob/ob mice maintained on high fat diets). 
Thus, it would seem that there is relatively little impact on normal keratinocyte 
maturation in diabetic states although the response to a challenge (i.e. wounding) was 
not investigated in this study. Further studies of the properties of diabetic keratinocytes 
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maintained ex vivo could be of interest. Similarly, pericytes, which are essential to a 
number of processes including angiogenesis and inflammation, are sensitive to elevated 
free fatty acid (FFA) levels, hypoxia, adipokine stimulation (particularly TNFα) and 
macrophage infiltration (Klöting and Blüher, 2014). Impaired pericyte function was 
reported to drive to adipocyte apoptosis, endothelia dysfunction and collagen 
degradation  (Seitz et al., 2011, Berlanga-Acosta et al., 2012).  
 
More generally, increased levels of cytokines (released from both adipose and immune 
cells) is emerging as a mediator of insulin-resistance, possibly stimulated by hypoxia 
(Trayhurn et al., 2008). While plasma levels of a range of cytokines remained stable in 
ob/ob mice compared to lean controls, deeper SAT depots expressed an inflammatory 
profile. I consistently observed a local reduction in these cytokines in dermal fat and 
non-fat skin tissues, with the exception of TNFα. TNFα levels are known to rise in 
hypoxic states, but I found an increase in the dermal/epidermal compartment, and not in 
the proximal fat compartment (the sub- or intra-dermal fat), suggesting that this rise was 
not in response to hypoxia. Consistent with this was a lack of monocytic infiltrates in 
diabetic dermis. Thus, it seems unlikely that increased cytokine exposure from an 
expanded subcutis, or from the circulation, promotes the degradation of reticular fibres. 
Previous studies have documented a reduction in insulin receptor levels in the fat and 
muscle of type 2 DM subjects in rodents and humans (Caro et al., 1986, Olefsky, 1976, 
Kerouz et al., 1997), which results in compromised insulin signalling and impaired 
glucose handling (Goodyear et al., 1995, Kerouz et al., 1997, Krook et al., 1998). 
Consistent with this, I found a reduction in the levels of the β1 subunit of the insulin 
receptor in dermal fibroblasts in ob/ob, db/db (as well as in ageing) mice. Thus, another 
possible contributing factor is that insulin-resistant dermal fibroblasts are impaired in 
their ability to secrete and organise collagen. 
 
Neonatal ob/ob fibroblasts do not display reduced growth characteristics (Lerman et al., 
2003b), and I observed impaired fibroblast physiology following the onset of 
hyperglycaemia, thus an insulin-resistant phenotype is acquired following exposure to 
elevated levels of insulin and glucose. Other supporting evidence from  in vitro studies 
of normal and diabetic fibroblast confirms that hyperglycaemia was associated with 
increased ROS production, impaired cell polarization, decreased migration speed, 
adhesion and maturation (Lamers et al., 2011). 
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However, one cannot ignore the possibility that the capacity of skin to repair damage 
sustained in hyperinsulinaemic states is compromised  by elevated cytokines from the 
expanded subcutis,  and further research is needed to profile these cytokines and study 
their impact on dermal fibroblasts isolated from a spectrum of hyperinsulinaemic states 
(from lean through DIO to ob/ob and db/db) to elucidate the influence of hypoxia, 
endothelial dysfunction, hyperglycaemia and adipokine signalling on cellular 
physiology.   
 
Diabetic skin damage represents a “perfect storm” of intrinsic, extrinsic, genetic and 
environmental factors. Figure 6.3 provides an overview of the complex pathways 
underlying cutaneous sequealae of hyperinsulinaemia and hyperglycaemia, adapted 
from the literature using the results presented in this thesis. 
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Figure 6-3 Signaling mechanisms leading to insulin resistance and endothelial dysfunction under 
obesity and type 2 diabetes 
 
 Primary insults include mitochondrial dysfunction, defective PI3 kinase signaling, decreased NO 
production, increased oxidative stress, and differential PKC isoform activation. Key words: pARP: poly 
(ADP-ribose) polymerase; AGE: advance glycation end products; DAG: diacylglycerol; NF-κB: nuclear 
factor kappa-B; PKC: protein kinase C; iNOS: inducible nitric oxide synthase; NADH: nicotinamide 
adenine dinucleotide; NO: nitric oxide; superoxide anion; ONOO−: peroxynitrite; PI3K: 
phosphatidylinositol 3-kinases; AKT: protein kinase B. Adapted from (Kolluru et al., 2012) and  the 
schematic figure on the left panel adapted and modified from (Tisdale, 2011) . 
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6.2 Conclusion  
Although murine models of human disease are widely studied, one must recognise 
physiological and anatomical differences. All layers of mouse skin are much thinner 
than human counterparts and some features, notably elastic fibres, can be difficult to 
discern in mice. However, while mouse skin does not necessarily model the full range 
of cutaneous sequelae observed in human type 2 diabetic subjects, it is likely that 
underlying cellular mechanisms are shared. An improved understanding of the 
contribution of the layers of the skin, particularly the dermis, to ageing and pathological 
processes may provide new insights into the mitigation of damage. In particular, 
improving insulin sensitivity and glucose utilisation in the dermal layers could have 
important consequences for cutaneous health. 
 
6.3 Future work 
6.3.1 Dermal fibroblast physiology in insulin resistant models 
It is known that diabetic fibroblasts maintain a compromised phenotype in vitro (for 
example in reduced collagen synthesis) (Ren et al., 2013, Varani et al., 2002). 
Investigations of insulin responsiveness of normal human dermal fibroblasts in culture, 
and the effects on glucose uptake, proliferation, and ECM synthesis (collagen and 
elastin) in response to increasing concentrations of insulin will enrich our understanding 
of insulin resistance and obesity effects on skin physiology. Another interesting 
experiment would be to look at compartmental glucose uptake in the layers of the skin 
(including the reticular and papillary dermis). This could be performed by feeding mice 
a labelled glucose analogue that was sufficiently stable to be detected in histological 
preparations (for example the fluorescent 2-deoxyglucose analogue 2-NBDG). Any 
differences observed between lean and diabetic mice would provide considerable 
mechanistic insight into glucose utilisation by different skin layers.  
 
6.3.2 The restoration of cutaneous insulin sensitivity and diabetic skin function 
The restoration of glycaemic control reverses many of the peripheral effects of diabetes 
(Lu et al., 2010). It would be worthwhile to investigate whether intervention to improve 
local insulin sensitivity in the skin would act to reduce diabetes associated phenotypes, 
and so improve cutaneous health. For example, thiazolidinediones (TZDs), via their 
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main target peroxisome proliferator-activated receptor gamma (PPAR γ), improve 
peripheral insulin sensitivity and are of potential utility in dermatology. PPARγ is 
expressed in many cutaneous compartments, including keratinocytes (Mao-Qiang et al., 
2004b) and dermal fibroblasts (Ghosh et al., 2004a), and TZDs  have many effects on 
diabetic skin,  including the restoration of abnormal epidermal differentiation markers 
(lorocrin, filaggrin), reducing fibrosis and inflammation, and protecting endothelial cells 
(Han et al., 2009, Tian et al., 2012, Shi-wen et al., 2010). Moreover, they may also act 
to suppress adverse effects of fat by reducing adipocyte hyperplasia through promotion 
of the proliferation of small adipocytes (Ezure and Amano, 2011) (Goossens, 2008). 
Systematic studies of the restoration of dermal integrity by TZDs in diabetic mice have 
yet to be performed, and in a pilot study I investigated db/db skin histology in sections 
prepared from mice treated centrally with the TZD Rosiglitazone (Figure 6.4). It is clear 
that intervention to improve systemic insulin sensitivity in my models promoted a 
restoration of subcutaneous adipose structure, and I am now investigating dermal 
organisation. Rosiglitazone does have some CVS contra-indications, and evaluation of 
local action, by either topical application in vivo or exposure in culture, will allow the 
study of the therapeutic benefits of local restoration of glucose control to be studied. In 
particular, the use of bespoke image analysis algorithms in concert with optimised TMA 
skin preparation will allow incremental improvements to be identified.  
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Figure 6-4 The effect of rosiglitazone on adipocyte size 
Representative images from six animals to show subcutaneous adipocytes section stained with 
H&E from 3 month db/db mice skin. Higher number of small adipocytes in subcutaneous tissue were 
observed from db/db mice treated with rosiglitazone for 35 days at 30mg/KG right panel) and in 
comparison to control (left panel). Images were captured at 20x. 
 
6.3.3 Investigation of fibroblast/ keratinocyte interactions 
While most studies have focused on the fibroblast function in isolation,  cellular cross-
talk  between keratinocytes, fibroblasts and endothelial cells is undoubtedly important 
(Egles et al., 2008, Schmidt and Horsley, 2013).  Living skin equivalent models could 
be used to study the influence of, for example, diabetic fibroblasts on insulin-sensitive 
keratinocyte homeostasis (and vice versa). In fact, one could manipulate a number of 
parameters in this system (for example cytokine exposure), so this would provide a very 
powerful model to dissect underlying pathological mechanisms. 
 
6.3.4 Role of adipokine signalling in skin damage.  
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The influence of the expanded SAT is highly damaging in obesity and type 2 diabetes. 
Adipocytes serve as  a buffer to prevent excess lipid being shunted to other tissues such 
as liver, muscle, heart, and pancreas, and insulin resistance in these organs occurs via 
various mechanisms (notable dysregulated insulin signalling) once this buffering 
capacity is exceeded. Recent studies found that the expansion of deep SAT correlates 
with metabolic disorders and insulin resistance more than the superficial SAT (Komolka 
et al., 2013, Marinou et al., 2014). Thus, it would much of interest to more fully 
understand the consequences of dysregulated insulin signalling in different depots of 
subcutaneous adipose tissue. In the first instance, techniques such as microarrays (or 
next generation sequencing) could identify candidate genes or processes discriminating 
the two SAT depots in insulin resistant states. Any mechanisms isolated could then be 
tested on cultures of human dermal fibroblasts, for example by determining the effects 
of exposing cells to panels of cytokines. Microarrays could also be used to reveal 
fibroblast processes impacted by exposure to exogenous agents such as cytokines.  
 
I believe that the future work results will enhance our understanding of cutaneous 
damage in murine models of obesity, and type two diabetes mellitus, and ageing. 
Likewise, help in detecting an early signs of cutaneous insulin resistance correlated 
phenotypes and more likely offer better approaches to prevent or at least cure the 
dermatological sequelae of type two diabetes mellitus. 
6.3.5 Studies of vasculature and epithelial appendages 
Superficial blood vessels in mouse skin can be difficult to discriminate, even when 
highlighted by a marker such as CD31. Indeed, I found little evidence of significant 
perturbations in diabetic vasculature. A broader panel of endothelial markers may 
provide insight into vascular pathology. I did not systematically investigate hair follicle 
or sebaceous gland structure. Anecdotal evidence suggests that diabetic mice do not 
have a frank hair phenotype, but this is worth of further study. 
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8 Appendices 
 
APPENDIX 1: Routinely used processing protocol 
 
STATION 
 
REAGENT 
 
TIME (mins) 
1 Formalin + 70 % EtOH 30   
2 70% EtOH 30 
3 80% 90 
4 90% 60 
5 100% 60 
6 100% 90 
7 100% 120 
8 Xylene (Histoclear) 30 
9 Xylene (Histoclear) 90 
10 Xylene (Histoclear) 60 
11 Wax 90 
12 Wax 60 
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APPENDIX 2: Short processing protocol 
  
STATION REAGENT TIME (min) 
1 50% EtOH , 10% 
Formalin 
10 
2 70% EtOH(40°C) 10 
3 80% EtOH(40°C) 10 
4 90% EtOH(40°C) 10 
5 100% EtOH(40°C) 10 
6 100% EtOH(40°C) 10 
7 100% EtOH(40°C) 10 
8 Histoclear(40°C) 10 
9 Histoclear(40°C) 10 
10 Histoclear(40°C) 10 
11 Paraffin wax (80°C) 10 
12 Paraffin wax (80°C) 10 
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APPENDIX 3: Long processing protocol 
STATION REAGENT TIME (min) 
1 50% EtOH 60 
2 70% EtOH 30 
3 80% EtOH 30 
4 90% EtOH 60 
5 100% EtOH 60 
6 100% EtOH 60 
7 100% EtOH 60 
8 Histoclear 15 
9 Histoclear 30 
10 Histoclear 60 
11 Paraffin wax (60°C) 15 
12 Paraffin wax (60°C) 90 
 
Tissue samples undergo automated processing during 12 steps involving dehydration 
(50%-100%  ethanol),  clearing  (xylene)  and  paraffin  impregnation  in  preheated 
(60°C)  paraffin  in  the  Leica  TP1020  tissue  processor  (Leica  Microsystems, 
Germany).  The vacuum function was used during processing to accelerate the speed of 
tissue processing (10mM sodium citrate, 0.05% Tween 20, pH6.0). 
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APPENDIX 4 : Softening agent formula  
REAGENT PERCENTAGE IN PBS 
Glycerol  10% 
Methanol 20 % 
Phenol  5% 
Acetone  5% 
Triton-X100  0.5% 
 
 
APPENDIX 5: list of antibodies used in the thesis  
ANTIBODIES COMPANY\CAT# 
PCNA (Anti-proliferating Cell Nuclear 
Antigen) 
Sigma p8825 
Abcam, ab2426 
Santcruz, sc9857 
Involucrin  Covance, prb140c 
Profilaggrin Covance, PRB-417P 
ZYMED S1-2100 
CD31  TCS Cellwork, zha-1225 
R&D AF 3628 
VEGF (Vascular endothelial growth 
factor) 
Abcam ab/1316-100 
HIF1-α Santa Cruz, USA, 1:50 
TIMP-1  Santa Cruz, sc-5538 
R&D,AF980 
CD68 Santa Cruz, sc 9139 
Keratin 14  Covance, PRB-155P 
RAGE IHCWorld, IW-PA1069 
α-Smooth Muscle antibody Sigma, A2547  
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APPENDIX 6: H&E staining protocol 
STAGE REAGENT DURATION NOTES 
1 Xylene 2x 2 min Dewaxing 
2 100% EtOH 2x 1 min 
Rehydration 
 90% EtOH 1 min 
 75% EtOH 1 min 
 Running water 1 min 
3 Hematoxylin 10 min Overstaining 
4 Running water 5 min Rinsing 
5 Acid alcohol 30 s Differentiation 
6 Running water  1 min Rinsing 
7 0.1% sodium 
bicarbonate 
30 s Bluing 
8 Running water 5 min Rinsing 
9 Eosin Y 3 min Counterstaining 
10 Running water 5 min Rinsing 
11 90% EtOH 30 s Dehydration 
 100% EtOH 30 s 
12 Xylene 1 2x1 min Clearing 
13 Mountant  Permanent mounting 
  
185 
 
APPENDIX 7: Sirius Red staining protocol  
STAGE DESCRIPTION DURATION NOTE 
1 Xylene (2x), x/e, EtOH 
100%(2x), EtOH 90% to 70% 
EtOH 
 2 min each stage Rehydration 
tissues  
2 Rinse in distilled H2O Few seconds  
3 0,1% Sirius Red 60 min at RT Staining  
4 Acid water 2 times (fresh a.w)   
5 100% EtOH (2x), e/x to 
xylene (2x) 
30 s each Dehydration  
6 Permanent mount As quick as possible Mounting  
 
Sirius Red (Direct Red 80) in saturated picric acid (0.1%picrosirius:1g Sirius red per 1l 
of saturated picric acid). Acid water: 5ml glacial acetic acid in 1l distilled water. 
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APPENDIX 8: Giemsa and Orcein protocol  
 
Stage 
 
REAGENTS 
 
DURATION 
 
NOTE 
1 Xylene (2x), x/e, EtOH 100% 
(2x), EtOH 90% to 70% EtOH 
2 min each stage Dehydration  
2 0,1% Orcein in acid alcohol  1 h at 25C Staining the elastic 
fibres  
3 Running tap water 5 min  
4 Acid alcohol 30 s Destaining/ 
differentation 
5 Running tap water Few s  
6 Giemsa 1 h at 56C Staining immune 
cells  
7 Running tap water 5 min  
8 95% EtOH/Eosin Y  1 min Staining collagen 
fibres 
9 100% EtOH to xylene 30 s each stage Dehydration  
10 Mountant 2 min each stage mounting  
 
 
Giemsa stock solution: dissolve 7.36g Giemsa in 500ml warm glycerol (~50ºC) for 30 
minutes with occasional mixing. Cool, add 500ml methanol. Filter before use. Store at 
RT. Dilute 1ml stock solution in 45ml H2O. 
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APPENDIX 9: RIPA buffer 
 
50mM Tris-HCI, pH 7.4 25 ml of 1M 
1% NP-40 5ml 
0.5% Na-deoxycholate 2.5 g 
0.1% SDS 0.5 g 
150mM NaCI 15 ml of 5M 
2mM EDTA 2 ml of 0.5M 
50mM                       NaF 1.05 g 
  
Final volume 500 ml. Store at 4
0
C. Add the protease/phosphatase inhibitors 
immediately prior use. 
 
 
